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Abstract
New catalysts for the epoxidation of olefins
This thesis describes the development of inexpensive and practical iron catalysts
for the environmentally benign epoxidation of olefins with hydrogen peroxide as
terminal oxidant. Investigations on ruthenium complexes derived from N,N,N-
tridentate ligands together with the co-ligand pyridine-2,6-dicarboxylic acid
(H2pydic) showed high catalytic activity in the epoxidation of various olefins. In
order to develop an improved, environmentally benign and more economical
procedure, these ruthenium catalysts were replaced by iron catalytic systems. By
systematic variation of ligands, metal sources and reaction conditions, it was
discovered that FeCl3·6H2O in combination with H2pydic and various amines as
bases and co-ligands shows high reactivity and good to excellent selectivity
towards epoxidation of aromatic and aliphatic olefins. Excellent results were
achieved in asymmetric epoxidation by the use of chiral diphenylethylene diamine
derivatives.
Die vorliegende Dissertation beschäftigt sich mit der Entwicklung von kosten-
günstigen und praktischen Eisenkatalysatoren für die umweltfreundliche
Epoxidation von Olefinen mithilfe von Wasserstoffperoxid als Oxidationsmittel. Bei
Untersuchungen zu Rutheniumkomplexen mit N,N,N-tridentaten Liganden und
Pyridin-2,6-dicarbonsäure (H2pydic) als Coliganden wurde hohe katalytische
Aktivität für die Epoxidation von verschiedenartigen Olefinen gefunden. Für die
Entwicklung eines verbesserten, umweltfreundlicheren und ökonomischeren
Verfahrens konnten diese Rutheniumkatalysatoren durch katalytische Eisen-
Systeme ersetzt werden. Durch systematische Änderung der Liganden,
Metallquellen und Reaktionsbedingungen wurde festgestellt, dass FeCl3·6H2O in
Kombination mit H2pydic und verschiedenen Aminen als Basen und Coliganden
hohe Aktivität und exzellente Selektivität gegenüber der Epoxidation von
aromatischen und aliphatischen Olefinen zeigt. Des Weiteren führte der Einsatz
von chiralen Diphenylethylendiamin-Derivaten zu sehr guten Ergebnisse bei der
asymmetrischen Epoxidation.
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11. Introduction
Oxidation of olefins to obtain value-added products is of major importance in the
chemical industry.[1] Among the various oxidation methods, epoxidation of olefins
continues to be an interesting field of research in industry and academia. The
formation of two C-O bonds in one reaction and the facile ring opening reactions
make epoxides versatile building blocks for materials, bulk and fine chemicals as
well as for agrochemicals and pharmaceuticals.[2] Despite all advancements in
catalytic oxidations, epoxides are still often synthesized by stoichiometric reaction
of olefins with peroxoacids generated from hydrogen peroxide and acids or acid
derivatives.[3] A drawback of this convenient method is the limited use for acid
labile olefins or epoxides and the generation of significant amounts of waste
(salts). Obviously, in the context of more sustainable production processes
reduction of waste by-products is highly desired.
Among the different epoxides the industrially most important examples with
respect to scale are ethylene oxide and propylene oxide. For example nowadays,
approximately seven million tons of propylene oxide are produced annually and
the demands grow steadily.[4] Three major routes are being used for this simple
epoxide manufacturing: chlorohydrin process, propylene oxide/styrene monomer
process and propylene oxide/tert-butyl alcohol process (Scheme 1). These
processes produce various by-products and must be incorporated into other
downstream treatment or production plants. These by-products can also be useful,
such as tert-butanol and styrene and the price of the epoxide is often constricted
when the by-product is over produced. With respect to environmental and
economical considerations, the applied oxidant hence determines the value of the
system to a significant extent.[5] It is apparent that molecular oxygen is the ideal
oxidant for this transformation.[6] However, mostly only one oxygen atom of
molecular oxygen is used productively for oxidation (50 % atom efficiency),[7] thus
typically stoichiometric amounts of by-products is generated during the reactions.
In spite of this, development of catalysts for the direct epoxidation of propylene
using molecular oxygen with hydrogen as the co-reductant is still one of the “Holy
Grail” reactions in this field.
2Apart from molecular oxygen, hydrogen peroxide, H2O2, is an environmentally
benign oxidant, which generates theoretically only water as co-product.[8] In this
respect, BASF and Dow launched the construction of the first propylene oxide
production plant using H2O2 as the oxidant recently (Scheme 1).[4] In future
hydrogen peroxide will have more applications in the synthesis of fine chemicals,
pharmaceuticals, agrochemicals and electronic materials owing to its characteristic
physical properties. Hence, the discovery and advancement of new improved
catalysts using H2O2 is an important and challenging goal in oxidation chemistry.[9]
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Scheme 1. Industrial processes for epoxidation of propylene.
31.1. Development of Epoxidation Catalysts Using H2O2
Excellent reviews appeared in recent years about the utilization of hydrogen
peroxide as an epoxidation oxidant in the presence of various catalysts.[9,10] The
combination of environmentally friendly H2O2 with non-toxic and inexpensive metal
catalysts is undoubtedly an ideal system for epoxidation reactions.[11]
Among the various potential oxidation metals, iron-based catalysts are preferable
because iron is the most abundant metal in the earth crust and is essential in
nearly all organisms.[12] Many biological systems such as hemoglobin, myoglobin,
cytochrome oxygenases, and non-heme oxgenases as well as [FeFe]
hydrogenase are iron containing enzymes or co-enzymes.[13,14] Following natures
path, biomimetic or bio-inspired approaches should be feasible to develop new
synthetically useful epoxidation protocols with iron catalysts.[15]
The following chapters describe recent efforts on the development of novel
ruthenium and iron epoxidation catalysts with hydrogen peroxide as oxidant.
41.1.1. Ruthenium catalyzed epoxidation
Ruthenium porphyrins have long been used as models for cytochrome P-450 for
the epoxidation of olefins.[16] Pyridine N-oxides and iodosobenzenes have been
usually used as the terminal oxidant. Comparably few examples showed
epoxidation activity with H2O2 or oxygen in the presence of ruthenium catalysts.
Most notably a sterically encumbered trans-dioxo ruthenium porphyrin complex
showed catalytic activity towards epoxidation of olefins using both oxygen atoms
of molecular oxygen.[17,18] Though this type of high valent ruthenium(VI) porphyrins
are highly interesting epoxidation catalysts, their tedious synthesis hindered their
further application, both in asymmetric and bulk chemical epoxidation.[13,19]
Ruthenium(VIII) tetraoxide (RuO4), which can be generated from RuCl3 or RuO2
with various oxidizing agents, is known to be a powerful oxidant. It has been
applied for cleavage of olefins to aldehydes, ketones and carboxylic acids.[16]
However, it is also possible to perform cis-dihydroxylation of olefins at low
temperature in short time.[20] Under particular conditions, a-ketols can also be
formed preferentially.[21] In literature relatively few examples described ruthenium-
catalyzed epoxidations of olefins using H2O2.[22]
During the re-investigation on the ruthenium-catalyzed asymmetric epoxidation
system of Nishiyama and co-workers using various oxidants,[23] it was discovered
that slow addition of alkyl peroxides or hydrogen peroxide significantly improved
the yield of chiral epoxides (vide infra).[24] Hence, the unproductive decomposition
of H2O2 to O2 is minimized. As model reaction the epoxidation of trans-ß-
methylstyrene was studied (Scheme 2). It was shown that pyridine-2,6-dicarboxylic
acid (H2pydic) is an efficient and essential ligand for this reaction (Table 1). It is
evident that the O,N,O-dianionic tridentate moiety is the origin of the catalyst
activity. Removal of only one carboxylic group or the pyridine nitrogen gave inferior
results. The developed reaction protocol is relatively general (Table 2). Both
aliphatic and aromatic olefins can be oxidized to the corresponding epoxides in
good to excellent yields. In most of the cases, 1 mol% of ruthenium is sufficient for
high product yield. In some cases, as low as 0.01 mol% of ruthenium catalyzes the
reaction efficiently. Hence, a maximum turnover number (TON) of 16,000 was
achieved. The major drawback of this reaction is the necessity of a relatively high
concentration of ligand loading (10 mol%).
5Ph Ph
OH2O2+Me
RuCl3, Ligand
tert-amyl alcohol
Me
Scheme 2. Epoxidation of trans-ß-methylstyrene with H2O2.
Table 1. Ligand effects in the RuCl3·xH2O catalyzed epoxidation of trans-ß-methyl-
styrene with H2O2.a[24]
Entry Ligand Conv. [%] Yield [%] Selec. [%]
1 - 34 0 0
2
NHO2C CO2H
100 >99 >99
3 N
O
Me
O
Me 26 0 0
4
N CO2H
CO2H
30 25 83
5
N CO2H
5 0 0
6
CO2HHO2C
29 0 0
7 NH
CO2HHO2C 56 46 82
[a] General conditions: 0.5 mmol trans-ß-methylstyrene, 1 mol% RuCl3·xH2O in 9 mL tert-amyl
alcohol, 12 h slow addition of 3.0 equiv. 30 % H2O2 in 1 mL tert-amyl alcohol, room
temperature, 10 mol% ligand.
6Table 2. Ru-catalyzed epoxidation of different olefins with H2O2.a[24]
Entry Substrate
RuCl3·xH2O
[mol%]
Conv. [%] Yield [%] Selec. [%]
1 Me Me 5 78 74 95
2 1b 100 90 90
3 0.1 79 66 83c)
4
Me
Me
0.1 100 95 95
5
Me
0.01 100 >99 >99
6 1 100 71 71
7
Me
1 100 70 70
8
Cl
1b 100 >99 >99
9
F
1 100 76 76
10
F3C
1b 49 46 93
11
Me
0.01 100 96 96
12 0.1 100 93 93
13
Me
0.1 100 90 90
14
Me
Me 0.1 100 96 96
15 0.01 100 97 97d
16 OAc 1 100 80 80
[a] General conditions: 0.5 mmol substrate, RuCl3·xH2O, 10 mol% pyridine-2,6-dicarboxylic
acid in 9 mL tert-amyl alcohol, 12 h slow addition of 3 equiv. 30 % H2O2 in 1 mL tert-amyl
alcohol, room temperature.
[b] 20 mol% pyridine-2,6-dicarboxylic acid.
[c] Product: 3-Vinyl-7-oxabicyclo[4.1.0]heptane.
[d] Respective values for Ru-concentration of 0.001 mol%: conversion 16 %, yield 16 %,
selectivity > 99 %.
7With respect to asymmetric epoxidation a variety of chiral ruthenium catalysts
have been developed (Scheme 3).[16] Mono-, bi-, tri- and tetradentate ligands as
well as macrocyclic porphyrins have been demonstrated as selective ligands for
this reaction. Moreover, various coordinating ligands including N, O, S or P donor
centers can all be beneficial to these Ru catalysts. In some cases combination of
ligands were advantageous. The coordinatively saturated ruthenium(II) complex,
Ru(pyridine-2,6-bisoxazoline)(pyridine-2,6-dicarboxylate) 1, which is composed of
two different meridional ligands, was of particular interest.[23] Indeed 1 is a more
practical epoxidation catalyst with PhI(OAc)2 by adding a defined amount of water
into the reaction mixture.[25] Later on, it was shown that alkyl peroxides[26] and
hydrogen peroxide[27] can be used as oxidants. Applying complexes of type 1, it
seemed possible to tune up the reactivity and (enantio)selectivity by modifying the
chiral (pybox) and the achiral (pydic) ligands separately.
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* *
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Scheme 3. Ruthenium catalysts for asymmetric epoxidation of olefins.
8Based on this concept several ruthenium(II) pre-catalysts for epoxidation were
synthesized (Scheme 4). They are all active oxidation catalysts towards various
aromatic olefins and produce the corresponding epoxides in good to excellent
yields (Table 3). With respect to the asymmetric induction, the complexes of
pyridine-2,6-bisoxazoline (pybox) (1) and pyridine-2,6-bisimidazoline (pybim) (12)
gave very similar results. The complex of pyridine-2,6-bisoxazine (pyboxazine)
(11) gave the best stereoselective induction and up to 84 % ee were obtained. It
was suggested that the 6-membered ring structure of the oxazine causes the
chiral carbon center closer to the active metal center. This argument was
supported by comparing the corresponding X-ray crystal structures of 1 and
11.[27a b] With spectroscopic methods, independent synthesis and DFT
calculations, mechanistic studies revealed an unusual pyridine N-oxide
intermediate.[27b, 37] Particularly interesting is the ruthenium complex 13. On one
hand, it is a very general epoxidation catalyst. Both aliphatic and aromatic olefins
can be epoxidized smoothly and all the 6 classes of substituted olefins work
nicely.[27e] A turnover number (TON) of 8800 with high conversion (93 %) was also
observed. On the other hand, 13 is also an excellent oxidation catalyst for
naphthalene[38] and alcohol oxidation.[39] It is noteworthy that 13 reached a TON of
14,800 for alcohol oxidation with 30 % aqueous H2O2 in solvent-free and base-free
conditions. The usefulness of this type of ruthenium catalysts is summarized in
Scheme 5.
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O
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Scheme 4. Selected ruthenium(II) catalysts for epoxidation of aromatic olefins
using 30 % H2O2.
9Table 3. Epoxidation of aromatic olefins with ruthenium complexes 1 and 11-13
with 30 % H2O2.
R1
O
R3R1
R3 30% H2O2+
5 mol% catalyst
tert-amyl alcohol, r.t.
12 h addition H2O2
R2 R2
*
R4 R4
*
Catalyst
Entry Substrate 1 11 12 13
1 Ph
75 % yield
42 % ee
85 % yield
59 % ee
76 % yield
42 % ee
71 % yield
-
2 Ph Me
82 % yield
58 % ee
95 % yield
72 % ee
100 %
65 % ee
>99 % yield
-
3 Ph Ph
100 % yield
67 % ee
100 % yield
54 % ee
97 % yield
71 % ee
-
-
4 Ph
Me
Me 91 % yield
72 % ee
91 % yield
84 % ee
82 % yield
68 % ee
>99 % yield
-
10
Ph
Ph PhI(OAc)2
Ph
Ph
O*
*
[a]
R N
H
O
OH
N
O
O
R
H2O2
R1 R2
OH
R1 R2
O
PhI(OAc)2
R N
O
OH
Y
Z
X
R N
H
O
OH
X
Me Y
Z
H2O2
OMe
O
O
Me
H2O2
CHO CO2H
+
tBuOOH
S
Me
O
tBuOOH R1
R2
R3
R1
R2
R3
O*
*
H2O2
O2
RCHO
R1
R2
R3
R4
R1
R2
R3
O*
*
R4
R1
R2
R3
R1
R2
R3
PhI(OAc)2
H2O
(1 equiv)
R1
R2
R3
O*
*
R1
R2
R3
O*
*
tBuOOH
R
R
N
N N
Ru
N
O O
Me
S
Me
Me
[b]
[c]
[d]
[e]
[f]
[g]
[h]
Me
R
Me
R
O
O
[i]
[j] [k]
[l]
R1 R2
OH
H2O2
R1 R2
O [m]
Scheme 5. Use of Ruthenium catalysts ([a] see ref. [23]. [b] see ref. [25]. [c] see
ref. [26]. [d] see ref. [27]. [e] see ref. [40]. [f] see ref. [41]. [g] see ref. [42]. [h] see
ref. [43]. [i] see ref. [38]. [j] see ref. [44]. [k] see ref. [45]. [l] see ref. [46]. [m] see
ref. [39]).
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1.1.2. Biomimetic iron catalyzed epoxidation
Iron is the most abundant element by mass on the earth.[47] Due to its low cost,
benignancy to the environment and biological relevance, there is an increasing
interest to use iron complexes as catalysts for a wide range of reactions.[48] In this
respect, iron catalysts for C-C [48a,49] and C-N [50] bond formation reactions,
hydrogenations[51] as well as oxidations draw much attention.[9 10,15] However, the
use of H2O2 in combination with simple iron complexes as oxidation catalysts is
still limited.[52,53] It is partly because H2O2 decomposes vigorously in the presence
of iron, which reduces the efficiency of the oxidant.[54] The generation of a highly
reactive free hydroxyl radical by Fenton or Gif Chemistry induces the
decomposition of the ligand and substrate as well as the product.[52d e] Hence, high
substrate to hydrogen peroxide ratio is usually employed to solve these problems.
In fact, only few examples of iron catalysts utilizing H2O2 as the oxidant are known
(Scheme 6).
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H H
H H
(CF3SO3)2
14[55]
N
N N
N
FeC6F5
C6F5
C6F5
C6F5
Cl
15[56]
N
N
Me
Me N
N
Fe
N
N
Me
MeN
N
Fe
O O
Me
O
(SbF6)2
16[57]
N
N
Me
Me N
N
Fe
NCCH3
NCCH3
(ClO4)2
17[58]
N
N
N
Fe
NCCH3
NCCH3
(CF3SO3)2
N
18[59]
N
N
Fe
H2O
O
(ClO4)4N
N
N
N
Fe
N
N OH2
19[60]
Scheme 6. Iron catalysts for epoxidation of olefins using H2O2.
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Olefins can be oxidized in the presence of anhydrous FeCl3 to a mixture of dimers,
epoxides, aldehydes and others using 100 % H2O2 in anhydrous CH3CN as the
oxidant.[53] The exceptional oxidizing power of anhydrous H2O2 and the low
selectivity of the reaction limit further applications of this system. Heme-models
such as 14 and 15 have been reported to catalyze the epoxidation of olefins to the
corresponding epoxides in good yield. The major drawback for these heme-model
systems is the low tunability of the catalysts for different olefins. A number of non-
heme models were reported recently. Of particular interest are complexes 16 and
17, which were synthesized by Jacobsen’s group and Que’s group with the same
parent ligand, respectively.[57,58] The self-assembling MMO-mimic 16 catalyzed the
epoxidation of a range of aliphatic olefins. Even the relatively non-reactive
substrate, 1-decene, can be oxidized to the corresponding epoxide in 85 % yield in
5 min. The presence of acetic acid not only affects the structure of the
intermediate, but also the selectivity of the products (Table 4). A higher epoxide to
cis-diol ratio was observed in the presence of HOAc. This effect is more significant
when 18 was employed as the catalyst. In-situ generation of peracetic acid was
thus suggested.[59b] Though these catalysts showed interesting selectivity towards
epoxides and diols for aliphatic olefins, it decomposed aromatic olefins to
unidentified products. This reduces the general application of this type of catalysts
for synthetic purpose. Stacks catalyst derived from phenanthroline is synthetically
more practical.[60] In spite of the fact that peracetic acid is used, a wide range of
olefins can be oxidized to the corresponding epoxides with only 0.25 mol% of
catalyst.
13
Table 4. Epoxidation of cyclooctene with 16 and 17 with 50 % H2O2.
50% H2O2+
Fe catalyst
CH3CN, temp.
O HO OH
+
Entry Catalyst :H2O2
Temp.
[°C]
O
a
HO OH
a
Additive Ref.
1
16
3 mol%
1:1.5 4 85 % 0 %
30 mol%
HOAc
[57]
2
17
10 mol%
100:1 30 75 % 9 % nil [58b]
3
17b
7 mol%
100:2.8 r.t. 91 % 5 % nil [59b]
4
17b
7 mol%
100:2.8 r.t. 102 %c 3 %
34 mol%
HOAc
[59b]
5
18
7 mol%
100:2.8 r.t. 30 % 41 %
29 mol%
HOAc
[59b]
6
18
7 mol%
100:2.8 r.t. 88 %c 14 %
29 mol%
HOAc
[59b]
7
19
0.25 mol%
1:2
CH3CO3H
0 100 % 0 % nil [60]
[a] Yield based on the limiting reagent.
[b] Trifluoromethansulfonate was the anion of the iron complex instead of perchlorate.
[c] A total yield over 100 % has been reported due to experimental error.
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Despite these known works, Fe catalysts are still under development for a general
epoxidation using aqueous H2O2 under neutral conditions. Instead of synthesizing
molecularly well-defined iron complexes as epoxidation catalysts, this problem
was tackled in another way. Based on the in-situ generation method from the
ruthenium system,[25] the technology was transferred to simple iron systems using
a combinatorial ligand strategy (Scheme 7).[61] It was found that FeCl3·6H2O can
substitute the ruthenium source in the model reaction with 2,6-bis(4-phenyl-4,5-
dihydrooxazol-2-yl)pyridine (Ph2-pybox) and H2pydic as ligands (Table 5).
However, the synthesized iron(II) complex with the N,N,N-tridentate Ph2-pybox is
less active than the in-situ generated catalyst. Noteworthy evidence including
mass spectrometric analysis and electronic absorption spectra suggests the pybox
ligand was decomposed during the reaction and generated the active catalyst
species. Combination of the fragments gave comparable result as the pybox
ligand alone as well. With this information and the screening method in hand, the
effect of base was demonstrated to be crucial in this system (Table 6).
NO
N N
O
PhPh
Ru
N
O
O
O
O
NO
N N
O
Ph Ph
N
O
OH
O
OH
Fe
N NN
N OO
NN
NO
N O
+
ligand variation
+
+
"Fe
source"
Scheme 7. Iron catalyst modification strategy.
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Table 5. Epoxidation of trans-stilbene with in-situ generated Fe catalysts.
Ph
Ph
Ph
Ph
O5 mol% "Fe source", L1, L2, 1 h, 65 °C
3 equiv. H2O2, tert-amyl alcohol, r.t., 12 h addition
Entry Fe source L1 L2
Conv.a,b
[%]
Yieldb
[%]
Selec.c
[%]
1 FeCl3·6H2O Ph2-pyboxd H2pydic 55 48 87
2 Fe(Ph2-pybox)Cl2 - - 22 15 67
3 FeCl3·6H2O - - 13 7 52
4 FeCl3·6H2O Ph2-pybox - 100 82 82
5 FeCl3·6H2O - H2pydic 69 53 77
6 FeCl3·6H2O
H O N H 2
P h
H2pydic 100 84 84
7 FeCl3·6H2O
H O N H 2
P h
- 9 6 69
[a] Reaction conditions: In a 25 mL Schlenk tube, iron trichloride hexahydrate (0.025 mmol),
Ph2-pybox (0.025 mmol) and H2pydic (0.025 mmol) were solved in tert-amyl alcohol (4 mL)
and heated for 1 h at 65 °C. Afterwards trans-stilbene (0.5 mmol), tert-amyl alcohol (5 mL)
and dodecane (GC internal standard, 100 µL) were added in sequence at r.t. in air. To this
mixture, a solution of 30 % hydrogen peroxide (170 µL, 1.5 mmol) in tert-amyl alcohol
(830 µL) was added over a period of 12 h at r.t. by a syringe pump.
[b] Conversion and yield were determined by GC analysis.
[c] Selectivity refers to the ratio of yield to conversion in percentage.
[d] 2,6-bis(4-phenyl-4,5-dihydrooxazol-2-yl)pyridine = Ph2-pybox.
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Table 6. Epoxidation of trans-stilbene with different bases.
Ph
Ph
Ph
Ph
O5 mol% FeCl3
.6H2O, 5 mol% H2pydic, 10 mol% base
3 equiv. H2O2, tert-amyl alcohol, r.t., 1 h addition
Entry Base Conv.a,b [%] Yield b [%] Selec.c [%]
1 KOH 33d 30 91
2 Et3N 86 74 86
3 N H 2 100 97 97
4
N
H
N 91 90 99
5
N
H
N
M e
100e 97 97
6
N
N
M e
78e 72 92
7
N
H
NM e 12e 11 92
8
N
56 50 89
9
H
N 100 97 97
[a] Reaction conditions: In a 25 mL Schlenk tube, FeCl3·6H2O (0.025 mmol), H2pydic
(0.025 mmol), tert-amyl alcohol (9 mL), base (0.05 mmol), trans-stilbene (0.5 mmol) and
dodecane (GC internal standard, 100 µL) were added in sequence at r.t. in air. To this
mixture, a solution of 30 % hydrogen peroxide (170 µL, 1.5 mmol) in tert-amyl alcohol
(830 µL) was added over a period of 1 h at r.t. by a syringe pump.
[b] Conversion and yield were determined by GC analysis.
[c] Selectivity refers to the ratio of yield to conversion in percentage.
[d] H2O2-addition over a period of 12 h.
[e] Addition of 2 equiv. of H2O2.
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It is apparent that all organic bases form active species with FeCl3·6H2O and
H2pydic. Notably, excellent activity was found with pyrrolidine, benzyl amine and 4-
methylimidazole. For some aromatic olefins, the reaction is finished in 5 minutes
and slow dosage of H2O2 is not necessary. However, the structure of the base has
dramatic effect to the system. Hence, it is evident that the organic base
deprotonates the H2pydic and acts as the ligand as well. As imidazole derivates
also play an essential role as ligands or bases in enzymes,[62] this combinatorial-
activity approach provides a general platform for searching functional mimics for
iron enzymes. Understanding the fundamental aspects of these systems should
allow developing synthetically more useful biomimetic iron catalyzed epoxidation
systems. Hence, by fine tuning the imidazole ligand, a bio-inspired
FeCl3/imidazole-system was also developed for epoxidations of olefins using
aqueous hydrogen peroxide as the oxidant. A wide range of imidazoles displayed
good selectivity for epoxidation of trans-stilbene. With 15 mol% of 5-chloro-1-
methylimidazole and 5 mol% FeCl3·6H2O, 87 % yield of trans-stilbene oxide with
94 % selectivity is achieved.[63]
This system showed a more general activity and higher selectivity towards various
olefins than that of the FeCl3·6H2O/H2pydic/pyrrolidine system (Table 7). However,
the H2pydic system has a higher activity for some substrates. Both reaction
systems demonstrated that it is possible to perform epoxidations with hydrogen
peroxide in the presence of easily manageable and simple Fe/Ligand catalysts.
Reports of the efforts to examine the reaction mechanism and to realize an
asymmetric version of these reactions are currently underway.
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Table 7. Scope and limitations of FeCl3·6H2O/H2pydic/pyrrolidine and
FeCl3·6H2O/5-chloro-1-methylimidazole systems.
Ar1
R2 5 mol% "Fe catalyst"
3 equiv. H2O2, tert-amyl alcohol, r.t., 1 h additionR3
Ar1
R2
R3
O
FeCl3·6H2O/H2pydic/pyrrolidine[61]
FeCl3·6H2O/5-chloro-1-
methylimidazole[63]
Entry Substrate
Conv.a,b
[%]
Yield b
[%]
Selec.c
[%]
Conv.a,b
[%]
Yield b
[%]
Selec.c
[%]
1 100 97 97 92 87 94
2
Me
40d 21 53 46 41 88
3 25d 11 44 39 25 64
4 22d 8 36 34 24e 71
5 85d 21 25 52 36 68
6 94d 93 99 74 70 95
[a] Reaction conditions: In a 25 mL Schlenk tube, FeCl3·6H2O (0.025 mmol), H2pydic
(0.025 mmol), tert-amyl alcohol (9 mL), base (0.05 mmol), trans-stilbene (0.5 mmol) and
dodecane (GC internal standard, 100 µL) were added in sequence at r.t. in air. To this
mixture, a solution of 30 % hydrogen peroxide (170 µL, 1.5 mmol) in tert-amyl alcohol
(830 µL) was added over a period of 1 h at r.t. by a syringe pump.
[b] Conversion and yield were determined by GC analysis.
[c] Selectivity refers to the ratio of yield to conversion in percentage.
[d] Addition of 2 equiv. of H2O2.
[e] Additionally 3 % trans-stilbene oxide and trans-stilbene were observed.
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Until very recently relatively few examples on asymmetric epoxidations using iron-
based catalysts were reported in the literature (Scheme 8). This can be partly
attributed to the rapid decomposition of H2O2 with iron catalysts. The other reason
possibly comes from inferior activity of iron porphyrins compared to their
manganese counterparts in the early studies of heme-models. Thus, researchers
concentrated on the development of manganese catalysts in the 90s.[64] As a
result, only handful of asymmetric epoxidation systems using iron porphyrin heme-
mimics are known and merely iodosobenzene was successfully applied as
oxidant.[65] Electron deficient polyfluorinated porphyrins catalyze epoxidation of
olefins with H2O2.[56] However, the synthesis of chiral porphyrins with electron
withdrawing groups has still not yet been realized because of their notorious
reputation for labour-intensive and expensive syntheses.[13,19] Aerobic epoxidation
of styrene derivatives with an aldehyde as co-reductant catalyzed by tris(,-
dicampholylmethanato) iron(III) complex 21 was also reported.[66] In spite of the
encouraging results, more environmentally benign oxidant and solvent are still to
be developed. Notably, in the dihydroxylation of of trans-2-heptene with H2O2
using biomimetic non-heme Fe-catalysts, [Fe(BPMCN)(CF3SO3)2] 22, 58 % of the
epoxide with 12 % ee was obtained.[58b] By elaborating 5760 metal-ligand
combinations, Francis and Jacobsen identified three Fe-complexes with peptide-
like ligands, which gave the epoxide in 15 – 20 % ee in the asymmetric
epoxidation of trans-ß-methylstyrene utilizing 30 % H2O2. The homogeneous
catalyst 23 derived from this study gave 48 % ee with 100 % conversion of trans-
ß-methylstyrene. It is clear in this example that a combinatorial ligand approach
can lead to promising new bio-inspired iron epoxidation catalysts.
The first breakthrough in non-porphyrin iron-catalyzed asymmetric epoxidation of
aromatic alkenes using hydrogen peroxide has been reported by us very
recently.[68] Here, good to excellent isolated yields of aromatic epoxides were
obtained with ee-values up to 97 % for stilbene derivatives.
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Scheme 8. Iron catalysts for asymmetric epoxidation of olefins.
In these investigations, trans-stilbene was used as the model substrate
(Table 8).[68] In earlier studies of non-asymmetric iron catalyzed epoxidations
decomposition of the Ph2-pybox ligand was observed. [61] Comparable activity was
obtained with H2pydic and phenylglycinol as ligand and base. However, only less
than 5 % ee was observed with the enantiomerically pure aminoalcohol. Further
investigation of other optically pure amines showed high yield of the epoxide,
albeit with low enantioselectivity. As ligands with a p-tolylsulfonamide substituent
gave significantly higher ee-values and good activity, formation of hydrogen bonds
as the key chiral information transferring step is suggestive. Optimization by ligand
modification showed that N-((1R,2R)-2-(benzylamino)-1,2-diphenylethyl)-4-methyl-
benzenesulfonamide (Table 8, entry 7) is the best ligand in terms of enantio-
selectivity (42 % ee).
It has been demonstrated that trans-1,2-disubstituted aromatic olefins gave
excellent activity with moderate to excellent ee’s (Table 9). It is mentionable that
the activity of substituted trans-stilbenes is in the order: para > meta > ortho,
presumably due to steric reasons. The higher steric bulkiness of the 4,4’-dialkyl
substituted trans-stilbenes, the higher is the enantiomeric excess (tBu > Me > H).
The highest ee-value was achieved with 2-(4-tert-butylstyryl)naphthalene as the
substrate in the presence of 10 mol% of the iron catalyst (Table 9, entry 9). 91 %
ee and 46 % isolated yield were obtained with the corresponding epoxide. By
slightly lowering the reaction temperature to 10 °C, 97 % ee was reached with
complete substrate conversion within one hour (Table 9, entry 10).
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Table 8. Iron catalyzed asymmetric epoxidation of trans-stilbene.
Ph
Ph
5 mol% FeCl3.6H2O, 5 mol% H2pydic
12 mol% Ligand
H2O2, tert-amyl alcohol, r.t. Ph
Ph
O*
*
Entry Ligand
Conv.a
[%]
Yielda
[%]
Selec.c
[%]
eeb
[%]
Ref.
1
H O N H 2
P h
100 84 84 <5 [61]
2 N
H O H
95 73 77 0 [68]
3d N
H N H 2
60 58 97 1 [68]
4d N
H O H
P h
P h 78 53 68 10 [68]
5e N
H F
P h
P h 100 98 98 17 [68]
6f
P h
T s H N N H 2
P h
100 86 86 28 [68]
7f
Ph
TsHN NHBn
Ph
100 87 87 42 [68]
[a] Reaction conditions: In a 25 mL Schlenk tube, iron trichloride hexahydrate (0.025 mmol),
chiral ligand (0.060 mmol) and H2pydic (0.025 mmol) and trans-stilbene (0.5 mmol) were
dissolved in hot tert-amyl alcohol (9 mL). Dodecane (GC internal standard, 100 µL) were
added in sequence at r.t. in air. To this mixture, a solution of 30 % hydrogen peroxide
(170 µL, 1.5 mmol) in tert-amyl alcohol (830 µL) was added over a period of 1 h at r.t. by a
syringe pump.
[b] Conversion and yield were determined by GC analysis.
[c] Selectivity refers to the ratio of yield to conversion in percentage.
[d] 36 h.
[e] 0 °C, 14 h.
[f] 1.0 mmol H2O2.
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Table 9. Iron-catalyzed asymmetric epoxidation of various aromatic olefins.[68]
Ar1
R2
5 m o l% F eC l3
.6H 2O , 5 m o l% H 2p yd ic
12 m o l% L ig and
H 2O 2, te rt am yl a lcoho l, r.t. Ar
1 R2
O*
*
Ligand =
TsHN NHBn
Ph Ph
Entry Substrate Conv.a [%] Yieldb [%] eec [%], abs. conf.
1 Ph Me 100d 94d 28, (+)-(2R,3R)e
2 Ph Ph 100 87 42, (+)-(2R,3R)
3 Ph OSiPh3 100 67 35, (+)-(2R,3R)f
4
Me
Me
100 92 64, (+)-(2R,3R)g
5
tBu
tBu
100 82 81, (+)-(2R,3R)g
6 Me Me >95 88 27, (+)-(2R,3R)h
7 tBu tBu >95 66 10, (–)-(2S,3S)h
8
Me
Me
60i 57i 55, (–)-(2S,3S)h
9i
tBu
100 46 91, (+)-(2R,3R)h
10j,k
tBu
100 40 97, (+)-(2R,3R)h
[a] Estimated by GC-MS and/or TLC which respectively showed absence of substrate peak
and traces.
[b] Isolated yield of pure product.
[c] Determined by HPLC on chiral columns.
[d] Determined by GC.
[e] Assigned by comparing the retention times of the enantiomers on a chiral HPLC with that of
an authentic sample of the (S,S)-enantiomer.
[f] Assigned by desilylation to the corresponding epoxy alcohol by analogy with literature
protocol and comparing the sign of optical rotation of the resulting product with that of an
authentic sample.[69]
[g] Determined by comparing the sign of the optical rotation of the major enantiomer on a
chiral detector coupled with a chiral HPLC with known data, the CD spectra of these
products are positive, opposite to those reported for the (S,S)-enantiomers.[70]
[h] Tentatively assigned by comparing the CD-spectrum with those of substituted trans-
stilbene oxides.
[i] Determined after 24 h by 1H NMR of crude product using an internal standard.
[j] 4 equiv. H2O2, 10 mol% H2-pydic, 10 mol% FeCl3.6H2O, 24 mol% ligand.
[k] Reaction at 10°C.
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1.2. Conclusion
In summary, it has been demonstrated that high activity, chemoselectivity and
even excellent enantioselectivity can be achieved in Fe-catalyzed epoxidations
with hydrogen peroxide. This long standing goal in oxidation catalysis is realized
by combining FeCl3 with appropriately chosen ligands. Chiral diamines and
pyridine-2,6-dicarboxylic acid as the ligand combination provide an excellent
platform for further improvement of this up-rising bio-inspired oxidation chemistry.
It is apparent that an advancement of the generality of these catalytic systems still
awaits. Further work to extend the substrate scope and towards a mechanistic
understanding of these new catalysts are underway.
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2. Objectives of this work
The epoxidation of olefins is an important synthetic method in organic chemistry as
well as for the chemical industry. Recently, hydrogen peroxide has become one of
the terminal oxidants of choice because it produces only water as by-product.
Moreover, H2O2 is advantageous regarding costs, safety and storage. Hence
developments on new catalytic systems using H2O2 are an important and
challenging goal in oxidation chemistry. Based on successful projects in
ruthenium-catalyzed oxidation reactions the Ru(pybox)(pydic) complex was
chosen as starting point for different catalyst modifications. By variation of the
ligands and metal sources the reactivity, (enantio)selectivity and generality should
be possible to tune up.
During these studies a new chiral ligand library of N,N,N-tridentate pyridinebis-
imidazolines, so-called pybims, was realized and applied in asymmetric ruthenium-
catalyzed epoxidation (Publication 4.1., Org. Lett. 2005 and Publication 4.2.,
Tetrahedron: Asymmetry 2005). The tunability of these ligands is much higher
compared to the related pybox ligands. Scope and limitations were investigated for
a variety of olefins. Furthermore these pybim ligands could be successfully applied
in the asymmetric ruthenium catalyzed transfer hydrogenation of aliphatic and
aromatic ketones (Publication 4.3., Adv. Synth. Catal. 2007) Enantioselectivities
up to > 99 % ee are achieved under optimized conditions.
To investigate the mechanistic aspects of the asymmetric ruthenium-catalyzed
epoxidation reaction synthetic, spectral and catalytic activity studies of novel
ruthenium(II) bipyridine and terpyridine complexes were established
(Publication 4.3., J. Organometallic Chem. 2006). Possible intermediates in the
reaction pathway were suggested. Moreover, a simplified protocol for the
epoxidation of olefins utilizing urea hydrogen peroxide complex was developed
during these studies.
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In order to develop a simple, environmentally benign and more economical
procedure, the possibility of replacing Ru by Fe as the metal in the epoxidation of
olefins with hydrogen peroxide was explored. The development of an efficient iron
catalyst system starting from the previous work on Ruthenium catalyzed
epoxidation should be very insightful.
By systematic variation of the reaction parameters, a new bio-inspired, convenient
and fast epoxidation protocol using economical and environmentally friendly
FeCl3.6H2O in combination with H2O2 was developed (Publication 3.5., Chem.
Commun. 2006 and 3.6., Asian J. Chem. 2007). Pyridine-2,6-dicarboxylic acid
(H2pydic) and pyrrolidine turned out to be the most effective ligands in this system.
Mass spectrometric and UV-VIS spectroscopic measurements were used for an
effective development and understanding of the catalyst system. The system
showed excellent reactivity and selectivity towards terminal and 1,2-disubstituted
aromatic olefins and moderate reactivity towards 1,3-dienes and aliphatic olefins.
All the reagents used in the system are simple and commercially available and the
reaction can be performed at room temperature and in air under mild conditions.
Unfortunately, aliphatic olefins and highly substituted aromatic olefins were less
reactive and selective applying the previous system. Hence, an improved Fe-
catalyzed epoxidation, which can be applied to all classes of olefins, was
developed (Publication 3.7, Eur. J. Org. Chem. 2008). This simple and practical
catalyst system consists of FeCl3.6H2O, H2pydic and a benzylamine derivative. It
was demonstrated that benzylamine is a preferred structural element for the co-
ligand in this general epoxidation method. The system showed good to excellent
reactivity to mono-, di-, and trisubstituted aromatic olefins as well as internal di-,
tri-substituted and functionalized aliphatic olefins. Noteworthy, inactive aliphatic
olefins can be oxidized in up to 96 % yield.
By studying the effect of the organic base in more detail, it was found that a
combination of FeCl3.6H2O with simple imidazole derivatives without any H2pydic
could perform epoxidations. Difficult tri-substituted olefins and styrenes could be
oxidized in good yields and selectivity (Publication 3.8., Tetrahedron Lett. 2007).
Only a few examples on asymmetric epoxidations using iron-based catalysts were
known in literature, hence the development of an asymmetric version still remains
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a challenging task. This goal was realized by combining FeCl3.6H2O and H2pydic
with diamine ligands (Publication 3.9., Angew. Chem. 2007). For the first time it
was demonstrated that high enantioselectivity can be achieved in Fe-catalyzed
epoxidation with hydrogen peroxide. Several trans-stilbene derivatives could be
oxidized in excellent yields and up to 97 % ee.
-Hydroxy--ketoester is an important scaffold found in numerous bioactive
molecules. The hydroxylation of 1,3-dicarbonyl compounds is a straightforward
approach to access these compounds. Based on the experience in iron-catalyzed
epoxidation an easy and practical method for the hydroxylation of -ketocarbonyl
compounds with hydrogen peroxide was developed. Applying cheap iron chloride
as catalyst system the -oxidation of -ketoesters proceeds smoothly in 75 - 90 %
yield (Publication 3.10., submitted to Tetrahedron Lett. 2008).
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Publication 3.1.
Synthesis of a New Chiral N,N,N-Tridentate
Pyridinebisimidazoline Ligand Library and Its Application in
Ru-Catalyzed Asymmetric Epoxidation
Santosh Bhor, Gopinathan Anilkumar, Man Kin Tse, Markus Klawonn, Christian
Döbler, Bianca Bitterlich, Anne Grotevendt, Matthias Beller
Org. Lett. 2005, 7 (16), 3393-3396
Contributions:
In this paper, I contributed to a significant amount of the argumentation and I
supported the synthetic work. I synthesized Pyridine-2,6-dicarboximidic acid
dimethyl ester (2) and 2,6-Bis-([4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-
pyridine (4) which serve as key-intermediates for the development of the ligand
library. My contribution as co-author of this paper is approximately 15 %.
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Ligand Library and Its Application in
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Santosh Bhor, Gopinathan Anilkumar, Man Kin Tse, Markus Klawonn,
Christian Do1bler, Bianca Bitterlich, Anne Grotevendt, and Matthias Beller*
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Received April 15, 2005
ABSTRACT
A small ligand library of chiral tridentate N,N,N-pyridinebisimidazolines have been synthesized for the first time. This new class of ligands can
be easily tuned and synthesized on multi g-scale. The usefulness of the ligands is shown in the ruthenium-catalyzed asymmetric epoxidation
with hydrogen peroxide as oxidant. Excellent yields (>99%) and good enantioselectivities (up to 71% ee) have been obtained for the epoxidation
of aromatic olefins.
Transition metal-catalyzed asymmetric reactions offer an
efficient and elegant possibility for the synthesis of enan-
tiomerically pure compounds.1 In general, the choice and
synthesis of a suitable chiral controller ligand is the crucial
step in the development of a new catalyst for stereoselective
reactions. Clearly, a multitude of chiral mono-, bi- and
multidentate ligands with P, N, O, and other coordinating
atoms are known today and used extensively for all kinds
of catalytic reactions. Prominent examples of so-called
privileged ligand classes include the salens,2 bisoxazolines,3
phosphinooxazolines,4 tartrate derivatives,5 and cinchona
alkaloids.6 Nevertheless, there is still an increasing need for
new and improved ligands. State-of-the-art chiral ligands7
(1) (a) Noyori, R., Ed. Asymmetric Catalysis in Organic Synthesis;
Wiley: New York, 1994. (b) Beller, M.; Bolm, C., Eds. Transition Metals
for Organic Synthesis, 2nd ed.; Wiley VCH: Weinheim, 2004. (c) Jacobsen,
E. N.; Pfaltz, A.; Yamamoto, H., Eds. ComprehensiVe Asymmetric Catalysis,
Springer: Berlin, 1999.
(2) (a) Jacobsen, E. N. In Catalytic Asymmetric Synthesis; Ojima, I., Ed.;
Wiley VCH: New York, 1993; Chapter 4.2. (b) Katsuki, T. In Catalytic
Asymmetric Synthesis, 2nd ed.; Ojima, I., Ed.; Wiley VCH: New York,
2000; pp 287-325. (c) Katsuki, T. AdV. Synth. Catal. 2002, 344, 131-
147.
(3) (a) Ghosh, A. K.; Mathivanan, P.; Cappiello, J. Tetrahedron:
Asymmetry 1998, 8, 1-45. (b) Jorgensen, K. A.; Johannsen, M.; Yao, S.;
Audrain, H.; Thornauge, J. Acc. Chem. Res. 1999, 32, 605-613.
(4) For a review, see: Helmchen, G.; Pfaltz, A. Acc. Chem. Res. 2000,
33, 336-345.
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Katsuki, T.; Martin, V. S.; Org. React. 1996, 48, 1-299. (c) Seebach, D.;
Beck, A. K.; Heckel, A. Angew. Chem., Int. Ed. 2001, 1, 92-139.
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should offer the user a series of advantages: obviously, it
should give highly selective and active as well as productive
catalysts. In addition, the ligand should be conveniently
prepared from mg- to kg-scale, and the synthesis should be
economically feasible. Unfortunately, each catalytic reaction
needs its own optimized ligand. To find the optimal catalyst
for a certain substrate the preparation of ligand libraries with
the same basic ligand skeleton should be possible without
problems. However, the systematic modification of the
structure of new ligands is often difficult and time-consum-
ing.
Herein, we report a new class of chiral ligands, which is
simply synthesized and can be easily varied by remote
functionalizations to allow for the preparation of ligand
libraries in a fast and practical manner.
The starting point of this work was our studies on
ruthenium-catalyzed epoxidation of olefins with C2-sym-
metric pyridinebisoxazolines (pybox) as the chiral ligand.8
While synthesizing new pybox ligands, we realized that the
preparation of such a ligand library is limited and time-
consuming due to the difficulty of functionalizations of the
ligand backbone and stepwise formation of the oxazoline
moiety.9
We thought that introducing a second nitrogen atom in
place of oxygen of pyridinebisoxazoline ligands would
provide a more flexible ligand scaffold, which might be
easily varied by N-alkylation, N-arylation, and N-acylation
to tune the reactivity as well as stereoselectivity in catalytic
asymmetric reactions (Figure 1).
Despite the importance of pybox ligands for numerous
stereoselective reactions,10 to the best of our knowledge
similar chiral pyridinebisimidazoline ligands, here abbrevi-
ated as pybim, have not been synthesized and applied in
asymmetric catalysis.
The synthesis of the pybim scaffold is easily done from
commercially available 2,6-dicyanopyridine 1 in two steps.
Treatment of 1 with a catalytic amount of sodium in
anhydrous methanol followed by neutralization with acetic
acid and removal of methanol under reduced pressure,
afforded the bisimidate 2 as a pale yellow solid in quantitative
yield.11
Condensation of 2 with chiral diamines such as R,R-1,2-
diaminocyclohexane and R,R-1,2-diphenylethylene-diamine
furnished the corresponding pyridine bisimidazoline ligands
3 and 4 in good to excellent yield. The pybims 3 and 4 are
stable to air and moisture and offer numerous possibilities
for further modification at the amine functionality. Note-
worthy, the synthesis of 4 has been performed without
problems on 10 g-scale.12
To demonstrate the usefulness of the concept a small
library of 14 pybims was prepared from 3 and 4 (Table 1).
Treatment with benzyl bromide in the presence of sodium
hydride gave the corresponding ligands 5a and 6a in 68%
and 65% yields respectively (Table 1, entry 1 and 3).
The reaction of tosyl chloride (Table 1, entry 2 and 4),
carbonyl chlorides (Table 1, entry 5-10, and 13) and
chloroformates (Table 1, entry 11, 12, and 14) with 3 or 4
gave the corresponding pybim ligands 5b, 6b-l in moderate
to very good yield (60 to 97%) by using DMAP in
dichloromethane at 0 °C to room temperature.
For the preparation of 6k, (S)-methoxy-R-methyl-2-
naphthalene acetyl chloride was prepared by refluxing the
corresponding acid in CHCl3 with excess of thionyl chloride
(Table 1, entry 13).
With the newly developed ligands in hand, we looked for
a suitable test reaction to demonstrate that substitution of
imidazoline NH group has a significant influence on
catalysis. In principle, pybim-type ligands should be useful
for any reaction, which use pybox ligands, e.g., aziridinations,
epoxidations, carbene reactions, addition of nucleophiles to
carbonyl groups, etc.10 Among the various catalytic reactions
known for pybox ligands asymmetric epoxidations with
hydrogen peroxide are among the most challenging meth-
ods.13 Therefore, we decided to study the behavior of the
(7) For a discussion on the “ideal catalyst”, see: Gladysz, J. A. Pure
Appl. Chem. 2001, 73, 1319-1324.
(8) (a) Tse, M. K.; Bhor, S.; Klawonn, M.; Do¨bler, C.; Beller, M.
Tetrahedron Lett. 2003, 44, 7479-7483. (b) Bhor, S.; Tse, M. K. Klawonn,
M.; Do¨bler, C.; Ma¨gerlein, W.; Beller, M. AdV. Synth. Catal. 2004, 346,
263-267. (c) Klawonn, M.; Tse, M. K.; Bhor, S.; Do¨bler, C.; Beller, M. J.
Mol. Catal. A 2004, 218, 13-19. (d) Tse, M. K.; Do¨bler, C.; Bhor, S.;
Klawonn, M.; Ma¨gerlein, W.; Hugl, H.; Beller, M. Angew. Chem., Int. Ed.
2004, 43, 5255-5260.
(9) (a) Desimoni, G.; Faita, G.; Quadrrelli, P. Chem. ReV. 2003, 103,
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Org. Chem. 1998, 63, 2961-2967. (e) Johnson, J. S.; Evans, D. A. Acc.
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Figure 1. From pybox to pybim ligands.
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new ligands in the ruthenium-catalyzed asymmetric epoxi-
dation8,14 of stilbene with hydrogen peroxide. For this
purpose, the pyridinebisimidazoline ligands 5a-b and 6a-l
were transformed into the novel class of Ru(pybim)(pydic)
complexes 7a-b and 8a-l, using disodium pyridine-2,6-
dicarboxylate and [Ru(p-cymene)Cl2]2 (Scheme 1).15 The
catalytic reactions were run at room temperature in the
presence of 5 mol% of Ru-complex using 3 equiv. of H2O2
(30% in water), which was slowly dosed into the reaction
mixture.
As shown in Table 2, all the Ru(pybim)(pydic) complexes
catalyzed the epoxidation of trans-stilbene. It is important
to note that the enantioselectivity and reactivity of the catalyst
is largely dependent on the respective substituent on the
nitrogen of the imidazoline ring (remote functionality) of
Ru(pybim)(pydic) complex. This is a clear proof of our
concept and by steric and electronic tuning at this position
an optimization of the catalyst is possible. Similar effects
(14) For a review using Ru complexes for epoxidation reactions see:
(a) Barf, G. A.; Sheldon, R. A. J. Mol. Catal. 1995, 102, 23-39. Recent
achievements in Ru based epoxidations with different oxidants, see: (b)
End, N.; Pfaltz, A. Chem. Commun. 1999, 589-590. (c) Gross, Z.; Ini, S.
Org. Lett. 1999, 1, 2077-2080. (d) Pezet, F.; Aı¨t Haddou, H.; Daran, J.
C.; Sadaki, I.; Balavoine, G. G. A. Chem. Commun. 2002, 510-511. Recent
examples using Ru salen complexes, see: (e) Takeda, T.; Irie, R.; Shinoda,
Y.; Katsuki, T. Synlett. 1999, 1157-1159. (f) Nakata, K.; Takeda, T.;
Mihara, J.; Hamada, T.; Irie, R.; Katsuki, T. Chem. Eur. J. 2001, 7, 3776-
3782. (g) Berkessel, A.; Kaiser, P.; Lex, J. Chem. Eur. J. 2003, 9, 4746-
4756.
(15) Nishiyama, H.; Shimada, T.; Itoh, H.; Sugiyama, H.; Motoyama,
Y. Chem. Commun. 1997, 1863-1864.
Table 1. Synthesis of a Pybim Library
Reagents and conditions: aCH2Cl2, reflux, 2 d; b 2.5 equiv. NaH, THF, 0 °C to room temperature, 4 h; c 3.0 equiv. DMAP, CH2Cl2, 0 °C to room
temperature, 5 h.
Scheme 1. Synthesis of Ru(pybim)(pydic) Complexes
Note: For R1 substituent see Table 1.
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might be expected for other catalytic reactions which proceed
in the presence of pybox ligands, too.
More specifically the Ru(R,R-cyclohexyl-N,N′-Bn2-py-
bim)(pydic) complex 7a gave a racemic mixture of trans-
stilbene oxide (79%) with low reactivity (Table 2, entry 1),
while Ru-complexes which were synthesized from tetra-
phenyl pybim ligands with N-benzoyl protection 8a-g led
to good to excellent yields (78 f 99%) and significant
enantioselectivities (33-56% ee) (Table 2, entries 5-9). Best
results for the epoxidation of trans-stilbene were obtained
applying the carbamate-functionalized complexes 8j and 8l.
Here, the enantioselectivity was increased up to 71% ee for
trans-stilbene oxide (97 f 99% yield) (Table 2, entry 12
and 14). Interestingly, also 8k, functionalized with the
sterically bulky and flexible chiral (S)-2-(6-methoxynaph-
thyl)propionic acid gave 69% ee for trans-stilbene oxide
(Table 2, entry 13).
Next, some preliminary substrate variation was done and
catalyst 8l was applied to different olefins (Table 3). To our
delight, mono-, di-, and trisubstituted aromatic olefins gave
good to excellent yields (76 f 99%) and moderate to good
enantioselectivity (42-68%) (Table 3). Specifically, the
result for styrene (Table 3, entry 1) is promising for further
development of this type of catalyst since it is one of the
most difficult substrates for epoxidation using hydrogen
peroxide and often found in the literatures with low yields
and enantioselectivity.16 To the best of our knowledge, the
maximum enantioselectivity is only 59% for styrene oxide
using hydrogen peroxide as the oxidant.8d
In summary, we have disclosed a novel class of chiral
tridentate, pyridinebisimidazoline ligands (pybims). The key
building blocks 3 and 4 are conveniently synthesized in two
steps from commercially available starting materials. Similar
compounds should be available by using other chiral 1,2-
diamines.
Ru-complexes derived from most of the new ligands are
effective catalysts for asymmetric epoxidation of alkenes with
hydrogen peroxide. Advantageously, compared to the well-
known pybox ligands systematic modification of the catalyst
system is possible due to the presence of the imidazoline
NH-groups. As proof of concept it is shown that these remote
functionalizations have an important impact on the outcome
of catalytic epoxidation reactions.
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Table 2. Ru(pybim)(pydic) Catalyzed Asymmetric Epoxidation
of trans Stilbene Using H2O2 as Oxidanta
entry catalyst time (h) conv. (%) yield (%)b ee (%)c
1 7a 16 85 79 1
2 7b 12 100 93 8
3 8a 16 90 79 11
4 8b 4 77 63 21
5 8c 12 100 90 34
6 8d 12 100 >99 38
7 8e 12 100 78 33
8 8f 12 100 >99 52
9 8 g 12 100 91 56
10 8h 12 100 97 28
11 8i 12 100 >99 60
12 8j 12 100 >99 71
13 8k 12 100 94 69
14 8l 12 100 97 71
a Reaction conditions: In a 25 mL Schlenk tube Ru complex (0.025
mmol) and trans stilbene (0.5 mmol) were dissolved in tert amyl alcohol
(9 mL). Dodecane (GC internal standard, 100 μL) was added. To this
mixture a solution of hydrogen peroxide (170 μL, 1.5 mmol) in tert amyl
alcohol (830 μL) was added over a period of 12 h by a syringe pump.
b Determined by comparing with authentic samples on GC FID. c Deter
mined by HPLC and the major enantiomer of trans stilbene oxide had
1R,2R configuration.
Table 3. Catalyst Scopea
a Reaction conditions: In a 25 mL Schlenk tube Ru catalyst 8l (0.025
mmol) and substrate (0.5 mmol) were dissolved in tert amyl alcohol (9
mL). Dodecane (GC internal standard, 100 μL) was added. To this mixture
a solution of hydrogen peroxide (170 μL, 1.5 mmol) in tert amyl alcohol
(830 μL) was added over a period of 12 h by a syringe pump. b Determined
by comparing with authentic samples on GC FID. c Determined by HPLC.
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Abstract A new class of easily tunable N,N,N pyridinebisimidazoline (pybim) ligands have been synthesized. The synthesis and
tunability of these chiral tridentate ligands are much easier and flexible compared to the popular pyboxes, making the former a suit
able ligand tool box for various asymmetric transformations. Ruthenium complexes of the new ligands were synthesized and applied
in the asymmetric epoxidation of olefins using hydrogen peroxide as the oxidant. Excellent yields and moderate to good enantio
selectivities were achieved in the epoxidation of aromatic olefins.
 2005 Elsevier Ltd. All rights reserved.
1. Introduction
Asymmetric synthesis continues to be an important area
of research in organic chemistry due to the special prop-
erties of enantiomerically pure compounds, which are
the focus of modern pharmaceutical industry.1 Among
the different methods available, transition metal-catal-
yzed asymmetric reactions offer an efficient and elegant
way for the synthesis of pure enantiomers.2 Generally,
the design and synthesis of a chiral controller ligand is
the most critical step in the development of a new cata-
lyst for asymmetric reactions. A wide variety of chiral
mono-, bi- and multidentate ligands with P, N, O and
other coordinating atoms are now available and used
extensively for all kinds of catalytic reactions. Promi-
nent examples of the so-called privileged ligand classes
include salens,3 bisoxazolines,4 phosphinooxazolines,5
tartrate derivatives6 and cinchona alkaloids.7 However,
there is still an increasing demand for new and improved
ligands. State-of-the-art chiral ligands8 should offer the
user a series of advantages: obviously it should give a
highly selective, active and productive catalyst. More-
over, the ligand should be prepared conveniently and
economically from a mg- to kg-scale. Unfortunately,
each catalytic reaction needs its own optimized ligand.
To find a suitable optimal catalyst for a specific reaction,
a library of ligands having a basic core skeleton amena-
ble for easy functionalization should be conceivable
without much difficulty. However, the systematic modi-
fication of a structure of new ligands is often difficult
and time consuming.
In this context, we designed a new chiral ligand scaffold,
which could be efficiently synthesized and easily func-
tionalized.9 Herein, we report the synthesis of a library
of a new class of chiral ligands by easy functionalization
of a basic skeleton, along with the application of these
ligands in the Ru-catalyzed asymmetric epoxidation of
olefins. The effect of acids as additives in these reactions
is also demonstrated.
The starting point of this work was our studies on ruthe-
nium-catalyzed epoxidation of olefins with C2-symmet-
ric pyridinebisoxazolines (pybox) as the chiral ligand.10
During the study of the pybox ligands, we came to real-
ize that the synthesis of a library of pybox ligands is lim-
ited and time consuming, due to the difficulty of
functionalization of the ligand backbone and step-wise
formation of the oxazoline moiety.11
To circumvent this problem, we thought of replacing the
oxygen atoms in pybox by nitrogens, which gives the
0957 4166/$ see front matter  2005 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetasy.2005.08.060
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advantage of functionalization at nitrogen in an easy
manner; thus allowing the synthesis of a library of
ligands from a basic skeleton by N-alkylation, N-aryl-
ation, N-acylation, etc. to vary the reactivity as well as
the selectivity in catalytic asymmetric reactions
(Fig. 1). Although pyboxes are extensively used in ste-
reoselective reactions,12 to the best of our knowledge,
analogous chiral pyridinebisimidazoline ligands, here
abbreviated as pybim, have not been synthesized and
applied in asymmetric catalysis prior to our work.9
2. Results and discussion
Bisimidate 2 was easily prepared by stirring the commer-
cially available 2,6-pyridinedinitrile 1 with a catalytic
amount of sodium in anhydrous methanol at room tem-
perature, followed by neutralization with acetic acid and
subsequent removal of the solvent (Scheme 1).13 Reac-
tion of bisimidate 2 with diamines should give the cyclic
diimine derivatives. Thus, treatment of 2 with (R,R)-1,2-
diphenylethylenediamine or (R,R)-1,2-diaminocyclohex-
ane smoothly afforded the corresponding pyridine
bisimidazoline derivatives (pybims) 3 and 4 in 84% and
95% yield, respectively, by refluxing in dichloromethane.
Interestingly, the related pyridinebisdiazepine 5 could be
also synthesized by reaction of 2 with (4S,5R)-4,5-
di-(aminomethyl)-2,2-dimethyl dioxolane. To the best
of our knowledge, this is the first example of a chiral
pyridinebisdiazepine. However, the preparation of the
corresponding bisbinaphthyl derivative failed, presum-
ably due to the greater strain in forming this benzoanel-
lated seven-membered ring (see Scheme 1).
Next, pybims 3 and 4 were taken for further studies due
to their stability in air and moisture, efficient formation
and scope for easy derivatization. Notably, the synthesis
of 3, has been performed on 10 g scale without any
problems and purification is possible by crystalliza-
tion.9,14 The presence of two secondary amino groups
on the pybims, which are amenable for easy functional-
ization, allows for the formation of a library of com-
pounds easily from a single basic skeleton, which is
not possible in the popular pybox ligands. Thus, 29
ligands were prepared by coupling pybims 3 and 4 with
a variety of reagents, such as acid chlorides, chlorofor-
mates and sulfonyl chlorides, etc.
Initially, we prepared a series of amide derivatives of 3
by reaction with acid chlorides in the presence of a base
in dichloromethane at room temperature (Table 1).
After screening bases, such as NaH, KOtBu, triethyl-
amine, pyridine, 4-dimethylaminopyridine (DMAP),
etc., we found that DMAP was the most suitable for this
reaction.
Hence, reaction of tetraphenyl pybim 3 with benzoyl
chloride in the presence of DMAP in dichloromethane
at room temperature furnished, after column chroma-
tography, dibenzoyl pybim 6a as a white solid in 96%
yield. The 1H NMR spectrum of 6a showed doublets
at d 5.15 and 5.19 with a coupling constant of 3.40 Hz
corresponding to the two pairs of mutually coupled vic-
inal protons on the imidazoline rings. The aromatic pro-
tons of the phenyl groups were observed at d 7.02 7.43
as multiplets and those of the pyridine rings were ob-
served at d 7.73 as doublet of a doublet and at d 7.83
as doublet.
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Figure 1. Design of pybim from pybox ligands.
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Scheme 1. Reagents and conditions: (a) Na (10 mol %), MeOH, rt; (b) (1R,2R) diphenylethylenediamine, CH2Cl2, 50 C; (c) (1R,2R)
diaminocyclohexane, CH2Cl2, 50 C; (d) (4S,5S) 4,5 diaminomethyl 2,2 dimethyldioxolane, CH2Cl2, 50 C; (e) (R) 2,2 diamino 1,1 binaphthyl,
CH2Cl2, 50 C.
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The 13C NMR spectra showed two peaks at d 60.4 and
71.9, corresponding to the two pairs of symmetrical ben-
zylic carbons on the imidazoline rings. The aromatic
carbons and the imino carbon on the imidazoline were
distributed from d 125.5 139.4, while the amide carbon
was observed at d 169.3. The IR spectrum showed the
characteristics of an amide carbonyl stretching vibration
with an absorption at 1670 cm 1. EI-MS showed a
molecular mass peak at 728 (M+), which was further
supported by HRMS.
Using the above reaction conditions, ligands 6b s were
prepared with a variety of substitution pattern, such as
mono-, di- and tri-substituted aryls, 1- and 2-naphthyls,
adamantyl and various alkyl groups (see Table 1). In the
case of the trimethylbenzoyl derivative 6f, reacting the
trimethylbenzoyl chloride with 3 in refluxing chlorobenz-
ene in the presence of NaH was necessary to furnish the
product in good yield (Table 1, entry 6). For the (S)-
methoxy-a-methyl-2-naphthalene acetyl derivative 6l,
the chloride required for the reaction was prepared
in situ from the corresponding acid with excess of thio-
nyl chloride in refluxing chloroform (Table 1, entry 12).
Next, we tried acylation with aliphatic carboxylic acid
derivatives. Menthyl- and adamantyl-derived pybims
6m and 6n were formed in excellent yields. Less bulky
aliphatic carboxylic acids formed the corresponding N-
acyl pybims also in excellent yields (Table 1, entries
15 18). Protecting the NH groups of 3 with trimethyl-
acetyl chloride met with defeat obviously due to steric
reasons. However, tert-butylacetyl chloride reacted
smoothly, affording 6s in 83% yield (Table 1, entry 19).
We then reacted 3 with chloroformates. Thus, by follow-
ing the above procedure, a series of carbamates 7a f was
prepared in excellent yields (Table 2). The reaction was
found to be fast compared to that of acid chlorides. In
addition, 7f was prepared by reaction of 3 with di-tert-
butyldicarbonate in the presence of DMAP at room
temperature (Table 2, entry 6). To vary the substituent
pattern of the pybim scaffold further, we reacted benzyl
bromide and tosyl chloride with 3, which afforded 7g
and 7h in 65% and 85% yield, respectively (Table 2,
entries 7 and 8).
Similar to 3, reaction of dicyclohexyl pybim 4 with ben-
zyl bromide and p-tosyl chloride gave products 8a and
Table 1. Synthesis of N acyl protected pybims from acid chlorides
N
H
N
N N
H
N
Ph
Ph
Ph
Ph3
NN
N N
N
Ph
Ph
Ph
Ph6a-s
R1-COCl, Base
R1 O O R1
Entry R1 Ligand Yield (%)
a
1 6a 96
2 6b 99
3
MeO
6c 87
4
F3C
6d 97
5
OMe
OMe
6e 47
6 6f 45b
7 6g 32
8 6h 87
9
Ph
Ph
6i 100
10 6j 94
11 6k 76
12
MeO
6l 62
13
O
6m 92
14 6n 96
15 H3C 6o 86
Table 1 (continued)
Entry R1 Ligand Yield (%)
a
16 6p 93
17 6q 92
18 6r 93
19 6s 83
Reagents and conditions:
aDMAP (3 equiv), CH2Cl2, rt, 1 5 h.
bNaH (3 equiv), PhCl, reflux, 45 h.
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8b in good yield (Table 2, entries 9 and 10). However,
reactions of 4 with benzoyl chloride, p-methoxy benzoyl
chloride and ()-menthyl chloroformate were unsuc-
cessful due to the instability of the products during col-
umn chromatography. The reason for this is not clear.
Attempts were also made to prepare urea derivatives of
the pybim by reaction of 3 with phenylisocyanate in the
presence of various bases and also using dibutyltindila-
urate,15 which resulted only in the trimerization of
phenylisocyanate.
All new compounds shown were fully characterized
(NMR, IR, MS and HRMS or EA) and gave satisfac-
tory analytical data.
During the synthesis of trimethylbenzoyl pybim 6f, we
isolated a considerable amount of the mono-protected
pybim 9 (Scheme 2). This prompted us to synthesize a
few more mono-protected pybims 10 12 by reaction of
3 with 1 equiv of a suitable acid chloride or chlorofor-
mate compound. The idea behind this was to also syn-
thesize asymmetrically substituted pybims by reacting
the free NH of the mono-protected pybim with a sec-
ond different protecting group.
We presumed that an unsymmetrical complex prepared
from such a ligand would direct the substrate (e.g., ole-
fin in epoxidation) to occupy a specific orientation in the
transition state and thereby induce selectivity during
catalysis. With this in mind, compounds 13 and 14 were
synthesized from the mono-protected pybims 9 and 11
with (+)-menthyl chloroformate and acetyl chloride,
respectively. Unfortunately, an attempted one-pot
sequential protection of the two amino groups of 3 by
different protecting groups was unsuccessful since it pro-
duced an inseparable mixture of products.
With a library of pybims in hand, we searched for a suit-
able reaction to test the usefulness of these ligands in
catalysis. Clearly, it was an objective to demonstrate
that the substitution of an imidazoline NH group had
a significant impact on catalysis. Due to the structural
analogy of the pybim ligands to the pyboxes, it was rea-
sonable to believe that any reaction that is catalyzed by
metal pybox complexes should also be suitable for pyb-
ims as well. Hence, pybims should act as suitable ligands
for aziridination, epoxidation, carbene reactions, addi-
tion of nucleophiles to carbonyl groups, etc.12 Amongst
the many catalytic reactions known for pyboxes, we
selected asymmetric epoxidation using hydrogen pero-
xide for our studies since we were recently involved in
investigating this type of reaction.10d,16
Consequently, we decided to investigate the behaviour
of the new ligands in the Ru-catalyzed asymmetric
epoxidation9,17 of styrene and trans-stilbene with
H2O2. For this purpose, ligand 6a was reacted with
[Ru(p-cymene)Cl2]2 and disodium pyridine-2,6-dicarb-
oxylate (pydic) in MeOH H2O mixture at 65 C to
afford, after purification by column chromatography,
the dark brown solid 15a in good yield (Table 3, entry
1).18 The 1H NMR of 15a showed two doublets at d
4.42 and 5.15 for two protons each corresponding to
the mutually coupled protons of the imidazoline rings.
The aromatic protons of the four phenyl groups and
those from the pyridine dicarboxylate ring were distrib-
uted from d 6.56 7.65. The three mutually coupled
protons of the pyridine ring of the pybim moiety reso-
nated at d 7.73 as a triplet and at d 8.22 as a doublet
(J 8.10 Hz).
Table 2. Synthesis of N protected pybims from chloroformates and
other halides
N
H
N
N N
H
N
R
R
R
R3
NN
N N
N
R
R
R
R
7, R = Ph
R1R1
R1-X
Base
8, R = -(CH2)4-
Entry R1 X Ligand Yield (%)
a
1
O Cl
O
7a 98
2 O Cl
O
7b 84
3
O
O
Cl
7c 94
4
O
O
Cl
7d 90
5
O
O
Cl
7e 94
6
O O
7f 91b
7
Br
7g 65c
8 S Cl
O O
7h 85
9
Br
8a 68c
10 S Cl
O O
8b 93
Reagents and conditions:
aDMAP (3 equiv), CH2Cl2, rt, 1 h.
b (Boc)2O (3 equiv), DMAP, (3 equiv), CH2Cl2, rt, 12 h.
cNaH (2.5 equiv), THF, rt, 4 h.
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In the 13C NMR, the two symmetrical benzylic carbon
atoms on the imidazoline rings were seen at d 74.1 and
77.5 while the two carbonyls were observed at d 170.2
and 170.4. Mass spectrum and elemental analysis were
in agreement with the structure assigned.
In a similar manner, Ru (pybim)(pydic) complexes 15b s,
16a h and 17a,b were prepared in good to excellent
yields (Table 3). All compounds were fully characterized
and gave satisfactory spectral and analytical data. Due
to the presence of a large hydrocarbon skeleton, the
di-tert-butylbenzoyl ligand 6g and the Fmoc-derived
ligand 7c were sparingly soluble in MeOH and therefore
modification of the general reaction condition was
needed to prepare the corresponding ruthenium
complexes 15g and 16c. Thus, in the case of 6g, the
complexation was performed in a mixture of 12:5:1
tert-amyl-OH/MeOH/H2O, which afforded complex
15g in acceptable yields (Table 3, entry 7). Formation
of 16c was achieved in 59% yield by using a mixture of
4:4:1 n-BuOH/MeOH/H2O as the solvent system.
Unsymmetrical ligands 12 14 were also transformed
into their respective ruthenium complexes 18 20 by
following the general complexation procedure in good
yields without any difficulty (Scheme 3).
We mentioned earlier that the synthesis of pybim ligands
4 is sometimes difficult due to their unstable nature during
purification by silica gel and alumina column chromato-
graphy.We circumvented this problem by reacting 4with
the appropriate acid chlorides or chloroformates and sub-
jecting the crude product directly to complexation with a
ruthenium source andNa2pydic. In this way, wewere able
to prepare ruthenium complexes 21 23 (Scheme 4).
With a number of Ru(pybim)(pydic) complexes in hand,
we tested the asymmetric epoxidation of styrene and
trans-stilbene using H2O2 as the oxidant. For the catal-
ysis experiments, we chose the reaction conditions,
which we developed earlier for the epoxidation of olefins
using pybox ligands (rt, 3 equiv of H2O2 (30% in water)
were slowly dosed into the reaction mixture by a syringe
pump).10d
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Scheme 2. Unsymmetrical pybim ligands.
Table 3. Synthesis of Ru(pybim)(pydic) complexes
NN
N N
N
R
R
R
R
6a-s: R = Ph, For R1 seeTable 1
R1R1
7a-h: R = Ph, For R1 seeTable 2
8a, b: R = -(CH2)4-, For R1 seeTable 2
NN
N N
N
R
R
R
R
R1R1
N O
O
O
O
Ru
15a-s
16a-h
17a, b
a
Reagents and conditions: (a) [Ru(p-cymene)Cl2]2, Na2pydic, MeOH, 
H2O, 65 
oC, 1 h.
Entry Ligand Complex Yield (%)
1 6a 15a 56
2 6b 15b 93
3 6c 15c 75
4 6d 15d 71
5 6e 15e 42
6 6f 15f 59
7 6g 15g 43
8 6h 15h 30
9 6i 15i 49
10 6j 15j 40
11 6k 15k 64
12 6l 15l 78
13 6m 15m 46
14 6n 15n 66
15 6o 15o 68
16 6p 15p 75
17 6q 15q 98
18 6r 15r 77
19 6s 15s 77
20 7a 16a 52
21 7b 16b 33
22 7c 16c 60
23 7d 16d 52
24 7e 16e 58
25 7f 16f 77
26 7g 16g 45
27 7h 16h 50
28 8a 17a 55
29 8b 17b 55
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To find the optimum catalyst concentration, the epoxi-
dation of styrene was performed using 16d with varying
catalyst loading. It was observed that full conversion
and best yield were obtained in the presence of
5 mol % of catalyst (Fig. 2). This catalyst loading was
used throughout our studies.
Next, all the complexes prepared were screened for the
asymmetric epoxidation of styrene and trans-stilbene
and the results are shown in Table 4. Almost all com-
plexes studied gave full conversion. However, it is
important to note that the chemo- and enantioselectivity
of the catalyst are dependent on the respective substitu-
ent on the nitrogen of the imidazoline ring (remote func-
tionality) of the Ru(pybim)(pydic) complex. Although a
rationalization on the electronic and/or steric influence
of the substituent at the nitrogen of the imidazoline ring
is difficult on the basis of the catalysis results depicted in
Table 4, certain groups such as the 2-naphthyl, menthyl,
etc. can be identified as potential substituents for the
control of enantioselectivity.
In the case of styrene epoxidation, the yield of the prod-
uct varied from 65% to 75% for benzoyl-protected pyb-
ims 15a l, while that for aliphatic N-acyl-protected
pybims 15n s showed a small increment (80 85%)
(Table 4, entries 1 12 and 14 19). The carbamate
complexes 16a f showed similar reactivities towards
styrene (70 80%) and trans-stilbene (87 100%); but the
enantioselectivities varied. To our delight, the dimeth-
oxybenzoyl pybim complex 15e and the menthyl
carbamate complex 16d showed the highest enantiose-
lectivities (45% and 43%) for styrene (Table 4, entries
5 and 23), which is one of the most difficult substrates
for epoxidation using H2O2 and often found in the liter-
ature with low yields and enantioselectivities.19
Due to the better reactivity of trans-stilbene, most of the
complexes gave excellent yields with this substrate.
Moreover, the enantioselectivities observed were also
good. Notable are the performances of 15e, 15i and
15j in the category of benzoyl-derived pybims and 16b,
16d and 16e in the category of carbamate-functionalized
pybims (Table 4, entries 5, 9, 10, 21, 23 and 24). In gen-
eral, the carbamate-derived complexes gave better
enantioselectivities both in styrene and trans-stilbene
epoxidation.
All the complexes derived from 4 showed poor perfor-
mances in both reactivity and enantioselectivity (Table
4, entries 28, 29, and 31 35). The unsymmetrical pybim
complex 19, which had a menthyl group on one side of
the pybim and a trimethylbenzoyl group at the other,
showed enantioselectivities comparable to those ob-
served for complex 16d (Table 4, entry 31 vs 23). The
enantioselectivities observed for 15e for styrene (45%)
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Figure 2. Effect of concentration of catalyst 16d on the epoxidation of
styrene.
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and 16d for trans-stilbene (71%) are comparable to the
highest values reported so far in the literature for the
asymmetric epoxidation using H2O2 as oxidant.
10d In
addition, the reactivities of pybim complexes are compa-
rable to that of pyboxes in the epoxidation of styrene
and trans-stilbene. Interestingly, the sterically bulky
and flexible (S)-methoxy-a-methyl-2-naphthalene acetyl
complex 15l gave 69% ee for trans-stilbene epoxide
(Table 4, entry 12).
Next, we tested the scope of the catalysts in the epoxida-
tion of other olefins. For this purpose, we selected com-
plexes 16b and 16d, and applied them in the epoxidation
of a variety of substrates. The results are shown in Table
5. To our delight, mono-, di- and tri-substituted aro-
matic olefins gave excellent yields (up to 100%) and
moderate to good enantioselectivities (see Table 5). Elec-
tron donating/withdrawing groups on the aromatic ring
of styrene did not influence much either the reactivity or
enantioselectivity (Table 5, entries 1 4). Excellent reac-
tivities and enantioselectivities were obtained with both
complexes 16b and 16d when b-substituted styrenes were
used as the substrates (Table 5, entries 5, 6, 8 and 9).
However, a-substituted styrenes gave poor enantioselec-
tivities (entries 11 and 12). Epoxidation of N-tosylcinn-
amylamine (Table 5, entry 13) using catalysts 16b and
16d gave very low ee (1 3%) and the epoxide was found
to be unstable in the GC column and thus a reliable data
on yield and selectivity could not be obtained.
Finally, we studied the epoxidation of styrene with 16d
in the presence of varying concentrations of acetic acid
as the additive. The use of acids for the enhancement
of efficiency of metal-catalyzed reactions is known in
the literature and the reason for such enhancements
can be attributed to the stabilization of the complex
under the reaction conditions.20 However, the results
revealed that acetic acid had no significant influence
on the conversion, yield or ee of the epoxidation of
styrene (Table 6).
Other carboxylic acids, such as trifluoroacetic acid, ben-
zoic acid, p-methoxy- and p-chloro-benzoic acids, were
also tested. Trifluoroacetic acid showed a marginal
Table 4. Ru(pybim)(pydic) catalyzed asymmetric epoxidation of styrene and trans stilbene using H2O2 as the oxidant
a
Entry Catalyst Ph Ph
Ph
Time (h) Conv. (%) Yield (%) ee (%) Time (h) Conv. (%) Yield (%) ee (%)
1 15a 12 100 64 15 12 100 90 34
2 15b 12 100 75 25 12 100 99 52
3 15c 12 100 78 1 12 100 99 38
4 15d 12 100 63 7 12 100 78 33
5 15e 12 100 77 45 16 92 84 46
6 15f 16 84 63 22 16 46 32 45
7 15g 12 100 67 18 12 100 96 40
8 15h 12 100 74 16 16 88 87 34
9 15i 12 100 70 32 12 100 95 70
10 15j 16 100 67 21 12 100 91 56
11 15k 12 100 76 6 12 100 99 43
12 15l 16 100 71 29 12 100 94 69
13 15m 12 100 67 23 12 100 90 39
14 15n 12 100 83 8 12 100 97 28
15 15o 12 100 84 20 12 100 97 51
16 15p 12 100 80 26 12 100 100 54
17 15q 12 100 85 28 12 100 100 52
18 15r 16 96 80 31 12 100 90 61
19 15s 12 100 80 30 12 100 100 66
20 16a 12 100 71 15 12 100 95 60
21 16b 12 100 77 26 12 100 99 71
22 16c 12 100 78 34 12 100 97 59
23 16d 12 100 72 43 12 100 97 71
24 16e 12 92 78 37 12 100 97 69
25 16f 12 100 77 13 16 94 87 59
26 16g 16 90 79 11
27 16h 12 100 73 17 16 77 63 21
28 17a 12 81 55 2 16 85 79 1
29 17b 12 100 63 31 12 100 93 8
30 18 12 100 70 6 12 100 93 39
31 19 12 100 68 42 12 100 93 71
32 20 12 100 86 34 12 100 100 57
33 21 16 87 67 3 16 98 93 5
34 22 16 88 64 3 12 100 93 7
35 23 16 94 61 9 16 94 90 7
a Reaction conditions: 0.5 mmol of olefin in tert amyl alcohol (9 mL) was oxidized in the presence of 5 mol % Ru catalyst using 1.5 mmol (170 lL) of
H2O2 (30% in water) in tert amyl alcohol (830 lL) by a syringe pump over a period of 12 h.
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Table 5. Scope and limitations of the Ru(pybim)(pydic) catalysts in asymmetric epoxidation
R1
R2 R1 R2
O
*
+ 30% H2O2
5 mol% Ru(pybim)(pydic)
tert-Amyl-OH, rt, 12 hR3 R3
*
Entry Substrate 16b 16d
Conv. (%) Yield (%) Selec.a (%) ee (%) Conv. (%) Yield (%) Selec.a (%) ee (%)
1 100 77 77 26 100 76 76 42
2 100 68 68 23 100 88 88 43
3
Cl
100 72 72 31 100 68 68 50
4
F3C
78 50 64 28 68 60 88 42
5 100 100 100 56 100 100 100 65
6
Ph
100 100 100 71 100 97 97 71
7 Cl 70 52 74 23 90 71 79 23
8 100 79 79 62 100 82 82 68
9 100 100 100 58 100 100 100 54
10
OH
100 47 47 11 100 47 47 7
11 100 69 69 2 100 55 55 1
12 100 73 73 3 100 72 72 0
13 NH
Ts
100 5 100 2
14 100 76 76 n.d.
a Selectivity refers to the ratio of yield to conversion in percentage.
Table 6. Effect of additives on the epoxidation of styrene
Ph Ph
O
*
+ 30% H2O2
5 mol% 16d, Additive
tert-Amyl-OH, RT., 12 h
HOAc (mol%) Conv. (%) Yield (%) ee (%) Additive (20 mol %) Conv. (%) Yield (%) ee (%)
0 100 76 42 CH3COOH 100 76 42
2.5 100 71 45 CF3COOH 100 54 32
5.0 100 72 43 PhCOOH 100 72 43
10.0 100 72 44 4 MeO C6H4CO2H 100 71 44
20.0 100 73 42 4 Cl C6H4CO2H 100 75 42
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decrease in yield and ee while all other acids showed no
appreciable influence.
Considering the parallels between pyboxes and pybims
in their structure, reactivity and enantioselectivity in
epoxidation reactions, a mechanistic pathway similar
to that proposed for Ru(pybox)(pydic) involving a
ruthenium dioxocomplex10d as the active species was
envisaged for the pybim-catalyzed epoxidation.
3. Conclusion
We have designed and synthesized a new class of easily
tunable pyridinebisimidazoline ligands (pybim). The
tunability of these ligands is much higher compared to
that of the structurally related pybox ligands. The
ligands were easily transformed into Ru(pybim)(pydic)
complexes and applied in the catalytic asymmetric epox-
idation of styrene and trans-stilbene. The newly devel-
oped pybim complexes showed comparable reactivities
and enantioselectivities to those obtained by using
pybox complexes. The scope and limitations of the com-
plexes were investigated on the asymmetric epoxidation
of a variety of olefins.
The facile synthesis of the pybim ligands together with
their easy tunability makes them a suitable toolbox
for application to numerous other catalytic asymmetric
reactions.
4. Experimental
4.1. General
All reagents were used as purchased from commercial
suppliers without further purification. Solvents were
dried and purified by conventional methods prior to use.
Melting points were determined on a Leica galen III
melting point apparatus and were uncorrected. Optical
rotations were measured with a Perkin Elmer (model
241MC) polarimeter. Column chromatography was
carried out using silica gel from Fluka. TLC was per-
formed on Merck 60 F254 silica gel plates.
1H and 13C
NMR spectra were recorded on a Bruker ARX-400
spectrometer using the solvent as the internal reference.
Data are reported as follows: chemical shifts (d) in parts
per million, coupling constants (J) in hertz. Mass spectra
were recorded with an AMD 402/3 mass spectrometer.
GC analyses were performed with a Hewlett Packard
HP 6890 model spectrometer and UV vis spectra were
recorded with a Shimadzu (model UV-1601) spectro-
photometer. HPLC analyses were performed with a
Hewlett Packard HP 1090 instrument using Chiralcel
AD, Chiralcel OB H, Chiralcel OD, Chiralcel OD-H
or Whelk chiral column. Elemental analyses were per-
formed on a CHNS 932 analyzer from Leo company.
4.2. Pyridine-2,6-dicarboximidic acid dimethyl ester 2
To pyridine-2,6-carbodinitrile 1 (5.35 g, 41.5 mmol) in
anhydrous MeOH (100 mL), was added metallic Na
(120 mg, 5.20 mmol). After stirring for 40 h at room
temperature, AcOH (300 lL, 5.25 mmol) was added
and the solvent removed under reduced pressure to give
2 as a pale yellow powder (8.50 g, 100 %), which was
used without further purification.
4.3. 2,6-Bis-([4R,5R]-4,5-diphenyl-4,5-dihydro-1H-
imidazol-2-yl)-pyridine 3
In a 50 mL oven dried pressure tube, 2 (455 mg,
7.06 mmol) and (R,R)-1,2-diphenylethylene diamine
(1.00 g, 4.70 mmol) were dissolved in dichloromethane
(30 mL). The resulting mixture was stirred at refluxing
temperature for two days. Then, water (20 mL) was
added, the phases separated and the aqueous phase
extracted with dichloromethane (2 · 20 mL). The
combined organic layer was dried over Na2SO4 and
the solvent removed in vacuo to give a light yellow solid,
which was purified by silica gel column chromatography
to give 3 as a white solid (1.15 g, 95%). Rf 0.52
(CH2Cl2/MeOH 10:1); mp 123 126 C; ½a20D ¼þ112:4 (c 0.52, CHCl3); 1H NMR (400 MHz, CDCl3):
d 4.90 (br s, 4H), 7.22 7.31 (m, 20H), 7.89 (t, J 7.8,
1H), 8.46 (d, J 7.8, 2H); 13C NMR (100 MHz, CDCl3)
d 74.9, 125.5, 127.1, 128.3, 129.2, 136.1, 138.2, 142.9,
162.1; EI-MS: m/z 519 (M+); Anal. Calcd (%) for
C35H29N5: C, 78.19; H, 5.81; N, 13.03. Found: C,
78.20; H, 5.58; N, 13.20.
4.4. 2,6-Bis-([4R,5R]-4,5-diphenyl-4,5-dihydro-1H-
imidazol-2-yl)-pyridine 3
A 100 mL pressure tube was charged with 2 (4.55 g,
23.6 mmol), (R,R)-1,2-diphenylethylenediamine (10.0 g,
47.1 mmol) and 75 mL of dichloromethane. The result-
ing mixture was stirred at reflux for two days. To the
reaction mixture, 50 mL of water was added and the
phases separated; the aqueous phase was extracted with
dichloromethane (2 · 50 mL). The combined organic
layers were dried over MgSO4 and the solvent removed
in vacuo to give a light yellow solid, which was purified
by crystallization (ether/ethyl acetate) to give 3 (7.62 g,
62%).
4.5. 2,6-Bis-([3aR,7aR]-3a,4,5,6,7,7a-hexahydro-1H-
benzoimidazol-2-yl)-pyridine 4
A 50 mL oven dried pressure tube was charged with 2
(804 mg, 4.17 mmol), (R,R)-1,2-diaminocyclohexane
(1.00 g, 8.75 mmol) and dichloromethane (40 mL).
After the resulting mixture was stirred at refluxing
temperature for two days, water (20 mL) was added
and the phases separated. The aqueous phase was
extracted with dichloromethane (2 · 20 mL). The com-
bined organic layer was dried over Na2SO4 and the
solvent removed in vacuo to give a light yellow solid,
which was purified by crystallization (ethyl acetate) to
give 4 as a white solid (1.12 g, 84%). mp 320
322 C; ½a20D ¼ þ242:4 (c 0.52, CHCl3); 1H NMR
(400 MHz, CDCl3): d (1.34m, 4H), 1.55 (m, 4H), 1.83
(m, 4H), 2.28 (m, 4H), 3.36 (m, 4H) 7.81 (t, J 7.3,
1H), 7.21 (d, J 7.3, 2H); 13C NMR (100 MHz,
CD2Cl2): d 21.6, 22.9, 30.7, 23.5, 137.3, 147.8, 164.6;
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EI-MS: m/z 323 (M+); Anal. Calcd (%) for C19H25N5:
C, 70.76; H, 7.79; N, 21.65. Found: C, 70.32; H, 7.81;
N, 21.59.
4.6. (3aR,6Z,8aS)-4,5,8,8a-tetrahydro-6-(6-((Z,3aR,8aS)-
4,5,8,8a-tetrahydro-2,2-dimethyl-3aH-[1,3]dioxolo[4,5-e]-
[1,3]diazepin-6-yl)pyridin-2-yl)-2,2-dimethyl-3aH-[1,3]di-
oxolo[4,5-e][1,3]diazepine 5
Compound 5 was prepared as described for the synthesis
of 3 using 2 (292 mg, 1.50 mmol), (4S,5R)-4,5-di-(ami-
nomethyl)-2,2-dimethyl dioxolane (500 mg, 3.10 mmol)
and 15 mL of dichloromethane in a pressure tube at
50 C. After 2 days, the solvents were removed in vacuo
to give a light yellow oil, which was purified by column
chromatography on neutral alumina to give a white
solid (100 mg, 16%). Rf 0.75 (CH2Cl2/MeOH 10:1,
neutral alumina); mp 232 234 C; ½a20D ¼ þ32:7
(c 0.21, CHCl3);
1H NMR (400 MHz, CDCl3): d 1.43
(s, 12H), 3.18 (br s, 4H), 3.68 (m, 4H), 3.85 (br s,
4H), 7.77 (t, J 7.9, 1H), 8.29 (d, J 7.9, 2H); 13C
NMR (100 MHz, CDCl3) d 26.8, 78.8, 80.4, 111.1,
122.4, 137.7, 151.3, 151.9; EI-MS: m/z 415 (M+); HRMS
(ESI+): calcd for C21H29N5O4: 415.2219. Found:
415.2213.
4.7. General procedure for the synthesis of N-acyl-
protected pybim ligands (procedure A)
A 50 mL oven dried one necked round bottom flask fit-
ted with a magnetic stirring bar was charged with 3
(208 mg, 0.4 mmol) and DMAP (147 mg, 1.2 mmol) in
anhydrous CH2Cl2 (15 mL). The mixture was cooled
to 0 C and then acid chloride or chloroformate
(1.2 mmol) added dropwise. The cooling bath was
removed and the reaction mixture stirred at rt and the
progress of the reaction was monitored by TLC. The
reaction mixture was then washed with water
(2 · 20 mL), dried over Na2SO4, concentrated and puri-
fied by column chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent.
4.8. 2,6-Bis-(1-benzoyl-[4R,5R]-4,5-diphenyl-4,5-dihydro-
1H-imidazol-2-yl)-pyridine 6a
Prepared according to general procedure A using 3
(200 mg, 0.38 mmol), DMAP (140 mg, 1.15 mmol),
benzoyl chloride (134 lL, 1.15 mmol) and dichloro-
methane (8 mL). The residue was purified by silica
gel column chromatography to give 6a as a white solid
(270 mg, 96%). Rf 0.27 (CH2Cl2/MeOH 100:5);
mp 110 113 C; ½a20D ¼ 68:1 (c 0.50, CHCl3); 1H
NMR (400 MHz, CD2Cl2): d 5.15 (d, J 3.4, 2H),
5.19 (d, J 3.4, 2H), 7. 02 7.06 (m, 4H), 7.11
7.13 (m, 6H), 7.25 7.29 (m, 6H), 7.33 7.36 (m,
6H), 7.39 7.43 (m, 8H), 7.73 (dd, J 6.7, 8.7, 1H),
7.83 (d, J 7.1, 2H); 13C NMR (100 MHz, CD2Cl2):
d 60.4, 71.9, 125.5, 126.3, 126.7, 126.9, 127.3,
127.4, 127.4, 128.0, 128.1, 128.3, 128.4, 129.1,
131.9, 134.6, 137.7, 139.4, 169.3; IR (KBr): m 3060,
1670, 1358 cm 1; EI-MS: m/z 728 (M+); HRMS
(ESI+): calcd for C49H38N5O2: 728.3025. Found:
728.3016.
4.9. 2,6-Bis-(1-(2-methyl-benzoyl)-[4R,5R]-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl)-pyridine 6b
Prepared according to general procedure A using 3
(208 mg, 0.4 mmol), DMAP (147 mg, 1.2 mmol) and
o-toluoyl chloride (160 lL, 1.2 mmol) in anhydrous
CH2Cl2 (15 mL) for 12 h followed by column chromato-
graphy on silica gel using MeOH CH2Cl2 as the
gradient eluent to give pale yellow crystals (304 mg,
100%). Rf 0.80 (CH2Cl2/MeOH 100:5); mp 116
118 C; ½a20D ¼ 115:7 (c 0.67, CHCl3); 1H NMR
(300 MHz, CD2Cl2): d 2.08 (s, 6H), 5.22 (br d,
J 2.43, 4H), 6.77 (t, J 7.53, 2H), 6.89 6.96 (m,
4H), 7.03 (t, J 7.92, 2H), 7.02 7.29 (m, 6H), 7.37
7.58 (m, 17H); 13C NMR (75 MHz, CD2Cl2): d 19.4,
70.6, 78.4, 124.3, 124.9, 125.3, 126.3, 127.1, 127.8,
128.1, 129.1, 129.2, 129.9, 130.5, 135.0, 137.1, 140.7,
141.8, 149.9, 168.8; IR (KBr): m 3061, 3027, 1675,
1625, 1331 cm 1; HRMS: calcd for C51H41N5O2ÆH
+:
756.3339. Found: 756.3326; Anal. Calcd (%) for
C51H41N5O2Æ2H2O: C, 77.35; H, 5.73; N, 8.84. Found:
C, 78.02; H, 5.44; N, 8.68.
4.10. 2,6-Bis-(1-(4-methoxy-benzoyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 6c
Prepared according to general procedure A using 3
(400 mg, 0.77 mmol), DMAP (206 mg, 1.69 mmol), 4-
methoxybenzoyl chloride (260 lL, 1.92 mmol) and
dichloromethane (10 mL). The residue was purified by
silica gel column chromatography using MeOH CH2Cl2
as the gradient eluent to give 6c as a white solid (527 mg,
87%). Rf 0.48 (CH2Cl2/MeOH 100:5); mp 191
193 C; ½a20D ¼ 86:4 (c 0.41, CHCl3); 1H NMR
(400 MHz, CD2Cl2): d 3.66 (s, 6H), 5.08 (d, 2H), 5.10
(d, 2H), 6.53 (d, J 8.9, 4H), 7.04 7.12 (m, 6H), 7.26
7.40 (m, 18H), 7.81 (dd, J 6.9, 8.3, 1H), 7.92 (d,
J 7.5, 2H); 13C NMR (100 MHz, CD2Cl2): d 56.1,
72.6, 79.9, 113.9, 125.2, 126.1, 127.2, 128.1, 128.3,
128.7, 129.7, 131.3, 138.1, 141.1, 142.5, 150.2, 161.6,
163.1, 169.9, 193.6; EI-MS: m/z 787 (M+); HRMS: calcd
for C51H42N5O4ÆH
+: 788.3238. Found: 788.3240.
4.11. 2,6-Bis-(1-(4-trifluoromethyl-benzoyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 6d
Prepared according to general procedure A using 3
(400 mg, 0.77 mmol), DMAP (281 mg, 2.31 mmol), 4-
trifluoromethylbenzoyl chloride (286 lL, 1.92 mmol)
and dichloromethane (10 mL). The residue was purified
by silica gel column chromatography using MeOH
CH2Cl2 as the gradient eluent to give 6d as a white solid
(600 mg, 97%). Rf 0.55 (CH2Cl2/MeOH 100:5);
mp 114 117 C; ½a20D ¼ 41:9 (c 0.50, CHCl3); 1H
NMR (400 MHz, CD2Cl2): d 5.13 (d, J 3.5, 2H),
5.22 (d, J 3.5, 2H), 7.09 7.18 (m, 6H), 7.30 7.38 (m,
20H), 7.15 7.38 (m, 20H), 7.41 7.45 (m, 4H), 7.85 (dd,
J 6.7, 8.5, 1H), 7.94 (d, 2H); 13C NMR (100 MHz,
CD2Cl2): d 72.4, 79.9, 125.6, 125.7, 125.8, 126.1, 127.0,
128.7, 128.9, 129.3, 129.8, 138.6, 139.2, 140.7, 141.8,
149.8, 160.3, 168.7; EI-MS: m/z 864 (M+); Anal. Calcd
(%) for C51H35N5F6O2: C, 70.91; H, 4.08; N, 8.11.
Found: C, 70.77; H, 3.85; N, 8.05.
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4.12. 2,6-Bis-(1-(2,6-dimethoxy-benzoyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 6e
Prepared according to general procedure A using 3
(208 mg, 0.4 mmol), DMAP (147 mg, 1.2 mmol) and
2,6-dimethoxybenzoyl chloride (245 mg, 1.2 mmol) in
refluxing 1,2-dichloroethane (15 mL) for 24 h followed
by chromatography on silica gel using MeOH CH2Cl2
as the gradient eluent afforded pale yellow crystals
(167 mg, 47%). Rf 0.25 (CH2Cl2/MeOH 100:5);
mp 135 138 C; ½a20D ¼ 86:1 (c 0.37, CHCl3); 1H
NMR (400 MHz, CDCl3): d 3.72 (s, 6H), 3.83 (s, 6H),
5.02 (d, J 2.82, 2H), 5.65 (d, J 2.56, 2H), 6.04 (d,
J 8.52, 2H), 6.16 (d, J 8.52, 2H), 6.57 (d, J 8.52,
2H), 6.85 (t, J 8.32, 2H), 7.05 (d, J 7.72, 2H),
7.33 7.55 (m, 15H), 7.56 (d, J 7.12, 4H); 13C NMR
(100 MHz, CDCl3): d 55.9, 58.4, 59.2, 104.5, 124.7,
125.5, 127.2, 127.5, 128.1, 128.5, 128.7, 129.3, 129.9,
130.9, 139.2, 148.9, 157.9, 164.1, 167.1; IR (KBr):
m 2934, 1674, 1628, 1596, 1112 cm 1; FAB-MS: m/z
848 (M+); HRMS: calcd for C53H46N5O6: 848.3448.
Found: 848.3437.
4.13. 2,6-Bis-(1-(2,4,6-trimethoxy-benzoyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 6f
Prepared according to general procedure A using 3
(415 mg, 0.8 mmol), NaH (64 mg, 2.4 mmol) and 2,4,
6-trimethylbenzoyl chloride (448 mg, 2.4 mmol) in reflux-
ing chlorobenzene (20 mL) for 45 h followed by chroma-
tography on silica gel using MeOH CH2Cl2 as the
gradient eluent afforded pale yellow crystals (296 mg,
45%). Rf 0.30 (CH2Cl2/MeOH 100:5); mp 96
98 C; ½a20D ¼ 49:2 (c 0.43, CHCl3); 1H NMR
(400 MHz, CD2Cl2): d 2.13 (br s, 18H), 4.82 (d,
J 8.52, 2H), 5.13 (d, J 8.52, 2H), 7.30 7.44 (m,
27H); 13C NMR (100 MHz, CD2Cl2): d 18.5, 19.2,
19.9, 69.1, 77.8, 122.9, 125.3, 126.1, 126.3, 126.5,
126.6, 127.6, 127.9, 128.2, 128.9, 129.4, 138.8, 141.5,
142.8; IR (KBr): m 2921, 1673, 1629, 1330 cm 1;
HRMS: calcd for C55H50N5O2: 812.3964. Found:
812.3965.
4.14. 2,6-Bis-(1-(3,5-di-tert-butylbenzoyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 6g
Prepared according to general procedure A using 3
(363 mg, 0.7 mmol), DMAP (244 mg, 2.0 mmol) and
3,5-di-tert-butylbenzoyl chloride (524 mg, 2.0 mmol) in
dichloromethane (20 mL) for 12 h followed by chroma-
tography on silica gel using MeOH CH2Cl2 as the gra-
dient eluent afforded pale yellow crystals (216 mg, 32%).
Rf 0.30 (CH2Cl2/MeOH 100:5); ½a20D ¼ 93:3 (c 0.45,
CHCl3);
1H NMR (400 MHz, CD2Cl2): d 1.00 (s, 36H),
5.18 (br s, 2H), 5.44 (d, J 4.96, 2H), 7.12 7.30 (m,
10H), 7.38 (t, J 7.12, 4H), 7.43 7.50 (m, 12H), 7.72
7.75 (m, 3H); 13C NMR (100 MHz, CD2Cl2): d 30.7,
34.6, 71.0, 78.8, 124.3, 125.0, 126.3, 127.8, 128.1,
129.1, 129.3, 134.9, 135.8, 137.4, 141.9, 169.6; IR
(KBr): m 2963, 1673, 1364 cm 1; HRMS: calcd for
C65H69N5O2ÆH
+: 952.5529. Found: 952.5536; Anal.
Calcd (%) for C65H69N5O2Æ3H2O: C, 77.58; H, 7.51;
N, 6.95. Found: C, 77.72; H, 7.04; N, 6.67.
4.15. 2,6-Bis-(1-phenylacetyl-[4R,5R]-4,5-diphenyl-4,5-
dihydro-1H-imidazol-2-yl)-pyridine 6h
Prepared according to general procedure A using 3
(208 mg, 0.4 mmol), DMAP (147 mg, 1.2 mmol) and
phenylacetyl chloride (159 lL, 1.5 mmol) in dichloro-
methane (15 mL) for 1.5 h at rt followed by chromatog-
raphy on silica gel using MeOH CH2Cl2 as the gradient
eluent afforded pale yellow crystals (246 mg, 87%).
Rf 0.30 (CH2Cl2/MeOH 100:5); mp 83 84 C;
½a20D ¼ þ27:4 (c 0.23, CHCl3); 1H NMR (300 MHz,
CD2Cl2): d 3.57 (s, 4H), 5.15 (d, J 2.64, 2H), 5.39
(d, J 2.82, 2H), 6.84 6.89 (m, 4H), 7.13 7.44 (m,
22H), 7.54 7.59 (m, 4H), 7.92 8.04 (m, 3H); 13C NMR
(75 MHz, CD2Cl2): d 43.3, 70.1, 78.1, 124.9, 125.1,
126.3, 127.0, 128.1, 128.5, 129.0, 129.4, 133.8, 138.2,
140.7, 141.7, 150.5, 158.6, 169.0; HRMS: calcd for
C51H41N5O2ÆH
+: 756.3338. Found: 756.3333; Anal.
Calcd (%) for C51H41N5O2ÆH2O: C, 79.15; H, 5.60; N,
9.05. Found: C, 79.15; H, 5.85; N, 8.37.
4.16. 2,6-Bis-(1-(diphenylacetyl)-[4R,5R]-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl)-pyridine 6i
Prepared according to general procedure A 3 (208 mg,
0.4 mmol), DMAP (147 mg, 1.2 mmol) and diphenylace-
tyl chloride (310 lL, 1.4 mmol) in 1,2-dichloromethane
(20 mL) for 2 h followed by chromatography on silica
gel using MeOH CH2Cl2 as the gradient eluent
afforded pale yellow crystals (366 mg, 100%). Rf 0.50
(CH2Cl2/MeOH 100:5); mp 108 109 C; ½a20D ¼ 29:6
(c 0.13, CHCl3);
1H NMR (400 MHz, CD2Cl2): d 5.00
(br s, 2H), 5.10 (d, J 2.80, 2H), 5.37 (br s, 2H), 6.80
(d, J 7.32, 4H), 6.99 7.33 (m, 32H), 7.57 (dd,
J 3.96, 7.36, 4H), 7.74 (d, J 7.76, 2H), 7.93 (t,
J 7.72, 1H); 13C NMR (100 MHz, CD2Cl2): d 40.1,
57.1, 116.5, 125.1, 126.3, 127.1, 127.3, 127.9, 128.1,
128.5, 128.6, 128.7, 128.8, 128.9, 129.0, 129.4, 135.8,
138.3, 140.7, 154.8, 169.7; IR (KBr): m 1686, 1366,
1152 cm 1; FAB-MS: m/z 908 (M+); HRMS: calcd for
C63H49N5O2ÆH
+: 908.3964. Found: 908.4009; Anal.
Calcd (%) for C63H49N5O2Æ2H2O: C, 80.15; H, 5.65;
N, 7.42. Found: C, 80.57; H, 5.01; N, 6.98.
4.17. 2,6-Bis-(1-naphthoyl-[4R,5R]-4,5-diphenyl-4,5-
dihydro-1H-imidazol-2-yl)-pyridine 6j
Prepared according to general procedure A using 3
(400 mg, 0.77 mmol), DMAP (281 mg, 2.31 mmol) and
1-naphthoyl chloride (255 lL, 1.69 mmol) in dichloro-
methane (16 mL). The residue was purified by silica gel
column chromatography using MeOH CH2Cl2 as the
gradient eluent to give 6j as a white solid (600 mg,
94%). Rf 0.37 (CH2Cl2/MeOH 100:5); mp 130
132 C; ½a20D ¼ 104:3 (c 0.20, CHCl3); 1H NMR
(400 MHz, CD2Cl2): d 5.17 (unresolved d, 2H), 5.51
(unresolved d, 2H), 6.98 (m, 4H), 7.15 (m, 2H), 7.34
7.70 (m, 31H); 13C NMR (100 MHz, CD2Cl2): d 70.2,
77.7, 116.6, 123.6, 123.6, 125.2, 126.2, 126.4, 126.9,
128.0, 128.1, 129.1, 129.2, 130.4, 132,8, 132.9, 135.6,
135,8, 137.5, 137.5, 140.8, 141.9, 149.2, 149.3, 156.2;
EI-MS: m/z 828 (M++1), 827 (M+); HRMS: calcd for
C57H42N5O2ÆH
+: 828.3338. Found: 828.3355.
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4.18. 2,6-Bis-(2-naphthoyl-[4R,5R]-4,5-diphenyl-4,5-
dihydro-1H-imidazol-2-yl)-pyridine 6k
Prepared according to general procedure A using 3
(260 mg, 0.5 mmol), DMAP (180 mg, 1.5 mmol) and
2-naphthoyl chloride (294 mg, 1.5 mmol) in 1,2-dichlo-
roethane (15 mL) for 2 h at rt followed by chromatogra-
phy on silica gel using MeOH CH2Cl2 as the gradient
eluent afforded pale yellow crystals (326 mg, 76%).
Rf 0.60 (CH2Cl2/MeOH 100:5); mp 129 130 C;
½a20D ¼ þ39:1 (c 0.39, CHCl3); 1H NMR (300 MHz,
CD2Cl2): d 5.16 (br s, 4H), 6.99 7.05 (m, 6H), 7.22
7.58 (m, 24H), 7.68 7.75 (m, 5H) 7.87 (d, J 7.71,
2H); 13C NMR (75 MHz, CD2Cl2): d 72.1, 79.0, 124.3,
124.8, 125.4, 126.4, 126.6, 127.5, 127.6, 127.8, 127.9,
128.0, 128.7, 129.0, 129.1, 131.7, 132.2, 134.5, 137.3,
140.2, 141.7, 149.2, 160.5, 169.6; IR (KBr): m 1669,
1358, 1321, 1136 cm 1; HRMS: calcd for
C57H41N5O2ÆH
+: 828.3338. Found: 828.3340; Anal.
Calcd (%) for C57H41N5O2ÆH2O: C, 80.92; H, 5.12; N,
8.27. Found: C, 80.72; H, 4.29; N, 7.90.
4.19. 2,6-Bis-(1-[(2S)-2-(6-methoxy-naphthalen-2-yl)-
propionyl]-[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-
imidazol-2-yl)-pyridine 6l
Prepared according to general procedure A using 3
(400 mg, 0.77 mmol), DMAP (281 mg, 2.31 mmol),
(S)-2-(6-methoxy-naphthaten-2-yl)-propionyl chloride
(574 mg, 2.31 mmol) and dichloromethane (10 mL).
The residue was purified by silica gel column chroma-
tography using MeOH CH2Cl2 as the gradient eluent
to give 6l as a white solid (450 mg, 62%). Rf 0.75
(CH2Cl2/EtOAc 8:2); mp 115 118 C; ½a20D ¼ 46:6
(c 0.25, CHCl3);
1H NMR (400 MHz, CD2Cl2): d 1.31
(d, 6H), 3.73 (q, 2H), 3.91 (s, 6H), 4.95 (d, J 4.8,
2H), 5.18 (d, J 4.8, 2H), 6.93 7.17 (m, 16H), 7.33
7.35 (m, 6H), 7.44 (m, 2H), 7.52 7.54 (m, 4H), 7.57
7.60 (m, 4H) 7.83 (d, J 7.6, 2H), 7.98 (t, J 7.6,
2H); 13C NMR (100 MHz, CD2Cl2): d 20.5, 45.6, 55.3,
68.4, 78.9, 105.5, 116.7, 118.7, 123.7, 125.3, 125.5,
126.0, 126.1, 127.6, 127.7, 128.1, 128.9, 129.3, 129.4,
133.7, 135.2, 137.5, 140.6, 141.7, 151.1, 157.8, 159.2,
171.3; EI-MS: m/z 944 (M+); HRMS: calcd for
C63H53N5O4: 944.4176. Found: 944.4167.
4.20. 2,6-Bis-(1-(2-(1R,2S,5R)-2-isopropyl-5-meth-
ylcyclohexyloxy-acetyl)-[4R,5R]-4,5-diphenyl-4,5-di-
hydro-1H-imidazol-2-yl)-pyridine 6m
Prepared according to general procedure A using 3
(416 mg, 0.8 mmol), DMAP (294 mg, 2.4 mmol) and
()-menthoxyacetyl chloride (540 lL, 2.4 mmol) in
dichloromethane (20 mL) for 1 h followed by chroma-
tography on silica gel using MeOH CH2Cl2 as the gra-
dient eluent afforded pale yellow crystals (673 mg, 92%).
Rf 0.75 (CH2Cl2/MeOH 100:5); mp 60 61 C;
½a20D ¼ 21:8 (c 0.16, CHCl3); 1H NMR (400 MHz,
CD2Cl2): d 0.54 (d, J 6.92, 6H), 0.72 (d, J 6.52,
6H), 0.79 (d, J 7.12, 6H), 0.80 1.23 (m, 8H), 1.49
1.68 (m, 10H), 2.87 (dt, J 4.16, 10.68, 2H), 3.85 (d,
J 14.64, 2H), 4.03 (d, J 14.68, 2H), 5.15 (d,
J 2.56, 2H), 5.42 (d, J 2.56, 2H), 7.24 7.49 (m,
20H), 8.03 8.12 (m, 3H); 13C NMR (100 MHz,
CD2Cl2): d 15.6, 20.8, 21.8, 22.9, 25.2, 31.5, 34.3, 39.9,
48.1, 69.5, 70.1, 77.7, 80.8, 124.8, 125.0, 126.5, 127.8,
128.0, 129.0, 129.2, 137.8, 140.8, 141.7, 150.1, 158.6,
169.5; IR (KBr): m 2954, 2924, 1680, 1617,
1383 cm 1; HRMS: calcd for C59H69N5O4ÆH
+:
912.5428. Found: 912.5410; Anal. Calcd (%) for
C59H69N5O4ÆH2O: C, 76.18; H, 7.69; N, 7.53. Found:
C, 76.18; H, 8.21; N, 6.46.
4.21. 2,6-Bis-(1-adamantoyl-[4R,5R]-4,5-diphenyl-4,5-
dihydro-1H-imidazol-2-yl)-pyridine 6n
Prepared according to general procedure A using 3
(200 mg, 0.38 mmol), DMAP (206 mg, 1.69 mmol) and
adamantoyl chloride (260 lL, 1.92 mmol) in dichloro-
methane (10 mL). The residue was purified by silica gel
column chromatography using MeOH CH2Cl2 as the
gradient eluent afforded 6n as a white solid (310 mg,
96%). Rf 0.53 (CH2Cl2/MeOH 100:5); mp 132
135 C; ½a20D ¼ 22:0 (c 0.50, CHCl3); 1H NMR
(400 MHz, CD2Cl2): d 1.43 1.46 (m, 6H), 1.52 1.60
(m, 14H), 1.77 1.80 (m, 12H), 5.16 (d, J 4.2, 2H),
5.29 (d, J 4.2, 2H), 7.24 7.26 (m, 4H), 7.32 7.42 (m,
16H), 7.95 (dd, J 6.8, 8.6, 1H), 8.03 (d, J 6.8, 1H),
8.03 (d, J 8.6, 1H); 13C NMR (100 MHz, CD2Cl2): d
28.1, 36.2, 39.0, 43.7, 71.3, 81.6, 124.2, 126.1, 126.5,
127.9, 127.9, 128.9, 129.2, 137.1, 141.1, 142.2, 150.7,
163.7, 181.3; EI-MS: m/z 844 (M+); HRMS: calcd for
C57H58N5O2: 844.4590. Found: 844.4574.
4.22. 2,6-Bis-(1-acetyl-[4R,5R]-4,5-diphenyl-4,5-dihydro-
1H-imidazol-2-yl)-pyridine 6o
Prepared according to general procedure A using 3
(420 mg, 0.81 mmol), DMAP (296 mg, 2.42 mmol) and
acetyl chloride (178 lL, 2.42 mmol) in dichloromethane
(20 mL) for 2 h followed by chromatography on silica
gel using MeOH CH2Cl2 as the gradient eluent
afforded a pale yellow solid (419 mg, 86%). Rf 0.45
(CH2Cl2/MeOH 100:5); mp 108 109 C; ½a20D ¼ 24:5
(c 0.35, CHCl3);
1H NMR (300 MHz, CD2Cl2): d 1.93
(s, 6H), 5.14 (d, J 2.64, 2H), 5.34 (d, J 2.64, 2H),
7.29 7.55 (m, 20H), 8.07 8.09 (m, 3H); 13C NMR
(75 MHz, CD2Cl2): d 24.5, 70.0, 78.0, 78.1, 124.7,
125.0, 126.3, 128.0, 128.1, 129.1, 129.3, 138.3, 140.8,
141.8, 150.4, 158.8, 168.0; IR (KBr): m 2929, 1727,
1405, 1210 cm 1; EI-MS: m/z 603 (M+); HRMS: calcd
for C39H33N5O2ÆH
+: 604.2707. Found: 604.2704.
4.23. 2,6-Bis-(1-pentanoyl-[4R,5R]-4,5-diphenyl-4,5-
dihydro-1H-imidazol-2-yl)-pyridine 6p
Prepared according to general procedure A using 3
(520 mg, 1.00 mmol), DMAP (367 mg, 3.00 mmol) and
valeryl chloride (358 lL, 3.00 mmol) in dichloromethane
(25 mL) for 2 h followed by chromatography on silica
gel using MeOH CH2Cl2 as the gradient eluent afforded
a pale yellow solid (637 mg, 93%). Rf 0.30 (CH2Cl2/
MeOH 100:5); mp 50 51 C; ½a20D ¼ 9:6 (c 0.24,
CHCl3);
1H NMR (300 MHz, CD2Cl2): d 0.68 (t,
J 7.35, 6H), 0.89 1.12 (m, 4H), 1.29 1.59 (m, 4H),
1.98 2.29 (m, 4H), 5.15 (d, J 2.82, 2H), 5.32
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(unresolved d, 2H), 7.29 7.56 (m, 20H), 8.02 8.09 (m,
3H); 13C NMR (75 MHz, CD2Cl2): d 13.4, 22.1, 26.7,
36.0, 69.9, 78.1, 124.4, 125.1, 126.2, 127.9, 128.1,
129.1, 129.3, 138.1, 141.0, 142.0, 150.8, 159.1, 171.1;
IR (KBr): m 2957, 2931, 1685 (br), 1453, 1380 cm 1;
EI-MS: m/z 687 (M+); HRMS: calcd for C45H45N5O2:
687.3568. Found: 687.3593; Anal. Calcd (%) for
C45H45N5O2ÆH2O: C, 76.57; H, 6.71; N, 9.92. Found:
C, 76.79; H, 6.76; N, 9.36.
4.24. 2,6-Bis-(1-(2-methyl propanoyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 6q
Prepared according to general procedure A using 3
(520 mg, 1.00 mmol), DMAP (367 mg, 3.00 mmol) and
isobutyryl chloride (315 lL, 3.00 mmol) in dichlorometh-
ane (25 mL) for 2 h followed by chromatography on silica
gel using MeOH CH2Cl2 as the gradient eluent afforded
a pale yellow solid (607 mg, 92%). Rf 0.45 (CH2Cl2/
MeOH 100:5); mp 86 87 C; ½a20D ¼ 34:8 (c 0.22,
CHCl3);
1H NMR (300 MHz, CD2Cl2): d 0.87 (d,
J 6.78, 6H), 0.93 (d, J 6.78, 6H), 2.37 2.45 (m, 2H),
5.14 (d, J 2.82, 2H), 5.27 (d, J 2.82, 2H), 7.30 7.54
(m, 20H), 7.99 8.10 (m, 3H); 13C NMR (75 MHz,
CD2Cl2): d 18.6, 19.8, 33.9, 70.1, 78.4, 124.3, 125.2,
126.2, 127.9, 128.1, 129.1, 129.3, 137.9, 141.1, 142.2,
151.1, 159.4, 175.8; IR (KBr): m 2973, 1691 (br), 1618,
1466, 1388 cm 1; EI-MS: m/z 659 (M+); HRMS: calcd
for C43H41N5O2: 659.3255. Found: 659.3263; Anal.
Calcd (%) for C43H41N5O2ÆH2O: C, 76.19; H, 6.39; N,
10.33. Found: C, 76.19; H, 6.18; N, 9.96.
4.25. 2,6-Bis-(1-(3-methyl butanoyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 6r
Prepared according to general procedure A using 3
(520 mg, 1.00 mmol), DMAP (367 mg, 3.00 mmol) and
isovaleryl chloride (367 lL, 3.00 mmol) in dichlorometh-
ane (25 mL) for 2 h followed by chromatography on
silica gel using MeOH CH2Cl2 as the gradient eluent
afforded a pale yellow solid (638 mg, 93%). Rf 0.35
(CH2Cl2/MeOH 100:5); mp 59 60 C; ½a20D ¼ 21:7
(c 0.21, CHCl3);
1H NMR (300 MHz, CD2Cl2): d 0.68
(d, J 6.39, 6H), 0.71 (d, J 6.39, 6H), 1.89 2.00 (m,
2H), 2.05 2.16 (m, 4H), 5.15 (d, J 2.82, 2H), 5.30 (d,
J 2.82, 2H), 7.31 7.55 (m, 20H), 8.01 8.10 (m, 3H);
13C NMR (75 MHz, CD2Cl2): d 22.1, 25.5, 45.0, 70.0,
68.2, 124.4, 125.1, 126.2, 127.9, 128.1, 129.1, 129.3,
138.0, 141.0, 142.0, 150.9, 159.2, 170.6; IR (KBr):
m 2958, 1691 (br), 1466, 1375 cm 1; EI-MS: m/z 687
(M+); HRMS: calcd for C45H45N5O2: 687.3568. Found:
687.3553; Anal. Calcd (%) for C45H45N5O2ÆH2O: C,
76.57; H, 6.71; N, 9.92. Found: C, 76.51; H, 6.54; N, 9.33.
4.26. 2,6-Bis-(1-(3,3-dimethyl butanoyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 6s
Prepared according to general procedure A using 3
(520 mg, 1.00 mmol), DMAP (367 mg, 3.00 mmol) and
tert-butylacetyl chloride (417 lL, 3.00 mmol) in dichlo-
romethane (25 mL) for 2 h followed by chromatography
on silica gel using MeOH CH2Cl2 as the gradient eluent
afforded a pale yellow solid (595 mg, 83%). Rf 0.25
(CH2Cl2/MeOH 100:5); mp 74 75 C; ½a20D ¼ 35:4
(c 0.21, CHCl3);
1H NMR (300 MHz, CD2Cl2): d 0.81
(s, 18H), 1.93 (d, J 15.24, 2H), 2.08 (d, J 15.24,
2H), 5.15 (d, J 2.82, 2H), 5.28 (d, J 2.82, 2H),
7.30 7.56 (m, 20H), 7.99 8.12 (m, 3H); 13C NMR
(75 MHz, CD2Cl2): d 29.3, 31.3, 47.9, 70.1, 78.1, 124.2,
125.2, 126.3, 127.9, 128.0, 129.0, 129.3, 138.0, 141.1,
142.1, 151.2, 159.4, 170.0; IR (KBr): m 2954, 1691
(br), 1466, 1361 cm 1; EI-MS: m/z 715 (M+); HRMS:
calcd for C47H49N5O2: 715.3881. Found: 715.3872;
Anal. Calcd (%) for C47H49N5O2ÆH2O: C, 76.91; H,
7.00; N, 9.54. Found: C, 76.98; H, 6.61; N, 8.96.
4.27. 2,6-Bis-(1-(phenoxycarbonyl)-[4R,5R]-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl)-pyridine 7a
Prepared according to general procedure A using 3
(260 mg, 0.5 mmol), DMAP (184 mg, 1.5 mmol) and
phenyl chloroformate (190 lL, 1.5 mmol) in dichloro-
methane (20 mL) for 1 h followed by chromatography
on silica gel using MeOH CH2Cl2 as the gradient eluent
afforded pale yellow crystals (387 mg, 98%). Rf 0.65
(CH2Cl2/MeOH 100:5); mp 90 91 C; ½a20D ¼ þ8:4 (c
0.38, CHCl3);
1H NMR (400 MHz, CDCl3): d 5.52 (d,
J 3.96, 2H), 5.63 (d, J 3.76, 2H), 6.96 6.99 (m,
4H), 7.24 7.34 (m, 6H), 7.46 7.52 (m, 6H), 7.60 7.72
(m, 10H), 7.76 7.79 (m 4H), 8.19 8.29 (m, 3H); 13C
NMR (100 MHz, CDCl3): d 70.5, 78.3, 121.0, 124.6,
125.3, 126.2, 127.9, 128.1, 129.0, 129.1, 129.2, 137.3,
140.7, 141.4, 149.6, 150.2, 158.4; IR (KBr): m 1744,
1631, 1493, 1355, 1201, 1328 cm 1; FAB-MS: m/z 759
(M+); HRMS: calcd for C49H37N5O4ÆH
+: 760.2924.
Found: 760.2927.
4.28. 2,6-Bis-(1-(1-naphthyloxycarbonyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 7b
Prepared according to general procedure A using 3
(260 mg, 0.5 mmol), DMAP (184 mg, 1.5 mmol) and 1-
naphthyl chloroformate (240 lL, 1.5 mmol) in dichloro-
methane (20 mL) for 1 h followed by chromatography
on silica gel using MeOH CH2Cl2 as the gradient eluent
afforded pale yellow crystals (369 mg, 84%). Rf 0.60
(CH2Cl2/MeOH 100:5); mp 104 106 C; ½a20D ¼ 7:2
(c 0.34, CHCl3);
1H NMR (400 MHz, CDCl3): d 5.52
(d, J 3.76, 2H), 5.70 (d, J 3.76, 2H), 7.07 (dd,
J 1.00, 7.72, 2H), 7.18 7.31 (m, 6H), 7.38 7.43 (m,
6H), 7.50 (m, 3H), 7.58 7.67 (m, 9H), 7.73 (d,
J 8.12, 2H), 7.79 7.81 (m, 4H), 7.87 (d, J 8.32,
2H), 8.10 (m, 1H), 8.21 (d, J 7.56, 2H); 13C NMR
(100 MHz, CDCl3): d 70.7, 78.3, 117.8, 120.8, 124.8,
125.1, 125.5, 125.8, 126.1, 126.2, 126.5, 127.6, 128.0,
128.2, 129.2, 129.4, 134.3, 137.2, 140.9, 141.6, 145.9,
149.5, 149.7, 158.7; IR (KBr): m 1749, 1335, 1224,
1153 cm 1; FAB-MS: m/z 860 (M+); Anal. Calcd (%)
for C57H41N5O4ÆH2O: C, 77.97; H, 4.94; N, 7.98. Found:
C, 77.88; H, 4.93; N, 7.54.
4.29. 2,6-Bis-(1-(9-fluorenylmethyloxycarbonyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 7c
Prepared according to general procedure A using
3 (208 mg, 0.4 mmol), DMAP (147 mg, 1.2 mmol) and
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9-fluorenylmethyl chloroformate (315 mg, 1.2 mmol) in
dichloromethane (20 mL) for 1 h followed by chroma-
tography on silica gel using MeOH CH2Cl2 as the gra-
dient eluent afforded pale yellow crystals (367 mg, 94%).
Rf 0.40 (CH2Cl2/MeOH 100:5); mp 115 116 C;
½a20D ¼ þ21:7 (c 0.12, CHCl3); 1H NMR (400 MHz,
CD2Cl2): d 3.87 (t, J 6.12, 2H), 4.07 (dd, J 7.92,
10.48, 2H), 4.33 (dd, J 5.68, 10.52, 2H), 5.08 (d,
J 3.36, 2H), 5.15 (d, J 3.16, 2H), 6.88 (dd,
J 1.00, 7.52, 2H), 7.00 (dt, J 1.20, 7.52, 2H), 7.04
(d, J 7.36, 2H), 7.09 7.19 (m, 8H), 7.27 7.35 (m,
8H), 7.38 7.49 (m, 10H), 7.67 (t, J 6.76, 4H), 7.89
7.96 (m, 3H); 13C NMR (100 MHz, CD2Cl2): d 46.7,
68.1, 69.7, 78.6, 119.8, 119.9, 124.0, 124.7, 125.0,
125.1, 126.3, 127.1, 127.6, 127.7, 127.9, 128.0, 129.1,
129.2, 137.4, 141.0, 141.1, 141.2, 142.1, 143.1, 143.9,
149.9, 151.6, 158.5; IR (KBr): m 1731, 1395, 1327,
1135 cm 1; HRMS: calcd for C65H49N5O4ÆH
+:
964.3857. Found: 964.3869; Anal. Calcd (%) for
C65H49N5O4Æ2H2O: C, 78.06; H, 5.34; N, 7.00. Found:
C, 78.69; H, 5.06; N, 6.91.
4.30. 2,6-Bis-(1-((1S,2R,5S)-2-isopropyl-5-methylcyclo-
hexyloxy carbonyl)-[4R,5R]-4,5-diphenyl-4,5-dihydro-
1H-imidazol-2-yl)-pyridine 7d
Prepared according to general procedure A using 3
(400 mg, 0.77 mmol), DMAP (281 mg, 2.31 mmol) and
(+)-menthyl chloroformate (364 lL, 1.69 mmol) in
dichloromethane (10 mL). The residue was purified by
silica gel column chromatography using MeOH CH2Cl2
as the gradient eluent to give a white solid (610 mg, 90%).
Rf 0.34 (CH2Cl2/MeOH 100:2); mp 88 90 C;
½a20D ¼ 1:1 (c 0.50, CHCl3); 1H NMR (400 MHz,
CD2Cl2): d 0.37 (d, 6H), 0.55 (d, 6H), 0.53 0.59 (m,
6H), 0.63 (d, J 8.12, 6H), 0.74 0.88 (m, 2H), 1.05 (m,
2H), 1.34 1.41 (m, 6H), 1.75 (m, 2H), 4.22 (unresolved
ddd, J 4.36, 2H), 5.04 (d, J 3.16, 2H) 5.24 (d,
J 3.16, 2H), 7.24 7.37 (m, 12H), 7.41 7.45 (m, 4H),
7.56 7.58 (m, 4H), 7.84 (d, J 7.16, 1H), 7.84 (d,
J 8.12, 1H), 7.96 (dd, J 7.12, 8.12, 1H); 13C NMR
(100 MHz, CD2Cl2): d 16.9, 21.0, 22.0, 24.1, 26.8, 31.8,
34.6, 40.8, 47.2, 69.9, 77.7, 79.1, 124.1, 125.8, 126.9,
128.4, 128.7, 129.7, 129.8, 137.8, 142.2, 143.1, 151.6,
151.8, 159.1; EI-MS: m/z 884 (M+); Anal. Calcd (%)
for C57H65N5O4: C, 77.43; H, 7.41; N, 7.92. Found: C,
77.04; H, 7.63; N, 7.85.
4.31. 2,6-Bis-(1-((1R,2S,5R)-2-isopropyl-5-methylcyclo-
hexyloxy carbonyl)-[4R,5R]-4,5-diphenyl-4,5-dihydro-
1H-imidazol-2-yl)-pyridine 7e
Prepared according to general procedure A using 3
(400 mg, 0.77 mmol), DMAP (281 mg, 2.31 mmol) and
()-menthyl chloroformate (364 lL, 1.69 mmol) in
dichloromethane (10 mL). The residue was purified by
silica gel column chromatography using MeOH CH2Cl2
as the gradient eluent to give a white solid (640 mg,
94%). Rf 0.34 (CH2Cl2/MeOH 100:2); mp 88
90 C; ½a20D ¼ 48:7 (c 0.25, CHCl3); 1H NMR
(400 MHz, CD2Cl2): d 0.67 (d, 6H), 0.76 (d, 6H),
0.70 0.79 (m, 2H), 0.95 1.13 (m, 6H), 1.39 1.46 (m,
2H), 1.60 1.69 (m, 6H), 1.86 1.90 (m, 2H), 4.58 (unre-
solved ddd, J 4.36, 2H), 5.28 (d, J 3.48, 1H), 5.40
(d, J 3.48, 1H), 7.43 7.62 (m, 12H), 7.58 7.62 (m,
4H), 7.71 7.73 (m, 4H), 8.03 (d, J 6.93, 1H), 8.03 (d,
J 8.32, 1H), 8.14 (dd, J 6.95, 8.32, 1H); 13C NMR
(100 MHz, CD2Cl2): d 16.3, 21.2, 22.3, 23.6, 26.7, 31.9,
34.7, 41.3, 47.6, 70.5, 77.3, 79.3, 124.4, 125.9, 127.0,
128.3, 128.7, 129.7, 129.8, 137.6, 142.1, 143.2, 151.5,
152.3, 159.6; EI-MS: m/z 884 (M+); Anal. Calcd (%)
for C57H65N5O4: C, 77.43; H, 7.41; N, 7.92. Found: C,
77.50; H, 7.65; N, 7.79.
4.32. 2,6-Bis-(1-(1,1-dimethylethyloxy carbonyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1-H-imidazol-2-yl)-pyridine 7f
Prepared according to general procedure A using 3
(260 mg, 0.5 mmol), DMAP (184 mg, 1.5 mmol) and
di-tert-butyldicarbonate (760 lL, 1.5 mmol) in dichloro-
methane (20 mL) for 12 h followed by chromatography
on silica gel using MeOH CH2Cl2 as the gradient eluent
afforded pale yellow crystals (337 mg, 91%). Rf 0.40
(CH2Cl2/MeOH 100:5); mp 84 85 C; ½a20D ¼ 17:1
(c 0.19, CHCl3);
1H NMR (400 MHz, CDCl3): d 1.35
(s, 18H), 5.39 (d, J 3.60, 2H), 5.54 (d, J 3.36, 2H),
7.48 7.57 (m, 6H), 7.64 7.76 (m, 10H), 7.86 (m, 4H),
8.21 (m, 2H), 8.27 (m, 1H); 13C NMR (100 MHz,
CDCl3): d 27.6, 69.4, 77.9, 82.4, 123.4, 124.9, 126.2,
127.6, 128.0, 129.0, 129.2, 137.3, 141.1, 142.2, 150.0,
151.0, 158.9; IR (KBr): m 2976, 1718, 1630, 1368,
1138 cm 1; HRMS: calcd for C45H45N5O4ÆH
+:
720.3550. Found: 720.3530.
4.33. 2,6-Bis-(1-benzyl-[4R,5R]-4,5-diphenyl-4,5-dihydro-
1H-imidazol-2-yl)-pyridine 7g
To a solution of 3 (434 mg, 0.83 mmol) in anhydrous
THF (15 mL) was added sodium hydride (80.2 mg,
3.34 mmol) at 0 C. After 15 min, benzyl bromide
(298 lL, 1.85 mmol) was slowly added and the reaction
mixture stirred at room temperature for 4 h. Then, the
reaction mixture was quenched with water and the aque-
ous phase extracted with dichloromethane (2 · 20 mL).
The organic layer was dried over Na2SO4 and the sol-
vents removed in vacuo to give pale yellow oil, which
was further purified by column chromatography on sil-
ica gel using MeOH CH2Cl2 as the gradient eluent to
afford 7g as a white solid (380 mg, 65%). Rf 0.57
(CH2Cl2/MeOH 100:5); mp 75 78 C; ½a20D ¼ þ33:7
(c 0.14 CHCl3);
1H NMR (400 MHz, CD2Cl2): d 4.02
(d, J 15.5, 2H), 4.38 (d, J 9.1, 2H), 4.92 (d,
J 9.1, 2H), 5.60 (d, J 15.5, 2H), 7.02 (m, 4H), 7.11
(m, 4H), 7.19 7.29 (m, 22H), 8.04 (dd, J 7.5, 8.1,
1H), 8.31 (d, J 7.9, 2H); 13C NMR (400 MHz,
CD2Cl2): d 50.0, 74.4, 78.5, 126.9, 127.6, 127.9, 127.9,
128.4, 128.9, 129.1, 129.2, 129.6, 136.5, 138.1, 138.6,
142.4, 144.6, 150.7, 163.2; EI-MS: m/z 699 (M+); Anal.
Calcd (%) for C49H41N5Æ0.5H2O: C, 83.02; H, 5.97; N,
9.88. Found: C, 82.68; H, 5.49; N, 9.62.
4.34. 2,6-Bis-(1-[toluene-4-sulfonyl]-[4R,5R]-4,5-diphen-
yl-4,5-dihydro-1H-imidazol-2-yl)-pyridine 7h
A 50 mL Schlenk tube was charged with 3 (400 mg, 0.77
mmol),DMAP(281 mg, 2.31 mmol) anddichloromethane
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(15 mL). The resulting mixture was cooled to 0 C, and
tosyl chloride (323 mg, 1.69 mmol) added neat at once.
The ice bath was removed, and the reaction mixture was
stirred at room temperature for 5 h. The solvent was
removed under vacuo, the residue partitioned between
saturated NH4Cl (25 mL) and ethyl acetate (25 mL),
and the aqueous phase re-extracted with ethyl acetate
(2 · 25 mL). The combined organic layer was dried over
MgSO4, and the solvent removed in vacuo. The residue
was crystallized from ethyl acetate/hexane to give 7h as
a white solid (635 mg, 99%). Rf 0.50 (CH2Cl2/MeOH
100:1); mp 105 107 C; ½a20D ¼ 29:6 (c 0.50, CHCl3);
1H NMR (400 MHz, CD2Cl2): d 2.11 (s, 6H), 5.18 (d,
2H), 5.37 (d, 2H), 7.85 (d, J 8.1, 4H), 7.15 7.38 (m,
20H), 7.47 (d, J 8.1, 4H), 8.12 (dd, J 6.5, 8.6, 1H),
8.18 (d, J 6.5, 1H), 8.18 (d, J 8.6, 1H); 13C NMR
(100 MHz, CD2Cl2): d 20.7, 71.0, 78.8, 125.5, 125.8,
125.9, 127.4, 127.5, 127.6, 128.3, 128.5, 129.2, 134.5,
136.4, 140.8, 140.9, 143.9, 149.4, 156.9; EI-MS: m/z
827 (M+); Anal. Calcd (%) for C49H41N5O4S2Æ
(C2H5)2OÆH2O:C, 69.18; H, 5.81; N, 7.61; S, 6.97. Found:
C, 69.36; H, 5.53; N, 7.37; S, 7.28.
4.35. 2,6-Bis-(1-benzyl-[3aR,7aR]-3a,4,5,6,7,7a-hexa-
hydro-1H-benzoimidazol-2-yl)-pyridine 8a
To a solution of 4 (200 mg, 0.62 mmol) in anhydrous
THF (15 mL) was added sodium hydride (59 mg,
2.47 mmol) at 0 C. After 15 min, benzyl bromide
(220 lL, 1.85 mmol) was slowly added and the reaction
mixture stirred at room temperature for 4 h. Then, the
reaction mixture was quenched with water and the aque-
ous phase extracted with dichloromethane (2 · 20 mL).
The organic layer was dried over Na2SO4 and the sol-
vents were removed in vacuo to give a light yellow solid,
which was purified by column chromatography on silica
gel using MeOH CH2Cl2 as the gradient eluent to give
8a as a white solid (213 mg, 68%). Rf 0.50 (CH2Cl2/
MeOH 9:1); mp 183 185 C; ½a20D ¼ þ191:2 (c 0.37,
CHCl3);
1H NMR (400 MHz, CD2Cl2): d 1.07 1.18
(m, 2H), 1.24 1.41 (m, 6H), 1.67 1.85 (m, 6H), 2.25
2.29 (m, 2H), 2.66 (ddd, J 3.3, 11.4, 14.7, 2H), 3.05
(ddd, J 3.3, 11.4, 14.7, 2H), 4.54 (d, J 15.6, 2H),
4.64 (d, J 15.6, 2H), 7.05 (m, 4H), 7.18 (m, 6H), 7.80
(dd, J 7.3, 8.4, 1H), 7.93 (d, J 7.3, 1H), 7.93 (d,
J 8.4, 1H); 13C NMR (100 MHz, CD2Cl2): d 25.2,
26.3, 30.5, 31.9, 51.3, 71.2, 71.4, 125.7, 127.6, 128.7,
138.1, 139.1, 151.1, 165.9; EI-MS: m/z 503 (M+); Anal.
Calcd (%) for C33H37N5ÆH2O: C, 75.97; H, 7.53; N,
13.42. Found: C, 76.07; H, 7.26; N, 13.21.
4.36. 2,6-Bis-(1-[toluene-4-sulfonyl]-[3aR,7aR]-3a,4,5,-
6,7,7a-hexahydro-1H-benzoimidazol-2-yl)-pyridine 8b
A 50 mL Schlenk tube was charged with 4 (323 mg,
1.00 mmol), DMAP (366 mg, 3.00 mmol) and dichloro-
methane (15 mL). The resulting mixture was cooled to
0 C, and tosyl chloride (476 mg, 2.50 mmol) added neat
at once. The ice bath was removed, and the reaction
mixture stirred at room temperature for 5 h. The solvent
was removed under vacuo, the residue partitioned
between saturated NH4Cl (25 mL) and ethyl acetate
(25 mL), and the aqueous phase re-extracted with ethyl
acetate (2 · 25 mL). The combined organic layer was
dried over MgSO4, and the solvent was removed in
vacuo. The residue was crystallized from ethyl acetate/
hexane to give 8b as a white solid (585 mg, 93%).
Rf 0.45 (CH2Cl2/MeOH 100:6); mp 254 255 C;
½a20D ¼ þ60:4 (c 0.50, CHCl3); 1H NMR (400 MHz,
CD2Cl2): d (1.59 1.76m, 6H), 1.9 2.1 (m, 2H), 2.13
2.21 (m, 4H), 2.60 (s, 6H), 2.66 (m, 2H), 2.90 (m, 2H),
3.50 (ddd, J 3.0, 10.9, 13.7, 2H), 3.58 (ddd, J 3.0,
10.9, 13.7, 2H), 7.38 (d, J 8.4, 4H), 7.82 (d, J 8.4,
4H), 7.88 (d, J 7.9, 2H), 8.12 (dd, J 7.5, 8.1, 1H);
13C NMR (100 MHz, CD2Cl2): d 22.1, 25.4, 26.0,
31.5, 31.7, 70.1, 72.7, 125.5, 128.6, 130.2, 136.2,
137.1, 144.8, 151.0, 158.9; EI-MS: m/z 631 (M+); Anal.
Calcd (%) for C33H37N5O4S2: C, 62.73; H, 5.90; N,
11.08; S, 10.15. Found: C, 62.77; H, 5.94; N, 10.99; S,
10.24.
4.37. 1-((4R,5R)-4,5-dihydro-2-(6-((4R,5R)-4,5-dihydro-
4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-yl)-4,5-diphen-
ylimidazol-1-yl)(mesityl)methanone 9
Prepared according to general procedure A using 3
(415 mg, 0.8 mmol), NaH (64 mg, 2.4 mmol) and 2,4,
6-trimethyl benzoyl chloride (448 mg, 2.4 mmol) in reflux-
ing chlorobenzene (20 mL) for 45 h followed by chroma-
tography on silica gel using MeOH CH2Cl2 as the gra-
dient eluent to afford pale yellow crystals (255 mg, 48%).
Rf 0.20 (CH2Cl2/MeOH 100:5); mp 96 98 C;
½a20D ¼ þ47:8 (c 0.16, CHCl3); 1H NMR (400 MHz,
CD2Cl2): d 1.96 (s, 3H), 2.01 (s, 6H), 4.43 (m, 1H),
5.25 (d, J 4.16, 2H), 5.62 (m, 2H), 6.35 (s, 1H), 6.37
(s, 1H); 6.97 7.18 (m 3H), 7.26 7.58 (m, 18H), 7.69 (d,
J 7.32, 2H); 13C NMR (100 MHz, CD2Cl2): d 19.2,
20.6, 69.1, 77.8, 116.7, 122.9, 125.3, 126.2, 126.5,
126.6, 127.2, 127.9, 128.5, 128.8, 129.0, 129.3, 129.4,
142.9, 149.2, 168.7; IR (KBr): m 3423, 2921, 1679,
1430, 1328 cm 1; FAB-MS: m/z 664 (M+); Anal. Calcd
(%) for C45H38N5O1ÆH2O: C, 79.15; H, 5.90; N, 10.25.
Found: C, 79.78; H, 6.29; N, 9.69.
4.38. 1-(3,5-Di-tert-butylphenyl)((4R,5R)-4,5-dihydro-2-
(6-((4R,5R)-4,5-dihydro-4,5-diphenyl-1H-imidazol-2-yl)-
pyridin-2-yl)-4,5-diphenylimidazol-1-yl)methanone 10
Prepared according to general procedure A using 3
(363 mg, 0.7 mmol), DMAP (244 mg, 2.0 mmol) and
3,5-di-tert-butyl benzoyl chloride (524 mg, 2.0 mmol) in
dichloromethane (20 mL) for 12 h followed by chroma-
tography on silica gel using MeOH CH2Cl2 as the gradi-
ent eluent to afford pale yellow crystals (335 mg, 52%).
Rf 0.20 (CH2Cl2/MeOH 100:5); mp 97 99 C;
½a20D ¼ 2:9 (c 0.19, CHCl3); 1H NMR (400 MHz,
CD2Cl2): d 1.13 (s, 18H), 4.77 (d, J 8.52, 1H), 5.06
(d, J 9.32, 1H), 5.26 (d, J 4.56, 1H), 5.31 (unresolved
d, 1H), 7.23 7.45 (m, 23H), 7.81 (t, J 7.92, 1H), 7.93
(dd, J 1.16, 7.72, 1H), 8.19 (dd, J 1.20, 7.92, 1H);
13C NMR (100 MHz, CD2Cl2): d 30.9, 34.6, 70.3, 72.6,
78.8, 81.1, 122.4, 123.5, 125.5, 125.9, 126.2, 126.5,
126.6, 127.2, 128.0, 128.5, 128.7, 128.9, 129.2, 134.9,
137.2, 140.8, 141.6, 147.9, 149.6, 150.8, 160.3, 161.7,
170.6; IR (KBr): m 3414, 2962, 1673, 1332 cm 1;
HRMS: calcd for C50H49N5OÆH
+: 736.4015. Found:
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736.3992; Anal. Calcd (%) for C50H49N5O1ÆH2O: C,
79.65; H, 6.82; N, 9.29. Found: C, 80.10; H, 6.71; N, 8.88.
4.39. 1-((1R,2R,5S)-2-isopropyl-5-methylcyclohexyloxy-
carbonyl)(4R,5R)-4,5-dihydro-2-(6-((4R,5R)-4,5-dihydro-
4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-yl)-4,5-di-phenyl-
imidazole-1-carboxylate 11
Prepared according to general procedure A using 3
(260 mg, 0.50 mmol), DMAP (61 mg, 0.5 mmol) and
(+)-menthyl chloroformate (90 lL, 0.42 mmol) in
dichloromethane (20 mL) for 2 h followed by chroma-
tography on silica gel using MeOH CH2Cl2 as the gra-
dient eluent to afford pale yellow crystals (126 mg, 36%);
Rf 0.20 (CH2Cl2/MeOH 100:5); mp 72 73 C;
½a20D ¼ þ60:6 (c 0.23, CHCl3). 1H NMR (400 MHz,
CD2Cl2): d 0.43 (d, J 6.94, 3H), 0.56 (d, J 6.98,
3H), 0.71 0.83 (m, 4H), 0.84 (d, J 6.52, 3H), 1.46
1.68 (m, 5H), 1.94 (br d, 1H), 4.33 (dt, J 4.16, 10.68,
1H), 4.85 (br d, J 7.92, 1H), 5.11 5.17 (m, 3H),
7.31 7.44 (m, 20H), 7.87 (dd, J 1.2, 7.76, 1H), 7.99
(t, J 7.72, 1H), 8.42 (dd, J 1.2, 7.92, 1H); 13C
NMR (100 MHz, CD2Cl2): d 15.4, 20.6, 21.8, 22.8,
25.4, 31.3, 34.0, 40.8, 46.8, 70.2, 76.8, 78.4, 123.4,
125.1, 125.7, 126.3, 127.9, 128.9, 129.1, 137.0, 141.7,
142.6, 147.9, 158.6, 162.1; IR (KBr): m 3421 (br),
2955, 1726, 1433 cm 1; EI-MS: m/z 701 (M+); HRMS:
calcd for C46H47N5O2ÆH
+: 702.3777. Found: 702.3808.
4.40. 1-((4R,5R)-4,5-Dihydro-2-(6-((4R,5R)-4,5-
dihydro-4,5-diphenyl-1H-imidazol-2-yl)pyridin-2-yl)-4,5-
diphenylimidazol-1-yl)(diphenyl)phosphine oxide 12
Prepared according to general procedure A using 3
(208 mg, 0.4 mmol), DMAP (147 mg, 1.2 mmol) and
diphenylphosphinyl chloride (230 lL, 1.2 mmol) in 1,2-
dichloromethane (20 mL) for 8 h followed by chroma-
tography on silica gel using MeOH CH2Cl2 as the gra-
dient eluent to afford pale yellow crystals (218 mg, 72%).
Rf 0.20 (CH2Cl2/MeOH 100:5); mp 121 122 C;
½a20D ¼ þ53:1 (c 0.72, CHCl3); 1H NMR (400 MHz,
CD2Cl2): d 4.59 (t, J 2.76, 1H), 4.89 (d, J 8.32,
1H), 5.11 (d, J 8.52, 1H), 5.16 (d, J 2.16, 1H),
7.08 7.13 (m, 6H), 7.21 7.34 (m, 13H), 7.39 7.50 (m,
1H), 7.79 (t, J 7.72, 1H), 8.12 (dd, J 1.00, 7.72,
1H), 8.26 (dd, J 1.20, 7.92, 1H); 13C NMR
(100 MHz, CD2Cl2): d 70.0, 74.8, 78.2, 78.8, 124.1,
125.3, 125.8, 126.2, 126.9, 127.1, 127.8, 127.9, 128.1,
128.2, 128.3, 128.8, 129.0, 131.2, 131.6, 131.8, 131.9,
135.8, 137.4, 142.2, 142.7, 147.3, 147.9, 154.8, 160.9,
161.7; IR (KBr): m 3422 (br), 1605, 1451, 1209
(P@O), 1122 cm 1; HRMS: calcd for C47H38N5POÆH
+:
720.2852. Found: 720.2868; Anal. Calcd (%) for
C47H38N5POÆH2O: C, 76.50; H, 5.46; N, 9.49. Found:
C, 76.05; H, 4.96; N, 9.13.
4.41. 2-(1-(2,4,6-Trimethyl-benzoyl)-[4R,5R]-4,5-diphen-
yl-4,5-dihydro-1H-imidazol-2-yl)-6-(1-((1R,2R,5S)-2-
iso-propyl-5-methylcyclohexyl-3-oxycarbonyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine 13
Prepared according to general procedure A using 9
(193 mg, 0.28 mmol), DMAP (70 mg, 0.57 mmol) and
(+)-menthyl chloroformate (130 lL, 0.57 mmol) in
dichloromethane (10 mL) for 6 h followed by chromato-
graphy on silica gel using MeOH CH2Cl2 as the gradi-
ent eluent to afford pale yellow crystals (247 mg, 99%).
Rf 0.80 (CH2Cl2/MeOH 100:5); mp 94 96 C;
½a20D ¼ 23:9 (c 0.13, CHCl3); 1H NMR (400 MHz,
CD2Cl2): d 0.44 (d, J 6.52, 3H), 0.51 (d, J 6.92,
3H), 0.57 (d, J 7.12, 3H), 0.59 0.95 (m, 5H), 1.16
1.46 (m, 4H), 2.02 (s, 6H), 2.08 (s, 3H), 4.21 (dt,
J 4.36, 10.68, 1H), 5.15 (d, J 3.16, 1H), 5.20 (d,
J 4.52, 1H), 5.24 (d, J 4.36, 1H), 5.72 (d, J
3.20, 1H), 6.38 (s, 1H), 6.47 (s, 1H), 7.31 7.58 (m,
21H), 7.74 (d, J 7.12, 2H); 13C NMR (100 MHz,
CD2Cl2): d 15.9, 19.4, 19.9, 20.3, 20.6, 21.4, 23.0,
25.8, 31.1, 33.8, 40.0, 46.1, 68.5, 69.7, 77.0, 77.5,
78.4, 122.7, 123.5, 125.2, 125.3, 125.4, 126.3, 126.4,
127.3, 127.8, 127.9, 128.0, 128.3, 128.9, 129.1, 129.4,
132.8, 135.8, 136.6, 139.1, 141.1, 142.5, 142.7, 149.8,
151.2, 157.8, 168.5; IR (KBr): m 2954, 2926, 1716,
1673, 1334 cm 1; HRMS: calcd for C56H57N5O3ÆH
+:
848.4540. Found: 848.4515; Anal. Calcd (%) for
C56H57N5O3ÆH2O: C, 77.66; H, 6.67; N, 8.08. Found:
C, 77.22; H, 7.15; N, 7.58.
4.42. 2-(1-((4R,5R)-(1R,2R,5S)-2-Isopropyl-5-methyl-
cyclohexyl-3-oxycarbonyl)-[4R,5R]-4,5-diphenyl-4,5-
dihydro-1H-imidazol-2-yl)-6-(1-(acetyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)pyridine 14
Prepared according to general procedure A using 11
(220 mg, 0.31 mmol), DMAP (116 mg, 0.94 mmol) and
acetyl chloride (69 lL, 0.94 mmol) in dichloromethane
(10 mL) for 2 h followed by chromatography on silica
gel using MeOH CH2Cl2 as the gradient eluent to afford
a pale yellow solid (189 mg, 81%). Rf 0.50 (CH2Cl2/
MeOH 100:5); mp 73 74 C; ½a20D ¼ 11:1 (c 0.23,
CHCl3);
1H NMR (300 MHz, CD2Cl2): d 0.42 (d,
J 6.57, 3H), 0.55 (d, J 6.99, 3H), 0.67 (d, J 7.14,
3H), 0.61 0.96 (m, 4H), 1.39 1.46 (m, 2H), 1.61 1.73
(m, 3H), 1.90 (s, 3H), 4.28 (dt, J 4.35, 10.74, 1H),
5.08 (d, J 2.64, 1H), 5.14 (d, J 3.39, 1H), 5.25 (d,
J 3.39, 1H), 5.36 (d, J 2.64, 1H), 7.28 7.47 (m,
17H), 7.56 7.58 (m, 3H), 7.90 (dd, J 1.86, 6.78, 1H),
8.03 (d, J 2.07, 2H); 13C NMR (75 MHz, CD2Cl2):
d 16.0, 20.4, 21.3, 23.1, 24.5, 25.9, 31.1, 33.9, 40.3,
46.6, 69.5, 69.8, 76.9, 78.1, 78.4, 124.0, 124.1, 125.1,
126.3, 127.8, 128.0, 129.1, 129.3, 137.8, 141.0, 141.4,
141.7, 142.5, 150.5, 151.2, 158.4, 158.7, 167.9; IR
(KBr): m 2955, 1717, 1627, 1453, 1373 cm 1; EI-MS:
m/z 743 (M+); HRMS: calcd for C48H49N5O3ÆH
+:
744.3908. Found: 744.3897.
4.43. General procedure for the preparation of
Ru(pybim)(pydic) complexes (procedure B)
A 25 mL oven dried Schlenk tube was charged with
[Ru(p-cymene)Cl2]2 (306 mg, 0.5 mmol) and pybim
(1 mmol) in 10 mL methanol. In another 25 mL Schlenk
tube 2,6-pyridinedicarboxylate disodium salt (211 mg,
1 mmol) was dissolved in a mixture of water (5 mL)
and methanol (5 mL). The solution was purged with
argon for ca. 10 min and then transferred via a cannula
into the Schlenk tube containing the ruthenium source
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at rt. The mixture was then heated at 65 C for 1 h,
cooled to rt and then diluted with CH2Cl2 (30 mL).
The mixture was washed with water (2 · 20 mL), dried
over Na2SO4, concentrated and purified by column
chromatography on silica gel using MeOH CH2Cl2 as
the gradient eluent to give the Ru(pybim)(pydic) com-
plex as a dark brown solid after crystallization from
CH2Cl2 hexane.
4.44. Ruthenium{2,6-bis-(1-benzoyl-[4R,5R]-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-2,6-
dicarboxylate} 15a
Prepared according to general procedure B using
6a (100 mg, 0.14 mmol), [Ru(p-cymene)Cl2]2 (42 mg,
0.070 mmol) and Na2pydic (29 mg, 0.140 mmol) to give
15a as a dark brown solid (78 mg, 56%). Rf 0.37
(CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CD2Cl2):
d 4.42 (d, J 4.1, 2H), 5.16 (d, J 4.6, 2H), 6.56 (d,
J 7.7, 4H), 6.92 (d, J 7.3, 4H), 7.03 7.06 (m, 4H),
7.17 (t, J 7.5, 4H), 7.23 7.29 (m, 10H), 7.42 7.50
(m, 8H), 7.61 7.65 (m, 1H), 7.73 (t, J 8.1, 1H), 8.22
(d, J 8.1, 2H); 13C NMR (100 MHz, CD2Cl2): d
74.1, 77.5, 125.9, 126.2, 126.3, 126.4, 128.5, 128.7,
128.7, 128.8, 129.2, 129.4, 132.7, 133.6, 134.9, 135.8,
136.3, 140.3, 149.0, 150.3, 163.1, 170.2, 170.4; UV vis
(CH2Cl2: kmax/nm, log e): 374 (4.00), 493 (4.26); FAB-
MS: m/z 994 (M+); Anal. Calcd (%) for C56H40N6O6-
RuÆ0.5H2O: C, 65.47; H, 3.99; N, 8.11. Found: C,
65.60; H, 4.09; N, 8.06.
4.45. Ruthenium{2,6-bis-(1-(2-methylbenzoyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}-
{pyridine-2,6-dicarboxylate} 15b
Prepared according to general procedure B using [Ru(p-
cymene)Cl2]2 (80 mg, 0.13 mmol), pybim 6b (206 g,
0.26 mmol) and disodium 2,6-pyridinedicarboxylate
(55 mg, 0.26 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
3% MeOH CH2Cl2 to afford 15b as a dark brown pow-
der (258 mg, 93%). Rf 0.25 (CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CDCl3): d 2.32 (s, 6H), 4.69 (d,
J 4.36, 2H), 5.08 (d, J 3.96, 2H), 6.84 (d, J 6.92,
4H), 6.89 (d, J 7.16, 4H), 7.15 7.23 (m, 3H), 7.31
7.51 (m, 19H), 7.74 7.83 (m, 3H), 8.02 (t, J 8.12,
1H), 8.80 (d, J 8.12, 2H); 13C NMR (100 MHz,
CDCl3): d 19.1, 31.5, 73.6, 125.3, 125.9, 126.1, 126.9,
127.0, 127.3, 128.8, 128.9, 129.2, 129.3, 130.8, 130.9,
133.6, 134.3, 136.4, 139.7, 148.6, 150.6, 162.6, 169.4,
170.5; UV vis (CH2Cl2: kmax/nm, log e): 491 (4.30),
365 (3.98); FAB-MS: m/z 1023 (M++1); HRMS: calcd
for C58H44N6O6RuÆH
+: 1023.2444. Found: 1023.2422.
Anal. Calcd (%) for C58H44N6O6RuÆH2O: C, 66.98; H,
4.46; N, 8.08. Found: C, 66.50; H, 4.01; N, 7.67.
4.46. Ruthenium{2,6-bis-(1-(4-methoxy-benzoyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}-
{pyridine-2,6-dicarboxylate} 15c
Prepared according to general procedure B using
6c (200 mg, 0.25 mmol), [Ru(p-cymene)Cl2]2 (78 mg,
0.13 mmol) and Na2pydic (54 mg, 0.25 mmol) to give
15c as a dark brown solid (200 mg, 75%). Rf 0.34
(CH2Cl2/MeOH 20:1);
1H NMR (400 MHz, CD2Cl2):
d 3.97 (s, 6H), 4.40 (d, J 4.0, 2H), 5.20 (d, J 4.0,
2H), 6.56 (dd, J 8.1, 1.2 Hz, 4H), 6.77 (unresolved
dd, 4H), 7.98 (m, 4H), 7.17 (tt, J 1.0, 7.4, 2H), 7.25
7.31 (m, 6H), 7.45 7.50 (m, 6H), 7.62 (dd, J 7.1, 8.1,
1H), 7.70 (d, J 8.1, 1H), 8.12 (d, J 8.1, 2H); 13C
NMR (100 MHz, CD2Cl2): d 55.6, 74.4, 77.5, 113.8,
125.5, 125.9, 125.9, 125.9, 126.3, 126.3, 128.6, 128.8,
129.1, 129.4, 131.2, 134.7, 136.4, 140.6, 149.1, 150.3,
163.5, 163.5, 170.1, 170.2; UV vis (CH2Cl2: kmax/nm,
log e): 372 (3.99), 491 (4.23); FAB-MS: m/z 1055
(M++1); Anal. Calcd (%) for C58H44N6O8RuÆ2H2O:
C, 63.90; H, 4.44; N, 7.71. Found: C, 63.96; H, 4.39;
N, 7.52.
4.47. Ruthenium{2,6-bis-(1-(4-trifluoromethyl-benzoyl)-
[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyri-
dine}{pyridine-2,6-dicarboxylate} 15d
Prepared according to general procedure B using
6d (200 mg, 0.25 mmol), [Ru(p-cymene)Cl2]2 (76 mg,
0.12 mmol) and Na2pydic (53 mg, 0.25 mmol) to give
15d as a dark brown solid (200 mg, 71%). Rf 0.40
(CH2Cl2/MeOH 100:6);
1H NMR (400 MHz, CD2Cl2):
d 4.45 (d, J 4.2, 2H), 5.10 (d, J 4.2, 2H), 6.55 (dd,
J 8.1, 0.9, 4H), 6.88 (unresolved dd, 4H), 7.04 (unre-
solved dd, 4H), 7.18 (unresolved tt, 2H), 7.24 7.33 (m,
6H), 7.48 (d, J 7.5, 2H), 7.51 7.55 (m, 8H), 7.63
(dd, J 7.8, 7.6, 1H), 7.82 (t, J 8.1, 1H), 8.35 (d,
J 8.1, 2H); 13C NMR (100 MHz, CD2Cl2): d 74.1,
77.7, 125.5, 126.5, 125.9, 126.0, 126.3, 126.4, 126.5,
128.8, 128.9, 129.1, 129.3, 129.6, 133.9, 135.1, 136.0,
137.0, 139.8, 148.8, 150.1, 162.5, 169.0, 170.1; UV vis
(CH2Cl2: kmax/nm, log e): 376 (4.00), 494 (4.25); FAB-
MS: m/z 1130 (M+); Anal. Calcd (%) for C58H38N6O6-
F6RuÆH2O: C, 60.68; H, 3.51; N, 7.32. Found: C,
60.51; H, 3.38; N, 7.12.
4.48. Ruthenium{2,6-bis-(1-(2,6-dimethoxybenzoyl)-
[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-
pyridine}{pyridine-2,6-dicarboxylate} 15e
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (55 mg, 0.09 mmol), 6e (156 mg,
0.17 mmol) and disodium 2,6-pyridinedicarboxylate
(36 mg, 0.17 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
2.5% MeOH CH2Cl2 to give 15e as a dark brown pow-
der (84 mg, 42%). Rf 0.25 (CH2Cl2/MeOH 100:5);
1H
NMR (400 MHz, CD2Cl2): d 3.15 (s, 6H), 3.60 (s, 6H),
4.26 (d, J 3.56, 2H), 4.91 (br s, 2H), 6.24 (d,
J 6.76, 2H), 6.47 6.64 (m, 10H), 7.03 7.26 (m, 14H),
7.48 (d, J 7.52, 2H), 7.62 (t, J 7.36, 1H), 7.86 (br
s, 1H), 9.03 (br s, 2H); 13C NMR (100 MHz, CD2Cl2):
d 55.6, 72.2, 78.5, 103.3, 103.8, 113.9, 125.8, 126.0,
126.5, 128.3, 128.5, 128.7, 128.9, 131.5, 133.8, 137.2,
140.1, 148.6, 150.7, 164.5; UV vis (CH2Cl2: kmax/nm,
log e): 488 (4.65); FAB-MS: m/z 1116 (M++2); HRMS:
calcd for C60H48N6O10RuÆH
+: 1115.2554. Found:
1115.2559. Anal. Calcd (%) for C60H48N6O10RuÆ2H2O:
C, 62.66; H, 4.56; N, 7.31. Found: C, 62.79; H, 4.94;
N, 7.01.
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4.49. Ruthenium{2,6-bis-(1-(2,4,6-trimethylbenzoyl)-
[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-
pyridine}{pyridine-2,6-dicarboxylate} 15f
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (98 mg, 0.16 mmol), 6f (266 mg,
0.33 mmol) and disodium 2,6-pyridinedicarboxylate
(70 mg, 0.33 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 15f as
a dark brown powder (217 mg, 59%). Rf 0.40
(CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CD2Cl2):
d 1.56 (s, 6H), 1.99 (s, 6H), 2.25 (s, 6H), 4.50 (d,
J 3.16, 2H), 4.62 (unresolved d, 2H), 6.46 (d,
J 7.52, 4H), 6.61 (m, 6H), 6.80 (s, 2H), 7.05 7.26
(m, 12H), 7.44 (d, J 7.52, 2H), 7.55 (t, J 7.76,
1H), 7.91 (t, J 8.12, 1H), 8.92 (d, J 7.72, 2H); 13C
NMR (100 MHz, CD2Cl2): d 18.3, 19.0, 20.9, 72.9,
76.0, 125.8, 126.1, 126.4, 127.7, 128.2, 128.4, 128.6,
128.9, 129.1, 132.2, 132.9, 135.0, 135.4, 135.8, 136.6,
139.8, 148.7, 150.8, 162.6, 169.2, 170.3; UV vis
(CH2Cl2: kmax/nm, log e): 763 (3.28), 489 (4.32), 356
(4.03); HRMS: calcd for C62H52N6O6RuÆH
+:
1079.3070. Found: 1079.3099. Anal. Calcd (%) for
C62H52N6O6RuÆH2O: C, 67.19; H, 4.91; N, 7.58. Found:
C, 67.25; H, 4.96; N, 7.28.
4.50. Ruthenium{2,6-bis-(1-(3,5-bis-(1,1-dimethylethyl)-
benzoyl)-[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-
2-yl)-pyridine}{pyridine-2,6-dicarboxylate} 15g
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (49 mg, 0.08 mmol), 6g (164 mg,
0.17 mmol) and disodium 2,6-pyridinedicarboxylate
(36 mg, 0.17 mmol) in a mixture of tert-amylalcohol/
MeOH/H2O (12:5:1 mL) at 65 C for 2 h followed by
chromatography on silica gel using MeOH CH2Cl2 as
the gradient eluent to afford 15g as a dark brown pow-
der (96 mg, 43%). Rf 0.35 (CH2Cl2/MeOH 100:5);
1H
NMR (400 MHz, CD2Cl2): d 1.12 (s, 36H), 4.33 (d,
J 3.96, 2H), 5.19 (d, J 3.96, 2H), 6.56 (d, J 7.16,
4H), 6.97 (m, 4H), 7.04 (t, J 7.92, 4H), 7.14 7.19
(m, 2H), 7.26 7.30 (m, 10H), 7.47 7.52 (m, 4H), 7.62
(t, J 7.92, 1H), 7.77 (t, J 8.12, 1H), 8.28 (d,
J 8.32, 2H); 13C NMR (100 MHz, CD2Cl2): d 30.8,
34.7, 73.9, 77.8, 122.7, 125.6, 125.9, 126.1, 126.3,
126.4, 127.2, 128.7, 129.2, 129.6, 132.9, 134.8, 136.3,
140.4, 149.0, 150.4, 151.5, 163.3, 170.1, 171.5; UV vis
(CH2Cl2: kmax/nm, log e): 595 (3.64), 491 (4.32), 371
(4.02); HRMS: calcd for C72H72N6O6RuÆH
+:
1219.4635. Found: 1219.4702. Anal. Calcd (%) for
C72H72N6O6RuÆH2O: C, 69.94; H, 6.03; N, 6.80. Found:
C, 69.96; H, 5.75; N, 6.64.
4.51. Ruthenium{2,6-bis-(1-(2-phenylacetyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}
{pyridine-2,6-dicarboxylate} 15h
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (107 mg, 0.17 mmol), 6h (264 mg,
0.35 mmol) and disodium 2,6-pyridinedicarboxyl-
ate (74 mg, 0.35 mmol) in MeOH/H2O (15:5 mL) at
65 C for 1 h followed by chromatography on silica gel
using MeOH CH2Cl2 as the gradient eluent to afford
15h as a dark brown powder (54 mg, 30%). Rf
0.25 (CH2Cl2/MeOH 100:5);
1H NMR (400 MHz,
CD2Cl2): d 3.68 (s, 4H), 4.28 (d, J 3.76, 2H),
5.28 (d, J 3.76, 2H), 6.44 (d, J 7.32, 4H), 6.96
7.02 (m, 6H), 7.07 7.15 (m, 8H), 7.21 7.25 (m, 6H),
7.31 7.44 (m, 6H), 7.56 7.66 (m, 3H), 7.76 (t, J
8.32, 1H), 8.65 (d, J 8.32, H); 13C NMR (100 MHz,
CD2Cl2): d 42.3, 71.2, 76.8, 125.4, 125.9, 126.1, 127.4,
127.8, 128.6, 128.8, 129.1, 129.2, 129.9, 132.9,
134.8, 135.8, 136.6, 140.0, 140.4, 152.5, 161.7, 170.1,
172.5; UV vis (CH2Cl2: kmax/nm, log e): 488 (4.32);
HRMS: calcd for C58H44N6O6RuÆH
+: 1023.2442.
Found: 1023.2456.
4.52. Ruthenium{2,6-bis-(1-(2,2-diphenylacetyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}-
{pyridine-2,6-dicarboxylate} 15i
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (73 mg, 0.12 mmol), 6i (215 mg,
0.23 mmol) and disodium 2,6-pyridinedicarboxy-
late (49 mg, 0.23 mmol) in MeOH/H2O (15:5 mL) at
65 C for 1 h followed by chromatography on silica
gel using MeOH CH2Cl2 as the gradient eluent to
afford 15i as a dark brown powder (137 mg, 49%).
Rf 0.45 (CH2Cl2/MeOH 100:5);
1H NMR (400 MHz,
CD2Cl2): d 4.21 (d, J 3.56, 2H), 5.01 (s, 2H),
5.18 (d, J 3.60, 2H), 6.28 (d, J 7.92, 4H), 6.87
(t, J 7.72, 4H), 6.93 6.95 (m, 4H); 7.05 7.27 (m,
22H), 7.39 7.42 (m, 8H), 7.58 (t, J 7.32, 1H),
7.72 (t, J 8.32, 1H), 8.61 (d, J 8.32, 2H); 13C
NMR (100 MHz, CD2Cl2): d 56.7, 70.7, 76.7,
125.1, 125.9, 126.7, 127.5, 127.8, 127.9, 128.3,
128.4, 128.9, 129.1, 129.3, 129.4, 130.0, 134.9, 136.0,
136.5, 138.8, 140.1, 148.6, 150.3, 161.9, 170.0, 170.3;
UV vis (CH2Cl2: kmax/nm, log e): 488 (4.32), 356
(4.04); HRMS: calcd for C70H52N6O6Ru: 1175.3118.
Found: 1175.3105. Anal. Calcd (%) for C70H52N6O6-
RuÆ2H2O: C, 69.47; H, 4.66; N, 6.94. Found: C, 69.12;
H, 4.40; N, 6.73.
4.53. Ruthenium{2,6-bis-(1-naphthoyl-[4R,5R]-4,5-diphen-
yl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-2,6-
dicarboxylate} 15j
Prepared according to general procedure B using 6j
(500 mg, 0.60 mmol), [Ru(p-cymene)Cl2]2 (184 mg,
0.30 mmol) and Na2pydic (126 mg, 0.60 mmol) to afford
15j as a dark brown solid (262 mg, 40%). Rf 0.31
(CH2Cl2/MeOH 100:6);
1H NMR (400 MHz, CD2Cl2):
d 4.43 (d, J 3.9, 2H), 4.90 (d, J 3.9, 2H), 6.61 (m,
8H), 7.02 7.24 (m, 16H), 7.39 7.42 (m, 2H), 7.45 49
(m, 4H), 7.60 (dd, J 7.1, 8.1, 1H), 7.82 7.90 (m,
7H), 7.95 (d, J 8.1, 2H); 13C NMR (100 MHz,
CD2Cl2): d 73.8, 76.9, 116.7, 124.2, 124.5, 125.9, 125.9,
126.2, 126.6, 126.6, 126.7, 127.1, 127.6, 128.4, 128.7,
129.1, 129.1, 129.6, 131.2, 130.7, 133.5, 135.0, 136.3,
140.0, 148.8, 150.5, 162.7, 169.1, 170.2; UV vis
(CH2Cl2: kmax/nm, log e): 492 (4.26); FAB-MS: m/z
1094 (M+); Anal. Calcd (%) for C64H44N6O6RuÆ2H2O:
C, 68.01; H, 4.28; N, 7.44. Found: C, 67.94; H, 4.00;
N, 7.22.
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4.54. Ruthenium{2,6-bis-(2-naphthoyl-[4R,5R]-4,5-diphen-
yl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-2,6-
dicarboxylate} 15k
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (104 mg, 0.17 mmol), 6k (286 mg,
0.34 mmol) and disodium 2,6-pyridinedicarboxylate
(72 mg, 0.34 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
2% MeOH CH2Cl2 to afford 15k as a dark brown pow-
der (247 mg, 64%). Rf 0.30 (CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CDCl3): d 4.79 (d, J 4.16, 2H),
5.40 (d, J 4.16, 2H), 6.88 (d, J 7.16, 4H), 7.16 (d,
J 6.96, 4H), 7.37 (t, J 7.72, 4H), 7.47 7.59 (m,
10H), 7.76 7.86 (m, 10H), 8.55 (d, J 8.12, 2H);
13C NMR (100 MHz, CDCl3): d 31.83, 74.35, 124.6,
125.9, 126.1, 126.7, 127.0, 127.7, 128.4, 128.5, 128.8,
128.9, 129.3, 129.6, 130.2, 131.7, 134.2, 135.0, 136.2,
140.6, 148.8, 150.5, 163.4, 170.5, 170.7; UV vis
(CH2Cl2: kmax/nm, log e): 495 (4.37), 378 (4.05); FAB-
MS: m/z 1095 (M++1); HRMS: calcd for C64H44N6-
O6Ru: 1094.2366. Found: 1094.2395. Anal. Calcd (%)
for C64H44N6O6RuÆ2H2O: C, 68.02; H, 4.28; N, 7.44.
Found: C, 68.20; H, 4.88; N, 7.01.
4.55. Ruthenium{2,6-bis-(1-[(2S)-2-(6-methoxy-naphthal-
en-2-yl)-propionyl]-[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-
imidazol-2-yl)-pyridine}{pyridine-2,6-dicarboxylate} 15l
Prepared according to general procedure B using 6l
(150 mg, 0.16 mmol), [Ru(p-cymene)Cl2]2 (49 mg,
0.080 mmol) and Na2pydic (34.0 mg, 0.16 mmol) to
afford 15l as a dark brown solid (150 mg, 78%).
Rf 0.45 (CH2Cl2/MeOH 100:6);
1H NMR (400 MHz,
CD2Cl2): d 1.50 (d, J 6.5, 6H), 3.80 (q, J 6.5, 2H),
3.86 (s, 6H), 4.05 (d, J 3.1, 2H), 5.18 (d, J 3.1,
2H), 6.02 (d, J 7.7, 2H), 6.46 (t, J 7.6, 4H), 6.72
(t, J 7.4, 2H), 7.01 (unresolved d, 2H), 7.07 7.10 (m,
6H), 7.24 (unresolved dd, 2H), 7.33 (d, J 7.8, 2H),
7.37 (m, 6H), 7.50 (t, J 7.8, 1H), 7.59 (t, 6H), 7.93
(t, J 8.3 Hz, 1H), 8.86 (d, J 8.3, 2H); 13C NMR
(100 MHz, CD2Cl2): d 20.8, 45.6, 55.3, 69.9, 76.5, 78.8,
105.5, 116.9, 119.2, 125.2, 125.4, 125.5, 125.6, 125.8,
127.9, 127.9, 128.1, 128.5, 129.0, 129.1, 129.3, 129.9,
133.8, 134.1, 136.1, 140.2, 148.6, 150.6, 158.0, 162.3,
169.9, 171.9; UV vis (CH2Cl2: kmax/nm, log e): 333
(3.65), 488 (4.27); FAB-MS: m/z 1211 (M+); Anal. Calcd
(%) for C70H56N6O8Ru: C, 69.47; H, 4.66; N, 6.94.
Found: C, 69.96; H, 4.49; N, 6.64.
4.56. Ruthenium{2,6-bis-(1-(2-(1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl-3-oxy-acetyl)-[4R,5R]-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-2,6-
dicarboxylate} 15m
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (168 mg, 0.27 mmol), 6m (500 mg,
0.55 mmol) and disodium 2,6-pyridinedicarboxylate
(116 mg, 0.55 mmol) in MeOH/H2O (15:5 mL) at
65 C for 1 h followed by chromatography on silica gel
using MeOH CH2Cl2 as the gradient eluent to afford
15m as a dark brown powder (297 mg, 46%). Rf 0.30
(CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CD2Cl2):
d 0.69 (d, J 6.92, 6H), 0.81 (d, J 6.92, 6H), 0.84
(d, J 6.56, 6H), 0.87 0.95 (m, 4H), 1.00 1.07 (m,
2H), 1.21 1.31 (m, 4H), 1.52 1.60 (m, 4H), 1.81 1.84
(m, 2H), 2.03 2.09 (m, 2H), 3.08 (dt, J 3.96, 10.52,
2H), 3.95 (d, J 14.68, 2H), 4.17 (d, J 14.68, 2H),
4.32 (d, J 3.96, 2H), 5.42 (d, J 3.96, 2H), 6.54 (d,
J 7.12, 4H), 7.02 7.10 (m, 8H), 7.17 7.21 (m, 2H),
7.32 7.34 (m, 6H), 7.45 (d, J 7.52, 2H), 7.61 (t,
J 8.32, 1H), 7.83 (t, J 8.32, 1H), 8.73 (d, J 8.36,
2H); 13C NMR (100 MHz, CD2Cl2): d 15.9, 20.7, 21.9,
23.1, 25.5, 31.4, 34.3, 39.8, 47.9, 68.2, 70.6, 77.2, 80.8,
125.4, 125.9, 126.2, 127.7, 128.7, 129.1, 129.2, 129.7,
136.7, 140.1, 148.8, 150.4, 162.0, 168.6, 170.1; UV vis
(CH2Cl2: kmax/nm, log e): 352 (3.92), 488 (4.28); HRMS:
calcd for C66H72N6O8Ru: 1178.4456. Found: 1178.4506.
Anal. Calcd (%) for C66H72N6O8RuÆH2O: C, 66.26; H,
6.23; N, 7.02. Found: C, 66.57; H, 6.36; N, 6.78.
4.57. Ruthenium{2,6-bis-(1-adamantoyl-[4R,5R]-4,5-di-
phenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-
2,6-dicarboxylate} 15n
Prepared according to general procedure B using 6n
(150 mg, 0.18 mmol), [Ru(p-cymene)Cl2]2 (54 mg,
0.09 mmol) and Na2pydic (37 mg, 0.18 mmol) to afford
15n as a dark brown solid (130 mg, 66%). Rf 0.35
(CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CD2Cl2):
d 1.56 (m, 6H), 1.65 (m, 8H), 1.82 1.85 (m, 6H), 1.90
1.96 (m, 12H), 4.26 (d, J 2.7, 2H), 5.53 (d, J 2.7,
2H), 6.52 (m, 4H), 7.04 7.08 (m, 8H), 7.19 (m, 2H),
7.29 7.33 (m, 6H), 7.48 (d, J 7.5, 2H), 7.64 (dd,
J 8.1, 7.3, 1H), 7.83 (dd, J 8.7, 7.5, 1H) 7.96 (d,
J 7.7, 2H); 13C NMR (100 MHz, CD2Cl2): d 28.1,
36.1, 39.4, 44.2, 71.5, 78.8, 125.1, 125.2, 125.8, 126.2,
126.6, 128.6, 128.7, 129.2, 129.5, 134.6, 136.1, 140.6,
149.1, 150.7, 165.1, 170.0, 181.1; UV vis (CH2Cl2:
kmax/nm, log e): 458 (3.96), 487 (4.22); FAB-MS: m/z
1111 (M++1); Anal. Calcd (%) for C64H60N6O6RuÆH2O:
C, 68.13; H, 5.54; N, 7.45. Found: C, 67.65; H, 5.59; N,
7.14.
4.58. Ruthenium{2,6-bis-(1-acetyl-[4R,5R]-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-2,6-
dicarboxylate} 15o
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (152 mg, 0.25 mmol), 6o (300 mg,
0.50 mmol) and disodium 2,6-pyridinedicarboxylate
(105 mg, 0.50 mmol) in MeOH/H2O (15:5 mL) at
65 C for 1 h followed by chromatography on silica gel
using MeOH CH2Cl2 as the gradient eluent to afford
15o as a dark brown powder (292 mg, 68%). Rf 0.35
(CH2Cl2/MeOH 100:5);
1H NMR (300 MHz, CD2Cl2):
d 2.15 (s, 6H), 4.31 (d, J 3.75, 2H), 5.22 (d, J 3.78,
2H), 6.56 (d, J 7.17, 4H), 7.03 7.23 (m, 10H), 7.36
(t, J 3.75, 6H), 7.44 (d, J 7.53, 2H), 7.60 (t,
J 7.14, 1H), 7.83 (t, J 8.10, 1H), 8.74 (d, J 8.28,
2H); 13C NMR (75 MHz, CD2Cl2): d 23.7, 72.0, 76.6,
125.4, 125.8, 126.1, 126.5, 127.8, 128.6, 129.1, 129.2,
129.7, 134.7, 136.8, 140.1, 148.7, 150.4, 162.2, 168.7,
170.2; UV vis (CH2Cl2: kmax/nm, log e): 487 (4.29);
HRMS: calcd for C46H36N6O6Ru: 870.1740, Found:
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870.1730. Anal. Calcd (%) for C46H36N6O6RuÆ4H2O: C,
58.65; H, 4.71; N, 8.92. Found: C, 59.08; H, 4.25; N,
8.82.
4.59. Ruthenium{2,6-bis-(1-pentanoyl-[4R,5R]-4,5-diphen-
yl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-2,6-
dicarboxylate} 15p
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (133 mg, 0.22 mmol), 6p (300 mg,
0.44 mmol) and disodium 2,6-pyridinedicarboxylate
(92 mg, 0.44 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 15p as
a dark brown powder (310 mg, 75%). Rf 0.10
(CH2Cl2/MeOH 100:5);
1H NMR (300 MHz, CD2Cl2):
d 0.80 (t, J 7.35, 6H), 1.21 1.32 (m, 4H), 1.56 1.64
(m, 4H), 2.20 2.31 (m, 2H), 2.37 2.47 (m, 2H), 4.31
(d, J 3.78, 2H), 5.23 (d, J 3.78, 2H), 6.56 (d,
J 7.17, 4H), 7.03 7.22 (m, 10H), 7.34 (t, J 3.00,
6H), 7.45 (d, J 7.56, 2H), 7.60 (t, J 7.17, 1H), 7.83
(t, J 8.28, 1H), 8.68 (d, J 8.28, 2H); 13C NMR
(75 MHz, CD2Cl2): d 13.5, 22.1, 26.7, 35.2, 71.5, 76.7,
125.3, 125.8, 126.1, 126.5, 127.6, 128.6, 129.0, 129.2,
129.7, 134.7, 136.9, 140.3, 148.7, 150.5, 162.4, 170.2,
171.8; UV vis (CH2Cl2: kmax/nm, log e): 487 (4.35);
HRMS: calcd for C52H48N6O6Ru: 954.2679. Found:
954. 2654. Anal. Calcd (%) for C52H48N6O6RuÆH2O:
C, 64.25; H, 5.18; N, 8.65. Found: C, 64.43; H, 5.23;
N, 8.34.
4.60. Ruthenium{2,6-bis-(1-(2-methyl propanoyl)-[4R,
5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-
pyridine}{pyridine-2,6-dicarboxylate} 15q
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (139 mg, 0.23 mmol), 6q (300 mg,
0.45 mmol) and disodium 2,6-pyridinedicarboxylate
(95 mg, 0.45 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 15q as
a dark brown powder (406 mg, 98%). Rf 0.15
(CH2Cl2/MeOH 100:5);
1H NMR (300 MHz, CD2Cl2):
d 1.00 (d, J 6.78, 6H), 1.12 (d, J 6.78, 6H), 2.59
2.68 (m, 2H), 4.33 (d, J 3.78, 2H), 5.27 (d, J 3.75,
2H), 6.56 (d, J 6.96, 4H), 7.03 7.23 (m, 10H), 7.32
7.35 (m, 6H), 7.45 (d, J 7.35, 2H), 7.61 (t, J 6.96,
1H), 7.82 (t, J 8.28, 1H), 8.52 (d, J 8.31, 2H); 13C
NMR (75 MHz, CD2Cl2): d 18.8, 19.8, 33.8, 71.4, 76.9,
125.3, 125.8, 126.1, 126.5, 127.2, 128.7, 129.0, 129.3,
129.7, 134.7, 136.7, 140.3, 148.8, 150.5, 162.6, 170.2,
176.6; UV vis (CH2Cl2: kmax/nm, log e): 352 (3.92),
488 (4.30); HRMS: calcd for C50H44N6O6RuÆH
+:
927.2444. Found: 927.2419. Anal. Calcd (%) for
C50H44N6O6RuÆH2O: C, 63.61; H, 4.91; N, 8.90. Found:
C, 63.49; H, 4.74; N, 8.52.
4.61. Ruthenium{2,6-bis-(1-(3-methyl butanoyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}-
{pyridine-2,6-dicarboxylate} 15r
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (133 mg, 0.22 mmol), 6r (300 mg,
0.44 mmol) and disodium 2,6-pyridinedicarboxylate
(92 mg, 0.44 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 15r as
a dark brown powder (320 mg, 77%). Rf 0.10
(CH2Cl2/MeOH 100:5);
1H NMR (300 MHz, CD2Cl2):
d 0.84 (d, J 6.39, 6H), 0.90 (d, J 6.42, 6H), 2.09
2.19 (m, 4H), 2.28 2.34 (m, 2H), 4.31 (d, J 3.57,
2H), 5.24 (d, J 3.57, 2H), 6.56 (d, J 7.17, 4H),
7.03 7.23 (m, 10H), 7.35 (t, J 3.21, 6H), 7.45 (d,
J 7.32, 2H), 7.61 (t, J 7.14, 1H), 7.85 (t, J 8.28,
1H), 8.65 (d, J 8.28, 2H); 13C NMR (75 MHz,
CD2Cl2): d 21.9, 22.3, 25.6, 44.1, 71.4, 76.8, 125.3,
125.8, 126.1, 126.6, 127.5, 128.6, 129.0, 129.2, 129.7,
134.7, 136.8, 140.3, 148.7, 150.5, 162.5, 170.2, 171.3;
UV vis (CH2Cl2: kmax/nm, log e): 350 (3.92), 487
(4.30); HRMS: calcd for C52H48N6O6Ru: 954.2679.
Found: 954.2660. Anal. Calcd (%) for C52H48N6O6RuÆ
H2O: C, 64.25; H, 5.18; N, 8.65. Found: C, 64.62; H,
5.31; N, 8.33.
4.62. Ruthenium{2,6-bis-(1-(3,3-dimethylbutanoyl)-
[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-
pyridine}{pyridine-2,6-dicarboxylate} 15s
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (128 mg, 0.21 mmol), 6s (300 mg,
0.42 mmol) and disodium 2,6-pyridinedicarboxylate
(88 mg, 0.42 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 15s as
a dark brown powder (315 mg, 77%). Rf 0.10
(CH2Cl2/MeOH 100:5);
1H NMR (300 MHz, CD2Cl2):
d 0.96 (s, 18H), 2.26 (d, J 7.35, 4H), 4.33 (d,
J 3.60, 2H), 5.22 (d, J 3.57, 2H), 6.56 (d, J 7.14,
4H), 7.03 7.24 (m, 10H), 7.35 (t, J 3.03, 6H), 7.45
(d, J 7.32, 2H), 7.60 (t, J 7.17, 1H), 7.85 (t,
J 8.28, 1H), 8.58 (d, J 8.28, 2H); 13C NMR
(75 MHz, CD2Cl2): d 29.4, 31.8, 47.1, 71.8, 76.7, 125.5,
125.8, 126.1, 126.6, 127.2, 128.6, 129.0, 129.2, 129.7,
134.7, 136.8, 140.4, 148.7, 150.6, 162.7, 170.2, 171.0;
UV vis (CH2Cl2: kmax/nm, log e): 354 (3.97), 488
(4.34); HRMS: calcd for C54H52N6O6Ru: 982.2992.
Found: 982.2984. Anal. Calcd (%) for C54H52N6O6RuÆ
H2O: C, 64.85; H, 5.44; N, 8.40. Found: C, 64.69; H,
5.64; N, 8.01.
4.63. Ruthenium{2,6-bis-(1-(benzyloxycarbonyl)-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}-
{pyridine-2,6-dicarboxylate} 16a
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (80 mg, 0.13 mmol), 7a (206 mg,
0.26 mmol) and disodium 2,6-pyridinedicarboxylate
(55 mg, 0.26 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
2.5% MeOH CH2Cl2 to afford 16a as a dark brown
powder (147 mg, 52%). Rf 0.10 (CH2Cl2/MeOH
100:5); 1H NMR (400 MHz, CD2Cl2): d 4.48 (d,
J 4.96, 2H), 5.58 (d, J 5.16, 2H), 6.65 (d, J 8.32,
4H), 7.02 (m, 4H), 7.11 (m, 4H), 7.20 7.41 (m, 18H),
7.51 (d, J 8.12, 2H), 7.65 (t, J 7.32, 1H) 7.75 (t,
J 8.32, 1H), 9.01 (d, J 8.32, 2H); 13C NMR
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(100 MHz, CD2Cl2): d 72.6, 75.9, 121.2, 126.0, 126.1,
126.3, 126.4, 126.5, 127.7, 128.7, 128.9, 129.3, 129.4,
134.9, 136.8, 140.4, 148.7, 150.1, 150.2, 160.3, 170.4;
UV vis (CH2Cl2: kmax/nm, log e): 486 (4.32); FAB-MS:
m/z 1026 (M+); HRMS: calcd for C56H40N6O8Ru:
1026.1951. Found: 1026.1991. Anal. Calcd (%) for
C56H40N6O8RuÆ2H2O: C, 63.33; H, 4.18; N, 7.91.
Found: C, 63.45; H, 3.59; N, 7.65.
4.64. Ruthenium{2,6-bis-(1-(1-naphthyloxycarbonyl)-
[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-
pyridine}{pyridine-2,6-dicarboxylate} 16b
Prepared according to general procedure B using [Ru(p-
cymene)Cl2]2 (86 mg, 0.14 mmol), 7b (258 mg,
0.29 mmol) and disodium 2,6-pyridinedicarboxylate
(61 mg, 0.29 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
2% MeOH CH2Cl2 to afford 16b as a dark brown pow-
der (118 mg, 33%). Rf 0.10 (CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CD2Cl2): d 4.53 (d, J 4.92,
2H), 5.75 (d, J 4.96, 2H), 6.71 (d, J 3.00, 4H),
7.12 7.17 (m, 6H), 7.20 (dd, J 1.00, 7.72, 2H), 7.24
7.33 (m, 8H), 7.35 7.40 (m, 6H), 7.44 7.53 (m, 6H),
7.64 (t, J 6.96, 1H) 7.65 (t, J 7.16, 1H), 7.77 (d,
J 8.32, 2H), 7.86 (d, J 8.32, 2H), 9.03 (d, J 8.32,
2H); 13C NMR (100 MHz, CD2Cl2): d 72.7, 76.0,
118.1, 120.6, 125.3, 126.1, 126.2, 126.3, 126.4, 126.7,
126.8, 127.9, 128.0, 128.8, 129.3, 129.5, 134.6, 135.1,
136.9, 140.5, 145.9, 148.7, 150.1, 150.2, 160.3, 170.4;
FAB-MS: m/z 1128 (M++2); HRMS calcd for
C64H44N6O8RuÆH
+: 1127.2342. Found: 1127.2326.
Anal. Calcd (%) for C64H44N6O8Ru: C, 66.14; H, 4.16;
N, 7.23. Found: C, 66.64; H, 4.71; N, 6.85.
4.65. Ruthenium{2,6-bis-(1-(9-fluorenylmethyl-oxycar-
bonyl)-[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-
2-yl)-pyridine}{pyridine-2,6-dicarboxylate} 16c
Prepared according to general procedure B using [Ru(p-
cymene)Cl2]2 (80 mg, 0.13 mmol), 7c (264 mg, 0.27
mmol) and disodium 2,6-pyridinedicarboxylate (57 mg,
0.27 mmol) in a mixture of n-BuOH/MeOH/H2O
(16:8:4 mL) at 65 C for 2 h followed by chromatogra-
phy on silica gel using EtOAc hexane as the gradient
eluent to afford 16c as a dark brown powder (195 mg,
60%). Rf 0.40 (EtOAc);
1H NMR (400 MHz,
CD2Cl2): d 4.16 (d, J 4.36, 4H), 4.57 (dd, J 5.36,
10.92, 2H), 4.76 (d, J 4.36, 2H), 4.88 (dd, J 5.16,
10.92, 2H), 6.37 (dd, J 1.00, 7.92, 4H), 6.71 (d,
J 6.92, 4H), 7.01 7.08 (m, 6H), 7.14 7.27 (m, 14H),
7.31 7.38 (m, 4H), 7.42 (d, J 7.52, 2H), 7.54 7.58
(m, 3H), 7.64 (d, J 7.56, 2H), 7.69 (t, J 8.32, 1H),
8.78 (d, J 8.32, 2H); 13C NMR (100 MHz, CD2Cl2):
d 42.0, 68.1, 71.8, 75.7, 119.9, 120.1, 124.5, 125.7,
125.8, 126.1, 127.2, 127.5, 127.9, 128.4, 128.6, 129.1,
135.8, 136.9, 140.7, 141.1, 141.4, 142.9, 143.3, 148.7,
150.1, 160.6, 170.3; UV vis (CH2Cl2: kmax/nm,
log e): 486 (4.35); FAB-MS: m/z 1230 (M+); HRMS:
calcd for C72H52N6O8RuÆH
+: 1231.3028. Found:
1231.3035. Anal. Calcd (%) for C72H52N6O8RuÆ3H2O:
C, 67.33; H, 4.55; N, 6.54. Found: C, 67.14; H, 4.30;
N, 6.35.
4.66. Ruthenium{2,6-bis-(1-((1S,2R,5S)-2-isopropyl-5-
methylcyclohexyl-3-oxycarbonyl)-[4R,5R]-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-2,6-
dicarboxylate} 16d
Prepared according to general procedure B using [Ru(p-
cymene)Cl2]2 (416 mg, 0.68 mmol), 7d (1200 mg, 1.36
mmol) and disodium 2,6-pyridinedicarboxylate (287
mg, 1.36 mmol) in MeOH/H2O (35:10 mL) at 65 C for
1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 16d as a
dark brown powder (814 mg, 52%). Rf 0.40 (CH2Cl2/
MeOH 100:5); 1H NMR (400 MHz, CD2Cl2): d 0.57 (d,
J 6.92, 6H), 0.60 (d, J 6.76, 6H), 0.73 0.87 (m, 4H),
0.89 (d, J 6.52, 6H), 0.92 1.16 (m, 10H), 1.43 1.52
(m, 4H), 4.27 (d, J 5.12, 2H), 4.68 (dt, J 4.36,
10.88, 2H), 5.28 (d, J 5.16, 2H), 6.54 (dd, J 1.00,
8.12, 4H), 7.01 7.09 (m, 8H), 7.17 (t, J 7.52, 2H),
7.25 7.29 (m, 6H), 7.42 (d, J 7.52, 2H), 7.56 (t,
J 7.16, 1H), 7.76 (t, J 8.32, 1H), 9.08 (d, J 8.32,
2H); 13C NMR (100 MHz, CD2Cl2): d 20.6, 21.7, 22.9,
25.3, 31.5, 34.0, 41.0, 47.0, 72.2, 75.7, 78.2, 125.8, 125.9,
126.4, 127.9, 128.4, 128.5, 129.1, 134.5, 135.8, 137.4,
141.1, 148.8, 150.4, 151.5, 160.9, 170.4; HRMS: calcd
for C64H68N6O8RuÆH
+: 1151.4220. Found: 1151.4206.
4.67. Ruthenium{2,6-bis-(1-((1R,2S,5R)-2-isopropyl-5-
methylcyclohexyl-3-oxycarbonyl)-[4R,5R]-4,5-diphenyl-
4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyridine-2,6-
dicarboxylate} 16e
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (69 mg, 0.11 mmol), 7e (200 mg,
0.23 mmol) and disodium 2,6-pyridinedicarboxylate
(48 mg, 0.23 mmol) in MeOH/H2O (35:10 mL) at
65 C for 1 h followed by chromatography on silica gel
using MeOH CH2Cl2 as the gradient eluent to afford
16e as a dark brown powder (214 mg, 81%). Rf 0.22
(CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CD2Cl2):
d 0.68 (m, 2H), 0.75 (d, J 6.9, 6H), 0.78 (d, J 6.9,
6H), 0.85 (d, J 6.5, 6H), 0.99 1.08 (m, 2H), 1.24
1.31 (m, 4 H), 1.40 1.49 (m, 2H), 1.64 1.77 (m, 6 H),
1.85 1.88 (m, 2H), 4.34 (d, J 4.8, 2H), 4.74 (unre-
solved ddd, J 4.4, 2 H), 5.33 (d, J 4.8, 2H), 6.55
(dd, J 8.2, 1.1, 4H), 7.03 7.10 (m, 8H), 7.10 (tt,
J 7.4, 1.1, 2H), 7.27 7.31 (m, 6H), 7.50 (d, J 8.3,
1H), 7.50 (d, J 7.1, 1H), 7.63 (dd, J 8.3, 7.1, 1H),
7.75 (t, J 8.2, 1H), 8.94 (d, J 8.3, 2H); 13C NMR
(100 MHz, CD2Cl2): d 15.9, 20.5, 21.7, 23.1, 26.5, 31.4,
33.9, 40.3, 47.2, 72.2, 75.4, 78.1, 125.9, 126.1, 126.2,
127.7, 128.5, 128.6, 129.1, 129.1, 134.5, 135.8, 137.2,
140.7, 148.9, 150.3, 151.4, 161.1, 170.3; UV vis
(CH2Cl2: kmax/nm, log e): 371 (3.58), 486 (4.26); FAB-
MS: m/z 1151 (M++1); Anal. Calcd (%) for
C64H68N6O8RuÆH2O: C, 65.79; H, 6.04; N, 7.19. Found:
C, 66.02; H, 6.28; N, 6.96.
4.68. Ruthenium{2,6-bis-(1-(1,1-dimethylethyloxy car-
bonyl)-[4R,5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-
2-yl)-pyridine}{pyridine-2,6-dicarboxylate} 16f
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (92 mg, 0.15 mmol), 7f (227 mg,
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0.30 mmol) and disodium 2,6-pyridinedicarboxy-
late (63 mg, 0.30 mmol) in MeOH/H2O (15:5 mL) at
65 C for 1 h followed by chromatography on silica
gel using 2.5% MeOH CH2Cl2 to afford 16f as a dark
brown powder (208 mg 77%). Rf 0.25 (CH2Cl2/
MeOH 100:5); 1H NMR (400 MHz, CD2Cl2): d
1.39 (s, 18H), 4.27 (d, J 5.16, 2H), 5.26 (d, J 5.36,
2H), 6.54 (dd, J 1.43, 7.92, 4H), 7.01 7.08 (m, 8H),
7.15 7.19 (m, 2H), 7.27 7.28 (m, 6H), 7.43 (d,
J 7.52, 2H), 7.56 (t, J 7.16, 1H), 7.75 (t, J
8.32, 1H), 8.89 (d, J 8.12, 2H); 13C NMR (100
MHz, CDCl3): d 27.7, 72.6, 75.7, 84.3, 125.7, 125.9,
126.0, 126.4, 127.6, 128.4, 128.5, 129.1, 134.4, 137.4,
141.2, 148.8, 150.5, 150.6, 161.2, 170.4; UV vis
(CH2Cl2: kmax/nm, log e): 486 (4.27), 373 (3.71); HRMS:
calcd for C52H48N6O8RuÆH
+: 987.2575. Found:
987.2581. Anal. Calcd (%) for C52H48N6O8RuÆH2O: C,
62.20; H, 5.02; N, 8.37. Found: C, 62.12; H, 5.36; N,
8.12.
4.69. Synthesis of ruthenium{2,6-bis-(1-benzyl-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}-
{pyridine-2,6-dicarboxylate} 16g
Prepared according to general procedure B using 7g
(61 mg, 0.09 mmol), [Ru(p-cymene)Cl2]2 (27 mg,
0.04 mmol) and Na2pydic (18 mg, 0.09 mmol) to
afford 16g as a dark brown solid (46 mg, 55%).
Rf 0.29 (CH2Cl2/MeOH 100:5);
1H NMR
(400 MHz, CD2Cl2): d 4.45 (br, 2H), 4.82 (br, 2H),
5.10 (br, 2H), 5.36 (br, 2H), 6.48 (d, J 7.3, 4H),
6.89 (m, 4H), 7.03 (t, J 7.2, 2H), 7.10 7.12 (m,
4H), 7.20 7.40 (m, 22H), 7.86 (br, 2H); 13C NMR
(100 MHz, CD2Cl2): d 50.4, 75.9, 77.3, 116.6,
125.4, 126.9, 127.3, 127.7, 127.8, 127.9, 128.6,
128.7, 129.0, 129.1, 132.9, 135.8, 138.3, 138.9, 148.7,
166.1; UV vis (CH2Cl2: kmax/nm, log e): 386 (sh)
(3.52), 499 (4.33); FAB-MS: m/z 966 (M+); HRMS
(ESI+): calcd for C56H44N6O4
102Ru: 966.2434. Found:
966.2468.
4.70. Ruthenium{2,6-bis-(1-[toluene-4-sulfonyl]-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}-
{pyridine-2,6-dicarboxylate} 16h
Prepared according to general procedure B using 7h
(54 mg, 0.06 mmol), [Ru(p-cymene)Cl2]2 (20 mg, 0.03
mmol) and Na2pydic (14 mg, 0.06 mmol) to afford
16h as a dark brown solid (39 mg, 55%). Rf 0.39
(CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CD2Cl2):
d 2.45 (s, 6H), 4.12 (d, J 5.7, 2H), 4.98 (d, J
5.7, 2H), 5.66 (d, J 7.5, 4H), 6.67 (m, 4H), 6.95
(t, J 7.4, 2H), 7.12 (d, J 7.9, 2H), 7.17 7.19 (m,
4H), 7.27 7.31 (m, 5H), 7.34 7.38 (m, 6H), 7.55 (d,
J 8.3, 4H), 8.00 (t, J 8.3, 1H), 9.41 (d, J
8.3, 2H); 13C NMR (100 MHz, CD2Cl2): d 21.5,
73.6, 76.1, 125.5, 126.0, 126.1, 127.0, 127.5, 128.3,
128.8, 129.3, 130.8, 132.0, 135.1, 135.8, 136.7, 140.6,
146.6, 148.1, 150.5, 156.1, 159.7, 170.2; UV vis
(CH2Cl2: kmax/nm, log e): 352 (sh) (3.90), 490 (4.22),
587 (sh) (3.55); FAB-MS: m/z 1094 (M+); HRMS
(ESI+): calcd for C56H44N6O8
102RuS2: 1094.2122.
Found: 1094.1705.
4.71. Ruthenium {2,6-bis-(1-benzyl-[3aR,7aR]-3a,4,5,6,
7,7a-hexahydro-1H-benzoimidazol-2-yl)-pyridine}{pyri-
dine-2,6-dicarboxylate} 17a
Prepared according to general procedure B using 8a
(100 mg, 0.20 mmol), [Ru(p-cymene)Cl2]2 (61 mg, 0.10
mmol) and disodium pyridine-2,6-dicarboxylate
(42 mg, 0.20 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
2.5% MeOH CH2Cl2 to afford 17a as a dark brown
powder (70 mg, 45%). Rf 0.17 (CH2Cl2/MeOH
100:5); 1H NMR (400 MHz, CD2Cl2): d 0.92 0.94 (m,
2H), 1.05 1.11 (m, 6H), 1.38 1.43 (m, 2H), 1.53 1.55
(m, 2H), 1.68 1.70 (m, 4H), 1.94 1.97 (m, 2H), 3.70
(br, 4H), 4.72 (br, 2H), 5.47 (br, 2H), 7.16 (t, J 7.9,
1H), 7.30 7.34 (m, 2H), 7.39 7.45 (m, 10H), 8.04 8.07
(m, 1H), 8.14 (d, J 7.4, 4H); 13C NMR (100 MHz,
CD2Cl2): d 23.9, 24.7, 28.9, 50.8, 70.1, 72.9, 78.8,
116.6, 126.4, 126.6, 127.6, 129.0, 133.7, 135.8, 150.4,
168.8; UV vis (CH2Cl2: kmax/nm, log e): 321 (3.72),
394 (3.48), 498 (4.30); FAB-MS: m/z 770 (M+); Anal.
Calcd (%) for C40H40N6O4RuÆH2O: C, 60.98; H, 5.37;
N, 10.67. Found: C, 60.95; H, 5.30; N, 10.79.
4.72. Ruthenium {2,6-bis-(1-[toluene-4-sulfonyl]-
[3aR,7aR]-3a,4,5,6,7,7a-hexahydro-1H-benzoimidazol-
2-yl)-pyridine}{pyridine-2,6-dicarboxylate} 17b
Prepared according to general procedure B using
8b (100 mg, 0.16 mmol), [Ru(p-cymene)Cl2]2 (48 mg,
0.08 mmol) and Na2pydic (33 mg, 0.16 mmol) to afford
17b as a brown solid (72 mg, 50%). Rf 0.24 (CH2Cl2/
MeOH 100:5); 1H NMR (400 MHz, CD2Cl2): d 0.67
0.70 (m, 2H), 0.82 0.88 (m, 2H), 1.05 1.14 (m, 2H),
1.26 (m, 2H), 1.45 1.48 (m, 2H), 1.69 1.71 (m, 4H),
2.39 (s, 6H), 2.47 2.50 (m, 4H), 3.67 3.73 (m, 2H),
7.30 (d, J 8.2, 4H), 7.44 (d, J 8.2, 4H), 7.77 (t,
J 8.1, 1H), 8.02 (d, J 7.7, 1H), 8.19 (d, J 7.7,
2H), 8.77 (d, J 8.1, 2H); 13C NMR (100 MHz,
CDCl3): d 14.0, 21.7, 24.3, 24.4, 27.4, 27.8, 29.6, 69.1,
71.8, 126.7, 127.2, 127.3, 127.9, 130.6, 135.8, 136.8,
145.6, 150.0, 151.2, 164.1, 170.9; UV vis (CH2Cl2:
kmax/nm, log e): 307 (sh) (4.01), 368 (sh) (3.65), 491
(4.17); FAB-MS: m/z 898 (M+); Anal. Calcd (%) for
C40H40N6O8RuS2: C, 53.50; H, 4.49; N, 9.36; S, 7.14.
Found: C, 53.16; H, 4.86; N, 8.94; S, 6.70.
4.73. Ruthenium{(2-(1-(diphenylphosphinyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl))-6-([4R,5R]-4,5-
diphenyl-4,5-dihydro-imidazol-2-yl)-pyridine}{pyridine-
2,6-dicarboxylate} 18
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (43 mg, 0.07 mmol), 12 (127 mg,
0.17 mmol) and disodium 2,6-pyridinedicarboxylate
(30 mg, 0.14 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 18 as a
dark brown powder (96 mg, 73%). Rf 0.10 (CH2Cl2/
MeOH 100:5); 1H NMR (400 MHz, CD2Cl2): d 4.20
(d, J 3.56, 2H), 5.01 (br s, 2H), 5.18 (d, J 3.60,
2H), 6.28 (d, J 7.92, 4H), 6.87 (t, J 7.72, 4H),
6.93 6.95 (m, 4H); 7.05 7.13 (m, 8H), 7.16 7.27 (m,
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6H), 7.57 (t, J 7.32, 1H), 7.72 (t, J 8.32, 1H), 8.61
(d, J 8.32, 2H); 13C NMR (100 MHz, CD2Cl2): d
56.6, 70.7, 76.7, 125.1, 125.9, 126.7, 127.5, 127.8,
127.9, 128.3, 128.4, 128.9, 129.1, 129.3, 129.4, 130.0,
134.9, 136.0, 136.5, 138.8, 140.1, 148.6, 150.3, 161.9,
170.1, 170.3; UV vis (CH2Cl2: kmax/nm, log e): 489
(4.17); HRMS: calcd for C54H41N6PO5RuÆH
+:
986.2008. Found: 986.2004.
4.74. Ruthenium{(2-(1-(2,4,6-trimethyl-benzoyl))-[4R,5R]-
4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-6-(1-((1S,2R,
5S)-2-isopropyl-5-methylcyclohexyl-3-oxycarbonyl)-[4R,
5R]-4,5-diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyri-
dine}{pyridine-2,6-dicarboxylate} 19
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (67 mg, 0.11 mmol), 13 (195 mg,
0.22 mmol) and disodium 2,6-pyridinedicarboxylate
(46 mg, 0.22 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 19 as a
dark brown powder (185 mg, 75%). Rf 0.40
(CH2Cl2/MeOH 100:5);
1H NMR (400 MHz, CD2Cl2):
d 0.57 (d, J 6.92, 3H), 0.61 (d, J 6.92, 3H), 0.91
(d, J 6.56, 3H), 0.74 1.69 (m, 5H), 1.21 1.34 (m,
2H), 1.42 1.55 (m, 2H), 1.94 (s, 6H), 2.24 (s, 3H), 4.38
(d, J 2.96, 1H), 4.40 (d, J 5.36, 1H), 4.55 (br s,
1H), 4.70 (dt, J 4.36, 10.72, 1H), 5.35 (d, J 5.56,
1H), 6.40 (d, J 7.52, 2H), 6.54 6.63 (m, 5H), 6.77 (s,
1H), 7.02 7.13 (m, 8H), 7.15 7.31 (m, 6H), 7.41 (dd,
J 1.20, 7.56, 1H), 7.44 (dd, J 1.20, 7.92, 1H), 7.56
(t, J 7.72, 1H), 7.84 (t, J 8.12, 1H), 8.83 (d,
J 7.92, 1H), 9.19 (d, J 8.32, 1H); 13C NMR
(100 MHz, CD2Cl2): d 15.5, 18.3, 18.9, 20.6, 20.9, 21.7,
22.8, 25.3, 31.5, 34.0, 41.0, 47.0, 72.3, 72.9, 75.7, 75.9,
78.3, 125.7, 125.8, 126.0, 126.3, 126.5, 127.8, 128.2,
128.5, 128.9, 129.0, 129.1, 129.2, 132.3, 132.9, 134.7,
135.3, 136.4, 137.5, 139.7, 141.1, 148.7, 150.3, 151.5,
154.7, 161.1, 169.0, 170.4; UV vis (CH2Cl2: kmax/nm,
log e): 487 (4.30); HRMS: calcd for C63H60N6O7RuÆH
+:
1115.3645. Found: 1115.3668. Anal. Calcd (%) for
C63H60N6O7RuÆH2O: C, 66.83; H, 5.52; N, 7.42. Found:
C, 66.63; H, 5.95; N, 7.03.
4.75. Ruthenium{(2-(1-((1S,2R,5S)-2-isopropyl-5-meth-
ylcyclohexyl-3-oxycarbonyl)-[4R,5R]-4,5-diphenyl-4,5-
dihydro-1H-imidazol-2-yl)-6-(1-acetyl)-[4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine}{pyri-
dine-2,6-dicarboxylate} 20
Prepared according to general procedure B using
[Ru(p-cymene)Cl2]2 (72 mg, 0.12 mmol), 14 (175 mg,
0.24 mmol) and disodium 2,6-pyridinedicarboxylate
(50 mg, 0.24 mmol) in MeOH/H2O (15:5 mL) at 65 C
for 1 h followed by chromatography on silica gel using
MeOH CH2Cl2 as the gradient eluent to afford 20
as a dark brown powder (171 mg, 72%). Rf 0.20
(CH2Cl2/MeOH 100:5);
1H NMR (300 MHz, CD2Cl2):
d 0.57 (d, J 6.96, 3H), 0.60 (d, J 6.96, 3H), 0.85
1.12 (m, 5H), 1.25 1.27 (m, 2H), 1.54 1.61 (m, 2H),
2.14 (s, 3H), 4.26 (d, J 3.78, 1H), 4.31 (d, J 5.28,
1H), 4.69 (dt, J 4.35, 10.74, 1H), 5.19 (d, J 3.78,
1H), 5.30 (d, J 5.28, 1H), 6.53 6.57 (m, 4H), 7.00
7.44 (m, 16H), 7.58 (t, J 7.35, 1H), 7.79 (t, J 8.28,
1H), 8.71 (d, J 7.89, 1H), 9.12 (d, J 7.89, 1H); 13C
NMR (75 MHz, CD2Cl2): d 15.4, 20.6, 21.7, 22.8, 23.7,
25.3, 31.5, 34.0, 41.0, 46.9, 72.0, 72.2, 75.7, 76.6, 78.2,
125.4, 125.7, 125.8, 125.9, 126.1, 126.2, 126.4, 127.7,
128.0, 128.4, 128.5, 128.6, 129.1, 129.2, 129.3, 129.7,
134.6, 136.8, 137.4, 140.1, 141.1, 148.7, 148.8, 150.2,
150.7, 151.4, 161.0, 162.1, 168.6, 170.3; UV vis
(CH2Cl2: kmax/nm, log e): 486 (4.30); HRMS: calcd for
C55H52N6O7Ru: 1010.2941. Found: 1010.2927; Anal.
Calcd (%) for C55H52N6O7RuÆH2O: C, 64.25; H, 5.29;
N, 8.17. Found: C, 64.22; H, 5.71; N, 7.96.
4.76. General procedure for the preparation of Ru(di-
cyclohexylpybim)(pydic) complexes via in situ generation
(procedure C)
In a 50 mL oven dried one necked round bottom flask fit-
ted with a magnetic stirring bar under argon, 4 (130 mg,
0.4 mmol) and DMAP (147 mg, 1.2 mmol) were dis-
solved in anhydrous CH2Cl2 (15 mL). The mixture was
cooled to 0 C and then the corresponding acid chloride
or chloroformate (1.2 mmol) added dropwise. The cool-
ing bath was removed and the reaction mixture was stir-
red at rt and the progress of the reaction monitored by
TLC. After full conversion, the reaction mixture was
washed with water (2 · 20 mL), dried over Na2SO4, con-
centrated and transferred into a 25 mL Schlenk tube and
dried in vacuum. To the remaining product methanol
(10 mL) and [Ru(p-cymene)Cl2]2 (306 mg, 0.5 mmol)
were added. Another 25 mL Schlenk tube was charged
with disodium 2,6-pyridinedicarboxylate (211 mg,
1 mmol) and dissolved in a mixture of water (5 mL) and
methanol (5 mL). The solution was purged with argon
for ca. 10 min and then transferred via a cannula into
the Schlenk tube containing the ruthenium source at rt.
The mixture was then heated at 65 C for 1 h, cooled to
rt and diluted with CH2Cl2 (30 mL). The mixture was
washed with water (2 · 20 mL), dried over Na2SO4, con-
centrated and purified by column chromatography on sil-
ica gel usingMeOH CH2Cl2 as the gradient eluent to give
the Ru(dicyclohexylpybim)(pydic) complex as a dark
brown solid after crystallization from CH2Cl2 hexane.
4.77. Ruthenium{2,6-bis-(1-benzoyl-[3aR,7aR]-3a,4,5,6,
7,7a-hexahydro-1H-benzoimidazol-2-yl)-pyridine}{pyri-
dine-2,6-dicarboxylate} 21
Prepared according to general procedure C using 4
(320 mg, 1 mmol), DMAP (269 mg, 2.2 mmol), benzoyl
chloride (0.29 mL, 2.5 mmol), [Ru(p-cymene)Cl2]2
(306 mg, 0.5 mmol) and disodium 2,6-pyridinedicarb-
oxylate (211 mg, 1 mmol) followed by chromatography
on silica gel using MeOH CH2Cl2 as the gradient eluent
to afford 21 as a dark brown crystalline product
(484 mg, 61%). Rf 0.25 (CH2Cl2/MeOH 100:5).
1H
NMR (400 MHz, CDCl3): d 0.83 1.32 (m, 10H), 1.51
1.59 (m, 6H), 3.52 (dt, J 3.56, 12.48, 2H), 3.91 (dt,
J 2.96, 11.68, 2H), 7.35 (t, J 8.08, 1H), 7.46 (t,
J 7.96, 4H), 7.56 (t, J 6.36, 2 H), 7.66 7.68 (m, 4
H), 7.72 (d, J 8.12, 2H), 8.08 (t, J 7.52, 1H), 8.28
(d, J 7.72, 2H); 13C NMR (100 MHz, CDCl3): d
24.2, 24.9, 28.2, 30.0, 71.4, 73.5, 125.0, 127.5. 127.7,
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129.3, 129.5, 133.6, 135.0, 135.7, 136.1, 150.6, 151.1,
164.6, 168.1, 172.2; UV vis (CH2Cl2: kmax/nm, log e):
492 (4.33), 379 (3.95); FAB-MS: m/z 798 (M+); Anal.
Calcd (%) for C40H36N6O6RuÆ3H2O: C, 56.40; H, 4.97;
N, 9.86. Found: C, 56.49; H, 4.64; N 9.53.
4.78. Ruthenium{2,6-bis-(1-(4-methoxybenzoyl)-[3aR,
7aR]- 3a,4,5,6,7,7a-hexahydro-1H-benzoimidazol-2-yl)-
pyridine}{pyridine-2,6-dicarboxylate} 22
Prepared according to general procedure C using 4
(323 mg, 1 mmol), DMAP (276 mg, 2.2 mmol), 4-meth-
oxy benzoyl chloride (514 mg, 3 mmol), [Ru(p-cym-
ene)Cl2]2 (306 mg, 0.5 mmol) and disodium 2,6-
pyridinedicarboxylate (211 mg, 1 mmol) followed by
chromatography on silica gel using MeOH CH2Cl2 as
the gradient eluent to afford 22 as a dark brown crystal-
line product (376 mg, 43%). Rf 0.40 (CH2Cl2/MeOH
100:5). 1H NMR (400 MHz, CDCl3): d 0.82 1.31 (m,
10H), 1.50 1.61 (m, 4H), 1.76 1.79 (m, 2H), 3.49 (dt,
J 3.16, 12.08, 2H), 3.83 (s, 6H), 3.96 (dt, J 2.96,
11.48, 2H), 6.91 (d, J 8.72, 4H), 7.28 (t, J 8.12,
1H), 7.60 (d, J 8.12, 2H), 7.64 (d, J 9.12, 4H), 8.07
(t, J 7.52, 1H), 8.27 (d, J 7.72, 2H); 13C NMR
(100 MHz, CDCl3): d 14.0, 22.6, 23.7, 24.5, 27.7, 29.4,
31.5, 55.5, 71.1, 72.9, 114.2, 124.3, 126.6, 127.1, 135.0,
150.1, 150.6, 163.5, 164.2, 167.1, 171.7; UV vis (CH2Cl2:
kmax/nm, log e): 492 (4.37), 380 (4.01); FAB-MS: m/z 858
(M+); Anal. Calcd (%) for C42H40N6O8RuÆH2O: C,
57.59; H, 4.83; N, 9.59. Found: C, 57.82; H, 4.68; N, 9.08.
4.79. Ruthenium{2,6-bis-(1-((1S,2R,5S)-2-isopropyl-5-
methylcyclohexyloxy-carbonyl)-[3aR,7aR]-3a,4,5,6,7,7a-
hexahydro-1H-benzoimidazol-2-yl)-pyridine}{pyridine-
2,6-dicarboxylate} 23
Prepared according to general procedure C using 4
(320 mg, 1 mmol), DMAP (269 mg, 2.2 mmol), ()-
menthyl chloroformate (0.64 mL, 3 mmol), [Ru(p-cym-
ene)Cl2]2 (306 mg, 0.5 mmol) and disodium 2,6-pyridine-
dicarboxylate (211 mg, 1 mmol) followed by chromato-
graphy on silica gel using MeOH CH2Cl2 as the gradi-
ent eluent to afford 23 as a dark brown crystalline
product (246 mg, 26%). Rf 0.50 (CH2Cl2/MeOH
100:5). 1H NMR (400 MHz, CDCl3): d 0.65 0.94 (m,
18H), 0.95 1.26 (m, 10H), 1.37 1.98 (m, 18H), 2.13 (d,
J 8.92, 2H), 2.60 (dd, J 2.96, 12.28, 2H), 3.28 (m,
2H), 3.64 (m, 2H), 4.81 (dt, J 4.36, 10.92, 2H), 7.53
(t, J 8.32, 1H), 8.05 (t, J 7.92, 1H), 8.25 (d, J
7.72, 2H), 8.45 (d, J 8.32, 2H); 13C NMR (100 MHz,
CDCl3): d 16.6, 20.7, 21.9, 23.6, 24.1, 24.5, 26.5, 27.8,
30.3, 31.4, 31.5, 34.0, 40.8, 47.2, 69.1, 71.6, 126.3,
127.1, 135.7, 150.6, 150.8, 151.3, 162.9, 171.7; UV vis
(CH2Cl2: kmax/nm, log e): 485 (4.32), 381 (3.64); FAB-
MS: m/z 954 (M+); Anal. Calcd (%) for C48H64N6O8-
RuÆ2H2O: C, 58.22; H, 6.92; N, 8.49. Found: C, 58.39;
H, 6.63; N, 8.25.
4.80. General procedure for asymmetric epoxidation with
hydrogen peroxide
In a 25 mL Schlenk tube, the ruthenium catalyst
(0.025 mmol) was stirred at room temperature in tert-
amyl alcohol (9 mL) for 10 min. Olefin (0.5 mmol) and
dodecane (GC internal standard, 100 lL) were added.
To this mixture, a solution of 30% hydrogen peroxide
(170 lL, 1.5 mmol) in tert-amyl alcohol (830 lL) was
added over a period of 12 h by syringe pump. After the
addition, aliquots were taken from the reaction mixture
and subjected to GC analysis for the determination of
yield and conversion. Finally, the reaction mixture was
quenched with saturated Na2SO3 solution (10 mL),
extracted with dichloromethane (2 · 10 mL) and washed
with water (20 mL). The combined organic layers were
dried over Na2SO4 and evaporated to give the crude
epoxides. A solution of the crude product in hexane
was used for the determination of the ee by HPLC.
4.81. Phenyloxirane
1H NMR (400 MHz, CDCl3) d 2.72 (dd, J 5.6, 2.6,
1H), 3.06 (dd, J 5.6, 4.2, 1H), 3.78 (dd, J 4.2, 2.6,
1H), 7.16 7.29 (m, 5H); 13C NMR (100 MHz, CDCl3)
d 51.3, 52.5, 125.6, 128.3, 128.6, 137.7; EI-MS: m/z
120 (M+, 41), 119 (65), 92 (37), 91 (100), 90 (64), 89
(79); HPLC (Chiralcel OD-H (02), hexane/EtOH
99.95:0.05, flow rate 0.5 mL/min): tR 6.27 min, 7.13 min.
4.82. 2-Tolyloxirane
1H NMR (400 MHz, CD2Cl2): d 7.14 7.22 (m, 4H), 3.98
(dd, J 3.97, 2.58, 1H), 3.13 (dd, J 5.75, 3.97, 1H),
2.65 (dd, J 5.75, 2.58, 1H), 2.42 (s, 3H); 13C NMR
(100 MHz, CD2Cl2): d 136.4, 136.2, 129.8, 127.6,
126, 124, 50.3, 50.1; EI-MS: m/z 134 (M+, 53), 119
(44), 118 (42), 117 (64), 105 (100), 103 (48), 91 (52), 78
(33), 77 (35); HPLC (Chiralpak AD-H, hexane/
EtOH, 99.95:0.05, flow rate 1.5 mL/min): tR 16.70 min,
19.84 min.
4.83. 4-Chlorophenyloxirane
1H NMR (400 MHz, CDCl3) d 2.68 (dd, J 5.6, 2.6,
1H), 3.07 (dd, J 5.6, 4.0, 1H), 3.76 (dd, J 4.0, 2.6,
1H), 7.12 7.26 (m, 4H); 13C NMR (100 MHz, CDCl3)
d 51.4, 51.9, 127.0, 128.8, 134.1, 136.3; EI-MS: m/z
156 (M++2, 9), 155 (M++1, 10), 154 (M+, 28), 153
(M+-1, 23), 125 (53), 119 (74), 89 (106); HPLC (Chiral-
cel OB H, hexane, flow rate 1.0 mL/min): tR 14.47 min,
17.18 min.
4.84. 4-Trifluoromethylphenyloxirane
1H NMR (400 MHz, CDCl3) d 2.77 (dd, J 5.6, 2.6,
1H), 3.19 (dd, J 5.6, 4.0, 1H), 3.92 (dd, J 4.0, 2.6,
1H), 7.4 (d, J 8.1, 2H), 7.6 (d, J 8.1, 2H); 13C
NMR (100 MHz, CDCl3) d 51.4, 51.6, 125.4 (q,
J 3.8), 125.9, 141.9; EI-MS: m/z 188 (M+, 14), 187
(20), 159 (49), 158 (48), 119 (100), 91 (37); HPLC (Chi-
ralcel AD-151, hexane, flow rate 0.5 mL/min): tR
12.30 min, 13.40 min.
4.85. trans-2-Methyl-3-phenyloxirane
1H NMR (400 MHz, CDCl3) d 1.44 (d, J 5.2, 3H), 3.03
(dq, J 2.0, 5.2, 1H), 3.57 (d, J 2.0, 1H), 7.23 7.4
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(m, 5H); 13C NMR (100 MHz, CDCl3) d 18.0, 59.2,
59.6, 125.7, 128.1, 128.5, 137.9; EI-MS: 134 (M+, 52),
133 (65), 105 (51), 91 (42), 90 (100), 89 (77), 77
(23); HPLC (Chiralcel OD-H (069), hexane/EtOH,
99.95:0.05, flow rate 1.0 mL/min): tR 11.90 min (2S,3S),
13.48 min (2R,3R).
4.86. trans-2,3-Diphenyloxirane
1H NMR (400 MHz, CDCl3): d 7.24 7.31 (m, 10H), 3.87
(s, 2H); 13C NMR (100 MHz, CDCl3): d 137.1, 128.6,
128.6, 125.5, 62.8; EI-MS: m/z 197 (M++1, 18), 196
(M+, 100), 195 (72), 178 (28), 167 (85), 90 (66), 89
(65); HPLC (Chiralcel OD-H, hexane/EtOH, 98:2, flow
rate 0.5 mL/min): tR 14.10 min (2S,3S), 4.79 min
(2R,3R).
4.87. trans-2-Chloromethyl-3-phenyloxirane
1H NMR (400 MHz, CDCl3) d 3.28 (ddd, J 5.8, 4.8,
1.9, 1H), 3.66 (dd, J 11.8, 5.8, 1H), 3.72 (dd,
J 11.8, 4.8, 1H), 3.82 (d, J 1.9, 1H), 7.26 7.38 (m,
5H); 13C NMR (100 MHz, CDCl3) d 44.3, 58.5, 60.9,
116.6, 125.6, 128.6, 135.9; GC-MS: m/z 168 (M+);
HPLC (Chiralpak AD-H, hexane/EtOH, 95:5, flow rate
1.0 mL/min): tR 7.62 min, 9.09 min.
4.88. 2,2-Dimethyl-3-phenyloxirane
1H NMR (400 MHz, CDCl3) d 1.04 (s, 3H), 1.45 (s, 3H),
3.83 (s, 1H), 7.21 7.33 (m, 5H); 13C NMR (100 MHz,
CDCl3) d 17.9, 24.7, 61.0, 64.5, 126.3, 127.3, 128,
136.6; EI-MS: m/z 148 (M+); HPLC (Chiralcel OD-H,
hexane/EtOH, 99.95:0.05, flow rate 0.5 mL/min): tR
11.78 min (3S), 18.63 min (3R).
4.89. 2-Phenyl-1-oxaspiro[2.5]octane
1H NMR (400 MHz, CDCl3) d 1.22 1.31 (m, 2H), 1.37
1.85 (m, 8H), 3.85 (s, 1H), 7.23 7.34 (m, 5H); 13C NMR
(100 MHz, CDCl3) d 24.5, 25.3, 25.5, 28.4, 35.4, 64.5,
65.5, 126.3, 127.2, 127.9, 136.3; GC-MS: m/z 188
(M+); HPLC (Chiralpak AD-H, hexane/EtOH, 90:10,
flow rate 1.0 mL/min): tR 4.34 min, 4.72 min.
4.90. (2-Methyl-3-phenyl-oxiranyl)-methanol
1H NMR (400 MHz, CDCl3): d 1.07 (s, 3H), 2.17 (dd,
J 8.7, 4.3 Hz, 1H), 3.74 (dd, J 12.5, 8.7 Hz, 1H),
3.84 (dd, J 12.5, 4.3 Hz, 1H), 4.20 (s, 1H), 7.25 7.36
(m, 5H); 13C NMR (100 MHz, CDCl3): d 13.41,
60.13, 63.66, 64.90, 126.36, 127.52, 128.06, 135.54; EI-
MS: m/z 164 (M+); HPLC (Chiralcel AD-H, hexane/
EtOH, 99.5:0.5, flow rate 0.5 mL/min): tR 12.24 min,
12.86 min.
4.91. 2-Methyl-2-phenyloxirane
1H NMR (400 MHz, CDCl3) d 1.65 (s, 3H), 2.73 (d,
J 5.4, 1H), 2.90 (d, J 5.4, 1H), 7.17 7.31 (m, 5H),
13C NMR (100 MHz, CDCl3) d 56.9, 57.2, 125.4,
127.6, 128.5, 141.3; EI-MS: m/z 134 (M+, 35), 133
(87), 105 (100), 104 (41), 103 (58), 91 (23), 79 (37), 78
(54), 77 (49); HPLC (Chiralcel OD-H, hexane/iso-pro-
panol, 99.95:0.05, flow rate 1.0 mL/min): tR 9.78 min,
12.77 min.
4.92. 1,2-Epoxy-1-phenylcyclohexane
1H NMR (400 MHz, CDCl3): d 7.23 7.32 (m, 4H), 7.15
7.2 (m, 1H), 2.99 (m, 1H), 2.16 2.25 (m, 1H), 2.00 2.09
(m, 1H), 1.87 1.95 (m, 2H), 1.44 1.58 (m, 2H), 1.34
1.44 (m, 1H), 1.18 1.3 (m, 1H); 13C NMR (100 MHz,
CDCl3): d 142.6, 128.4, 127.3, 125.4, 62.1, 60.3, 29,
24.8, 20.2, 19.9; EI-MS: m/z 175 (M++1, 10), 174
(M+, 82), 173 (100), 159 (21), 145 (40), 129 (50), 117
(47), 115 (58), 105 (68), 91 (58), 77 (43). HPLC (Chiral-
cel AD-H, hexane/EtOH, 99.95:0.05, flow rate 1.0 mL/
min): tR 8.35 min, 9.07 min.
4.93. 4-Methyl-N-(trans-3-phenyl-oxiranylmethyl)-
benzenesulfonamide
Mp 128 131 C; Rf 0.23 (hexane/ethyl acetate 3:1);
1H NMR (400 MHz, CDCl3): d 2.41 (s, 3H), 3.10
(ddd, J 2.0, 3.4, 4.6, 1H), 3.23 (ddd, J 4.6, 6.8,
14.1, 1H), 3.38 (ddd, J 3.4, 6.0, 14.1, 1H), 3.74 (d,
J 2.0, 1H), 4.82 (unresolved dd, 1H), 7.14 7.17 (m,
2H), 7.28 7.31 (m, 5H), 7.74 (d, J 8.3, 2H); 13C
NMR (100 MHz, CDCl3): d 21.51, 43.70, 55.55, 60.12,
125.66, 127.06, 128.51, 128.88, 129.84, 131.04, 135.69,
135.89, 136.71, 143.75; EI-MS: m/z 303 (M+); HRMS:
calcd for C16H17NO3S: 303.0929. Found 303.0939;
HPLC (Whelk01 [R,R], hexane/EtOH, 90:10, flow rate
1.0 mL/min): tR 10.01 min, 11.38 min.
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Abstract: Tridentate N,N,N-pyridinebisimidazolines
have been studied as new ligands for the enantiose-
lective transfer hydrogenation of prochiral ketones.
High yields and excellent enantioselectivity up to
>99% ee have been achieved with an in situ gener-
ated catalytic system containing dichlorotris(triphe-
nylphosphine)ruthenium and 2,6-bis-([4R,5R]-4,5-
diphenyl-4,5-dihydro-1H-imidazol-2-yl)-pyridine
(3a) in the presence of sodium isopropoxide.
Keywords: asymmetric transfer hydrogenation; ke-
tones; phosphines; ruthenium; tridentate nitrogen
ligands
Enantiomerically pure alcohols have a wide range of
applications, for example, building blocks and syn-
thons for pharmaceuticals, agrochemicals, polymers,
syntheses of natural compounds, auxiliaries, ligands
and key intermediates in organic syntheses.[1] Within
the different molecular transformations to chiral alco-
hols, transition metal-catalyzed reactions offer effi-
cient and versatile strategies, such as addition of or-
ganometallic compounds to aldehydes, hydrosilyla-
tion, and hydrogenation of prochiral ketones.[2] From
an economic and environmental point of view the
asymmetric hydrogenation, in particular the transfer
hydrogenation, represents a powerful tool for their
synthesis because of its high atom economy and
safety advantages.[3] Here, Noyoris ruthenium-based
catalysts comprising chiral tosylated diamines consti-
tute state-of-the-art transfer hydrogenation sys-
tems.[3d,4] Based on this seminal work an increasing
number of ruthenium catalysts with chiral bidentate
N,N-ligands were developed in the last decade.[3] Sig-
nificantly fewer systems are known in which transfer
of chiral information is promoted by tridentate li-
gands.[5,6] Up to now only a limited number of auspi-
cious tridentate nitrogen-containing N,N,N ligands
were established in the field of transfer hydrogena-
tion. For example (R)-phenyl-ambox (1)[5] and differ-
ent pyridinebisoxazoline (pybox) ligands (2)[6] have
been applied for the reduction of acetophenone
(Scheme 1).
Recently, we reported the synthesis of a new class
of chiral tridentate amines.[7] The preparation and
tunability of these pyridinebisimidazolines (3) (so-
called pybim ligands, Scheme 1) are easier and more
flexible compared to the popular pyboxes, making the
former a suitable ligand tool box for various asym-
metric transformations. To date there is no report on
the performance of these ligands in hydrogenation re-
actions. The resemblance between pybim (3) and
pybox (2) stimulated our research to study the poten-
tial of this class of ligands in the transfer hydrogena-
tion of aromatic and aliphatic ketones.
In exploratory experiments, isopropyl alcohol-based
transfer hydrogenation of acetophenone was exam-
ined using a simple in situ catalyst system composed
of [RuCl2(C6H6)]2, 2,6-bis-([4R,5R]-4,5-diphenyl-4,5-
Scheme 1. N,N,N Tridentate ligands.
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dihydro-1H-imidazol-2-yl)-pyridine (3) and triphenyl-
phosphine. To ensure complete formation of the
active catalyst and avoid an induction period the reac-
tion mixture was heated for 10 min at 100 8C in the
presence of base followed by addition of acetophe-
none. First, studies for optimizing the reaction condi-
tions were carried out with 1 mol% of pre-catalyst
and 5 mol% of base. It is well-known that transfer hy-
drogenations are sensitive to the nature of the base.
Thus, the influence of different bases on selectivity
and conversion was investigated initially (Table 1).
Best results were obtained for sodium isopropoxide
and K2CO3 with conversions up to 95% and enantio-
meric excesses up to 94% (Table 1, entries 1 and 8).
Interestingly, NaOH and KOH the most commonly
used bases for transfer hydrogenations gave only
moderate enantioselectivity (78% and 80%, Table 1,
entries 3 and 4). In addition, we tested some organic
nitrogen-containing systems such as DBU, DABCO,
NEt3, N(i-Pr)2Et and pyridine, but only with N(i-
Pr)2Et did we obtain significant amounts of product
in a reasonable time (Table 1, entry 10). Next, the
concentration of sodium isopropoxide was varied at
different temperatures. As expected, the increase of
the amount of base led to an acceleration of reaction
rate; however, this was accompanied by an unaccepta-
ble decrease of enantioselectivity (Table 1, entries 13–
15). In contrast, improved ee is obtained by reducing
the amount of base to a ruthenium-to-base ratio of 1
to 0.5 (Table 1, entries 16 and 17). Notably, in the ab-
sence of base the transfer of hydrogen did not occur.
Based on these results we investigated the behavior
of the metal precursor.
Applying different ruthenium sources such as
[RuCl2(PPh3)3], [RuHCl(PPh3)3],
[8] RuCl3·x H2O,
Ru3(CO)12 and Ru(cod)(methylallyl)2, lower conver-
sion and/or poor selectivity were achieved. Neverthe-
less, [RuCl2(PPh3)3] showed an enantiomeric excess of
>99%, which is to our knowledge the highest enan-
tioselectivity in this model reaction for a chiral triden-
tate ligand (Table 1, entry 17). However, a slight
excess of pybim 3a, 3 equivs. with respect to 1 equiv.
Table 1. Transfer hydrogenation of acetophenone in the presence of pybim ligand 3a and different bases.[a]
Entry Base Base:Metal Temp. [8C] Conv. [%][b] ee [%][b]
1 NaO i Pr 5 100 80 94 (S)
2 KO t Bu 5 100 99 9 (S)
3 NaOH 5 100 79 78 (S)
4 KOH 5 100 85 80 (S)
5 LiOH 5 100 72 80 (S)
6 K3PO4 5 100 65 70 (S)
7 K2HPO4 5 100 19 96 (S)
8 K2CO3 5 100 95 93 (S)
9 Cs2CO3 5 100 45 67 (S)
10 N(i Pr)2Et 5 100 18 90 (S)
11 NaO i Pr 5 60 93 84 (S)[c]
12 NaO i Pr 5 80 91 83 (S)[d]
13 NaO i Pr 5 90 91 88 (S)
14 NaO i Pr 50 90 98 87 (S)
15 NaO i Pr 250 90 99 44 (S)
16 NaO i Pr 0.5 100 88 95 (S)
17 NaO i Pr 0.5 100 96 >99 (S)[e]
18 NaO i Pr 0.5 110 58 84 (S)
[a] Reaction conditions: in situ catalyst A {1.9106 mol [RuCl2(C6H6)]2, 3.810
6 mol ligand 3a, 3.8106 mol PPh3}; addi
tion of the corresponding base: entries 1 13: 1.9105 mol, entry 14: 1.9104 mol, entry 15: 9.5104 mol and for en
tries 16 18: 1.9106 mol in 2.0 mL isopropyl alcohol, 10 min at corresponding temperature then addition of 3.8104
mol acetophenone, 1 h at corresponding temperature.
[b] Conversion and ee were determined by chiral GC (50 m Lipodex E, 95 200 8C) analysis with diglyme as internal stan
dard.
[c] Reaction time 14 h.
[d] Reaction time 4 h.
[e] In situ catalyst B {3.8106 mol [RuCl2(PPh3)3], 1.1410
5 mol 3a}. Conversion was determined by GC (30 m HPAgilent
Technologies 50 300 8C) with diglyme as internal standard and ee was determined by chiral HPLC (Chiralcel OB H,
eluent: n hexane/ethanol, 99:1, flow rate: 2 mLmin1) analysis.
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of ruthenium, was necessary to achieve high enantio-
selectivity. To compare the difference of catalyst
system A and catalyst system B, we investigated the
conversion-time and the enantioselectivity-time de-
pendency (Scheme 2). No significant change of enan-
tioselectivity was observed in the shown time frame,
while after 24 h full racemization occurred with cata-
lyst A. Noteworthy, the analysis of the conversion-
time behavior proved a higher catalyst activity for cat-
alyst B, while for catalyst A a slight deceleration was
monitored. We assume a better stabilization of the
active species by an excess of 3a and PPh3.
As shown in Table 2 we also examined different
pybox ligands (2a–c), but only unsatisfying results
were obtained demonstrating the advantage of 3a
(Table 2, entries 1–3).
Noyori et al. proposed a metal-ligand bifunctional
mechanism for the hydride transfer process (“NH ef-
fect”).[4,13b] Hence, the NH group of the imidazoline
rings could be involved in the selectivity transfer and
increase the coordination affinity between substrate
and catalyst. Due to the formation of a second bind-
ing site, a more favorable position for transferring the
chiral information is attained.[5,9,13]
In order to understand the role of the free NH
functionality for our pybim ligand 3a, different substi-
tutions at the imidazoline units were carried out. The
corresponding monoprotected ligands 3b, c were syn-
thesized by reaction of 3a with one equivalent of 3,5-
di-tert-butylbenzoic acid chloride or Ph2P(O)Cl. We
presumed that the resulting unsymmetrical complexes
would direct the substrate to occupy a specific orien-
tation in the transition state and thereby induce in-
creased selectivity during catalysis. However, 3,5-(t-
Bu)2C6H3)CO (3b) or Ph2PO substitution (3c) de-
creased the enantioselectivity in the model reaction
significantly (Table 2, entries 5 and 6). To confirm the
results of the monosubstituted ligands an exchange of
both hydrogens with Boc (3d) or Bz (3e) protecting
groups was carried out. A further decrease of enantio-
selectivity was observed (Table 2, entries 7 and 8).
Thus, there is a crucial necessity of both NH function-
alities for obtaining high enantioselectivity in the
transfer hydrogenation of acetophenone. Interestingly,
the NH group is not necessary to achieve significant
conversions (Table 2, entry 8), which is in contrast to
previous reports by Noyori et al. , for example cata-
lysts containing N-dimethylamino alcohols are com-
pletely inactive compared to their N-monomethyl
counterparts.[3d,13b] To estimate the influence of the li-
gands in more detail we varied also the phosphorus
ligand part (Table 3). Among the different achiral li-
gands best results were obtained with PPh3, (p-MeO-
C6H4)3P and (p-Me-C6H4)3P (Table 3, entries 1, 3 and
Scheme 2. Conversion time and enantioselectivity time be
havior of catalyst A and catalyst B. Reaction conditions: in
situ catalyst A (1.9106 mol [RuCl2(C6H6)]2, 3.810
6 mol
ligand 3a, 3.8106 mol PPh3) or in situ catalyst B (3.8
106 mol [RuCl2(PPh3)3], 1.1410
5 mol 3a); addition of
sodium isopropoxide (1.9106 mol) in 2.0 mL 2 propanol,
10 min at 100 8C then addition of 3.8104 mol acetophe
none, reaction temperature: 100 8C. Conversion was deter
mined by GC (30 m HP Agilent Technologies 50 300 8C)
with diglyme as internal standard and ee was determined by
chiral HPLC (Chiralcel OB H, eluent: n hexane/ethanol,
99:1, flow rate: 2 mLmin1) analysis.
Table 2. Transfer hydrogenation of acetophenone in the
presence of different pybox and pybim ligands.[a]
Entry Ligand Time [h] Conv. [%][b] ee [%][b]
1 2a 1 6 11 (R)
2 2b 1 10 18 (S)
3 2c 1 22 8 (R)
4 3a 1 83 98 (S)
5 3b 2 95 26 (R)
6 3c 2 74 29 (S)
7 3d 1 4 7 (R)
8 3e 1 77 7 (S)
[a] Reaction conditions: 3.8106 mol [RuCl2(PPh3)3], 1.14
105 mol ligand, 3.8106 mol PPh3, 1.910
6 mol NaO
i Pr, 2.0 mL isopropyl alcohol, 10 min at 100 8C then ad
dition of 3.8104 mol acetophenone.
[b] Conversion and ee were determined by chiral GC (50 m
Lipodex E, 95 200 8C) analysis with diglyme as internal
standard.
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5). Methyl substitution in the o-position of arylphos-
phines decreased the enantioselectivity dramatically
compared to that at the p-position (from 97% ee to
rac, entries 4 and 5). Moderate conversion and selec-
tivity were obtained for electron-poor substituted ar-
ylphosphines (Table 3, entries 6 and 7). Interestingly,
also more basic and sterically hindered alkylphos-
phines such as PCy3, P(t-Bu)3, and n-BuPAd2 showed
only low activity (Table 3, entries 8–10).
Furthermore, we applied chelating arylphosphine li-
gands. For bis(diphenylphosphino)methane (DPPM)
only disappointing conversion and selectivity were ob-
tained (Table 3, entry 12). By increasing the number
of CH2 groups in the bridge an increase of the enan-
tiomeric excess was detected (Table 3, entries 13–15),
probably due to a weaker coordination of the second
phosphine group to the ruthenium. In addition, to im-
prove the enantioselectivity and to increase the enan-
tiomeric differentiation in the shape of the catalysts,
we investigated the influence of chiral phosphines.
Therefore, we tested chiral monodentate ligands (S)-4
and (S)-5 in the transfer hydrogenation of acetophe-
none in combination with pybim ligand 3a. Recently,
we have demonstrated the successful application of
such chiral monodentate 4,5-dihydro-3H-dinaphtho-
[2,1-c ;1’,2’-e]phosphepines in various asymmetric hy-
drogenations using molecular hydrogen.[10] Further-
more, Gladiali and co-workers reported previously
the application of this ligand class in the rhodium-cat-
alyzed asymmetric hydrogenation of C=C bonds.[21]
However, only ligand (S)-4 showed comparable enan-
tioselectivity to PPh3 of 95% ee, while (S)-5 gave
poor selectivity and conversion, due to a similar basic-
ity to achiral alkylphosphines (Table 3, entry 16 and
17).
Next, we explored the influence of the concentra-
tion of PPh3. The results indicated a necessity of
1 equiv. of PPh3 relating to 1 equiv. of ruthenium,
while the reaction with more than 1 equiv. of PPh3 or
in the absence of PPh3 resulted in a decrease of enan-
tioselectivity (Table 3, entries 1 and 2). Noteworthy,
the use of an excess of PPh3 has no disordered effect
on selectivity while a negative influence was reported
for other catalytic systems when PPh3 was not re-
moved.[5,6] In analogy to Gimeno et al.[6,11] and Yu
et al.[12] we assume a cis-coordination of the phos-
phine with respect to the N-N-N plane, which forms
after removal of the cis-coordinated chlorides (with
respect to each other) a highly selective vacancy for
substrate coordination and chirality transfer.
To demonstrate the usefulness of the novel catalysts
we employed system A ([RuCl2(C6H6)]2/pybim/PPh3)
and B ([RuCl2(PPh3)3]/pybim) in the asymmetric
transfer hydrogenation of six aromatic and one ali-
phatic ketones (Table 4). In general, catalyst system
A gave some higher enantioselectivities compared to
catalyst B. Substituted acetophenones and propiophe-
none gave enantioselectivities up to 98% ee (Table 4,
entries 1–5). In the case of methoxy-substitution the
position of the substituent plays an important role,
because ortho-substitution was favored (Table 4, en-
tries 3 and 4). A chloro substituent in the a-position
to the carbonyl group proved to be problematic and
deactivated both catalysts (Table 4, entry 6). Com-
pared to aromatic ketones, aliphatic ketones are more
challenging substrates. Nevertheless, 1-cyclohexyletha-
none was reduced by catalyst A in good yield and
enantioselectivity (Table 4, entry 7).
Table 3. Influence of different phosphorus ligands on the trans
fer hydrogenation of acetophenone.[a]
Entry P Ligand Temp.
[8C]
Conv.
[%][b]
ee
[%][b]
1 Ph3P 100 80 94 (S)
2 without 100 61 7 (S)
3 (p MeO C6H4)3P 90 91 87 (S)
[c]
4 (o Me C6H4)3P 100 20 rac
5 (p Me C6H4)3P 100 41 97 (S)
6 [3,4 (CF3)2 C6H3]3P 90 24 66 (S)
[c]
7 (p F C6H4)3P 100 53 76 (S)
8 Cy3P 90 2 15 (S)
[c]
9 t Bu3P 100 1 12 (S)
10 n BuPAd2 100 4 5 (S)
11 (i PrO)3P 100 28 75 (S)
12 Ph2P(CH2)PPh2 100 37 rac
13 Ph2P(CH2)2PPh2 100 43 rac
14 Ph2P(CH2)5PPh2 100 43 6 (S)
15 Ph2P(CH2)6PPh2 100 15 37 (S)
16 90 90 95 (S)[c]
17 90 8 24 (S)
[a] Reaction conditions: in situ catalyst {1.9106 mol [RuCl2
(C6H6)]2, 3.810
6 mol 3a, 3.8106 mol of the correspond
ing P ligand}, 1.9105 mol NaO i Pr, 2.0 mL isopropyl alco
hol, 10 min at described temperature then addition of 3.8
104 mol acetophenone, 1 h at described temperature.
[b] Conversion and ee were determined by chiral GC (50 m Lip
odex E, 95 200 8C) analysis with diglyme as internal stan
dard.
[c] Experiments also performed at 100 8C, but only low enantio
selectivities or conversions were obtained.
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Various methods (1H, 13C, 31P and 15N NMR, COSY
NMR, HMQC NMR and MS) were used for charac-
terization of the pre-catalyst, but unfortunately no
precise structure has been proven. The 31P NMR spec-
trum of the pre-catalyst in CDCl3 indicated a single
compound, because a singlet appeared at 30 ppm
(free PPh3: 6 ppm and O=PPh3: 27 ppm). Further-
more, the composition of the pre-catalyst was con-
firmed by HR-MS as [RuCl2(PPh3)(3a)] (calculated
mass: 953.17549, detected mass: 953.17572). However,
the coordination abilities of ligand 3a are so far un-
clear, because a rapid exchange of NH protons was
detected, which causes a broad signal in the 1H NMR
spectrum for the four protons adjacent to the nitrogen
atoms and furthermore one signal for the correspond-
ing carbons in the 13C NMR spectrum.
Next, we focused our attention on a deeper com-
prehension of the reaction mechanism. For metal-cat-
alyzed transfer hydrogenation two general mecha-
nisms are accepted, designated as direct hydrogen
transfer via formation of a six-membered cyclic transi-
tion state composed of metal, hydrogen donor and ac-
ceptor, and the hydridic route, which is subdivided
into two pathways, the monohydride and dihydride
mechanism (Scheme 3). More specifically, the forma-
tion of monohydride-metal complexes promotes an
Table 4. Transfer hydrogenation of prochiral ketones.[a]
Entry Alcohol Catalyst A[b,c,d] Catalyst B[b,c,d]
Conv. [%] ee [%] Conv. [%] ee [%]
1 89 89 (S) >99 85 (S)
2 84 94 (S) >99 89 (S)
3 86[e] 72 (S) 68[f] 74 (S)
4 >99 98 ( ) 99 g] 70 ( )
5 >99 97 (S) 98[e] 87 (S)
6 12[g] 70 (R) <2[f] 12 (R)
7 91 82 (S) 96[f] 72 (S)
[a] Reaction conditions: in situ catalyst A {1.9106 mol [RuCl2(C6H6)]2, 3.810
6 mol 3a, 3.8106 mol PPh3), 1.910
5 mol
NaO i Pr, 2.0 mL isopropyl alcohol, 10 min at 100 8C then addition of 3.8104 mol substrate, 1 h at 100 8C.
[b] Conversion and ee were determined by chiral GC (entry 1: 25 m Lipodex E, 80 180 8C; entry 2: 25 m Lipodex E, 100 8C;
entry 3: 50 m Lipodex E, 90 105 8C; entry 4: 50 m Lipodex E, 90 180 8C; entry 5: 25 m Lipodex E, 90 180 8C; entry 6:
50 m Lipodex E, 95 180 8C; entry 7: 25 m Lipodex E, 100 8C) analysis with diglyme as internal standard.
[c] In situ catalyst B {3.8106 mol [RuCl2(PPh3)3], 1.1410
5 mol 3a}.
[d] The absolute configurations were determined by comparing the sign of specific rotation with reported data.
[e] 4 h.
[f] 8 h.
[g] 24 h.
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exclusive hydride transfer from carbon (donor) to car-
bonyl carbon (acceptor) (Scheme 3), whereas a hy-
dride transfer via dihydride-metal complexes leads to
no accurate prediction of hydride resting state, be-
cause the former hydride was transferred to the car-
bonyl carbon (acceptor) as well as to the carbonyl
oxygen (acceptor) (Scheme 3). Indications for both
pathways (hydridic route) have been established by
various research groups, when following the hydride
transfer catalyzed by metal complexes, e.g., Ru, Rh or
Ir.[13]
Reaction of cyclopropyl phenyl ketone (“radical
clock”-substrate) with isopropyl alcohol in the pres-
ence of 1 mol% catalyst A gave exclusively the corre-
sponding cyclopropylphenyl alcohol (>99% by
1H NMR). Apparently there is no radical reduction
induced by the transition metal or by sodium alkox-
ides.[14] The second assumption is also confirmed by
performing the reduction of acetophenone in the
presence of base and in the absence of the ruthenium
catalyst. Here, no product at all was detected.
Next, we followed the incorporation of hydrogen
from the donor molecule (isopropyl alcohol) into the
product by applying a deuterated donor.[15] The pre-
catalyst (1 mol%) is generated by stirring a solution
of isopropyl alcohol-d8, 0.5 equivs. of [RuCl2(C6H6)]2,
ligand 3a and PPh3 for 16 h at 65 8C. Then, sodium
isopropoxide-d7 was added and the solution was stir-
red for 10 min at 100 8C. The reaction mixture was
charged with acetophenone and after 1 h compound
13 was observed as main product (>99%) by
1H NMR (Scheme 4).[16] The result proved an exclu-
sive transfer of the deuterium into the carbonyl
group, therefore a CH activation of the substrate/
product under the described conditions did not occur.
Furthermore, this result rules out an enol formation
in the catalytic cycle.[17]
To specify the position and the nature of the trans-
ferred hydride, the reaction was performed with iso-
propyl alcohol-d1 (hydroxy group deuterated) as sol-
vent/donor and sodium isopropoxide as base under
identical reaction conditions. In the transfer hydroge-
nation of acetophenone we obtained a mixture of two
deuterated 1-phenylethanols (Scheme 4, 14a and
14b).The ratio between 14a and 14b (85:15) indicated
a specific migration of the hydride, albeit some scram-
bling was detected.[18] This was probably caused by re-
arrangement of the hydride complex, starting from
HNRuD via N=Ru(HD) to DNRuH and subse-
quent transfer process into acetophenone yielding
14b. In conclusion the incorporation is in agreement
with the monohydride mechanism, implying the for-
mation of a metal hydride species in the catalytic
cycle (Scheme 3). Furthermore, this indication is con-
firmed by the above-mentioned influence of the NH
groups. In conclusion, the transfer of hydrogen, in the
case of catalyst A, is subdivided into the hydride
transfer by the metal and the proton transfer by the
NH group in analogy to the metal-ligand bifunctional
catalysis.[13r]
We demonstrated for the first time the successful
application of chiral tridentate pyridinebisimidazoline
ligands in the asymmetric ruthenium-catalyzed trans-
fer hydrogenation of aliphatic and aromatic ketones.
Enantioselectivities up to >99% ee were obtained
under optimized reaction conditions. Comparison ex-
periments of 3a with monoprotected pybims and
pybox ligands displayed the crucial influence of the
free NH functionality. Mechanistic experiments indi-
cated the transfer of hydrogen from the donor mole-
cule into the substrate via a metal-ligand bifunctional
mechanism.
Scheme 3.Monohydride and dihydride mechanisms for
transfer hydrogenations.
Scheme 4. Deuterium incorporation into acetophenone catalyzed by catalyst system A.
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Experimental Section
General Remarks
All manipulations were performed under an argon atmos
phere using standard Schlenk techniques. Isopropyl alcohol
was used without further purification (purchased from
Fluka, dried over molecular sieves). Sodium isopropoxide
was prepared by reacting sodium with isopropyl alcohol
under an argon atmosphere (stock solution). All ketones
were dried over CaH2, distilled in vacuum and stored under
argon, except 4’ methoxyacetophenone and phenacyl chlo
ride, which were used without further purification.
BuP(Ad)2
[19] and N phenyl 2 (di tert butylphosphino) pyr
role[20] were synthesized according to literature protocols.
General Procedure for the Transfer Hydrogenation of
Ketones
In a 10 mL Schlenk tube, the in situ catalyst was prepared
by stirring a solution of [RuCl2(C6H5)]2 (1.910
6 mmol),
ligand 3a (3.8106 mmol) and PPh3 (3.810
6 mmol) in
1.0 mL isopropyl alcohol for 16 h at 65 8C. To this mixture
sodium isopropoxide (1.9105 mmol in 0.5 mL isopropyl al
cohol (stock solution)) was added and the solution stirred at
100 8C for 10 min. After addition of the corresponding
ketone (0.38 mmol in 0.5 mL isopropyl alcohol (stock solu
tion)) the reaction mixture was stirred for 1 h at 100 8C. The
solution was cooled to room temperature and filtered over a
plug of silica. The conversion and ee were measured by GC
without further manipulations.
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Abstract
Various Ru(L1)(L2) (1) complexes (L1 = 2,2
0 bipyridines, 2,2 0:6 0,200 terpyridines, 6 (4S) 4 phenyl 4,5 dihydro oxazol 2 yl 2,2 0 bipy
ridinyl or 2,2 0 bipyridinyl 6 carboxylate; L2 = pyridine 2,6 dicarboxylate, pyridine 2 carboxylate or 2,2 0 bipyridinyl 6 carboxylate) have
been synthesized (or in situ generated) and tested on epoxidation of olefins utilizing 30% aqueous H2O2. The complexes containing pyr
idine 2,6 dicarboxylate show extraordinarily high catalytic activity. Based on the stereoselective performance of chiral ruthenium com
plexes containing non racemic 2,2 0 bipyridines including 6 [(4S) 4 phenyl 4,5 dihydro oxazol 2 yl] [2,2 0]bipyridinyl new insights on the
reaction intermediates and reaction pathway of the ruthenium catalyzed enantioselective epoxidation are proposed. In addition, a sim
plified protocol for epoxidation of olefins using urea hydrogen peroxide complex as oxidizing agent has been developed.
 2006 Elsevier B.V. All rights reserved.
Keywords: Ruthenium; Olefin; Epoxidation; Homogeneous catalysis; Mechanism
1. Introduction
Oxidation reactions constitute one of the core technolo-
gies which convert simple bulk raw materials, such as alk-
anes and olefins, to value-added products in higher
oxidation states [1]. However, in the area of fine chemicals
and pharmaceuticals they are less established on industrial
scale compared to reductions and CC coupling reactions.
For a more general application of oxidation reactions,
the ‘‘ideal’’ oxidant should be in high atom-economy, envi-
ronmentally benign, readily available and safe as well [2].
Air (molecular oxygen) is undoubtedly the perfect oxidant
of choice for a number of oxidation reactions. However,
only one oxygen atom of O2 is productive for most oxida-
tions (50% atom efficiency), thus such processes produce
significant amount of waste from the co-reductant [3,4].
Apart from molecular oxygen, hydrogen peroxide (H2O2)
has been shown to be a useful oxidant with respect to the
criteria mentioned above [5,6]. Due to its handling and
price it is particularly useful for liquid-phase oxidations
for the synthesis of fine chemicals, pharmaceuticals, agro-
chemicals and electronic materials. Hence, developments
on new catalytic systems using H2O2 are an important
and challenging goal in oxidation chemistry [7,8].
With regard to enantioselective epoxidations of olefins,
titanium (Sharpless epoxidation) [9] and manganese (Jac-
obsen Katsuki epoxidation) [10] based catalysts are still
in the state-of-the-art. Very recently Katsuki et al. demon-
strated that a titanium schiff base catalyst showed very
good activity and excellent ee in asymmetric epoxidation
utilizing aqueous H2O2 [11]. In the last decade significant
0022 328X/$ see front matter  2006 Elsevier B.V. All rights reserved.
doi:10.1016/j.jorganchem.2005.12.069
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progress using organic catalysts based on chiral ketones
(Shi, Yang and other’s ketone catalysts) [12,13] has also
been reported. Besides, the polypeptide-catalyzed stereose-
lective epoxidation of enones under phase transfer condi-
tions seems to be an industrially applicable process [14].
Chiral Lewis acids [15] and chiral amines [16] catalyzed
epoxidation of a,b-unsaturated olefins also have been
demonstrated.
Generally, there are several problems associated with
the use of H2O2 in asymmetric epoxidations [8]. For
instance H2O2 usually decomposes to O2 in the presence
of transition metal catalysts. Over stoichiometric amount
of H2O2 is often employed to solve this problem. However,
the stability of the catalyst in high concentration of H2O2
as well as the selectivity, especially enantioselectivity, in
the presence of water obviously could be problematic. It
is also apparent that oxidative cleavage of the olefin com-
petes with the productive epoxidation. Therefore, even
after decades of extensive research efforts, the development
of general and catalytic asymmetric epoxidation methods
using H2O2 is still underway [16,11,17].
Our interest has been aroused by ruthenium-catalyzed
oxidation reactions with its wide range of applicability
and broad variation of ligand type especially in asymmetric
epoxidation of olefins [18]. In this regard, we chose Ru(pyr-
idine-2,6-bisoxazoline)(2,6-pyridinedicarboxylate) (1) as
our starting point as it contains two different meridional
ligands [19]. It is patently advantageous that by modifying
the chiral (pybox) and the achiral (pydic) ligands sepa-
rately, the reactivity and (enantio)selectivity should be pos-
sible to tune up easily. Applying this concept, we were able
to make 1 to become a more practical epoxidation catalyst
by adding a controlled amount of water to the reaction
mixture [20a]. This also led to the development of enantio-
selective epoxidation protocols applying alkyl peroxides
[20b] and hydrogen peroxide [20d,20e,20f]. Noteworthy,
highly productive and robust ruthenium catalysts with
turnover number (TON) up to 10000 have also been devel-
oped for non-asymmetric epoxidation with 30% aqueous
H2O2 [20c,20e]. Most recently, a ligand library of N,N,N-
tridentate pyridinebisimidazolines, so-called pybim ligands,
was also realized during the course of these studies [20f,21].
Fig. 1 shows four of more than 70 catalysts which we have
tested in the epoxidation of olefins with H2O2.
In this paper, we describe our work on the synthesis of
novel ruthenium(II) bipyridine and terpyridine complexes.
Spectral and catalytic activity studies using these complexes
shed light on the mechanism of the ruthenium-catalyzed
asymmetric epoxidation. Besides a simplified protocol for
the epoxidation of olefins utilizing urea hydrogen peroxide
complex has been developed.
2. Results and discussion
In our previous studies, we have shown that various
ruthenium complexes, such as 1 and 2 allow for the epox-
idation of aromatic olefins with high selectivity (chemose-
lectivity up to 99%; enantioselectivity up to 85%) [22].
With regard to the mechanism of this novel asymmetric
epoxidation, we have established the role of the protic sol-
vent, the effect of acid additives, and the relative rate of dif-
ferent catalysts. In addition, competitive reactions with
different olefins suggested an unsymmetric oxo-transfer
transition state [22b]. Modelling studies on the reactivity
of the core structure 1 0 at the B3LYP/LANL2DZ density
functional level of theory showed that an N-oxide coordi-
nating intermediate is likely to be the most thermodynam-
ically stable isomer of all possible intermediates. Scheme 1
shows a preliminary mechanistic picture of the reaction.
Initially, the carboxylate on 1 0 dissociates in a protic sol-
vent and makes the oxidation of the ruthenium center
much faster. Hence, the ruthenium(III) species D forms,
which is further oxidized to intermediates A. A3 is the most
stable one suggested by theoretical calculation. However,
from the evidence of kinetic studies, A1 is suspected to be
the active oxo-transfer intermediate [23]. After epoxidation
of the olefin D is regenerated (cycle A). Alternatively, inter-
mediates A can be further oxidized to complexes B which
transfer the oxygen atom to the olefin and regenerate inter-
mediates A (cycle B).
Unfortunately, so far any isolation of ruthenium inter-
mediates in higher oxidation state was not successful.
Also initial attempts to synthesize the mono- or di-N-
oxide of 2,6-bis-[(4S)-4-phenyl-4,5-dihydrooxazol-2-yl]pyr-
idine (S,S-Ph2-pybox) by oxidation with m-CPBA [24] or
cyclization of (S)-2-hydroxy-amino-2-phenylethanol with
dimethyl pyridine-2,6-dicarboximidate [25] did not yield
the desired N-oxide ligands. Apparently S,S-Ph2-pybox
and its N-oxides are not stable in strong oxidizing and
acidic conditions.
Therefore, we chose the more robust 2,2 0:6 0,200-terpyri-
dines as our model ligand system. Though the turnover
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Fig. 1. Ruthenium catalysts for epoxidation of olefins with H2O2.
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number (TON) of the ruthenium terpyridine complex 3 is
around 40 times larger than that of 1 (TON of 1 and 3
are 200 and 8000, respectively) [20d,20e], competition
reactions showed that the relative rate of 3 is only 1.8
2.4 times faster than that of 1 [22b]. This shows good agree-
ment with our hypothesis that the high productivity of 3 is
due to its robustness and not electronic or steric reasons.
Owing to better solubility, 4,4 0,400-tri-tert-butyl-2,2 0:6 0,2 0-
terpyridine 5a was subjected to selective oxidation with
m-CPBA to yield 6 and 7 in 53% and 81%, respectively
(Scheme 2) [26].
Next, 6 and 7 were reacted with [Ru(p-cymene)Cl2]2 as
illustrated in Scheme 3. In case of 6 only metal species with
a molecular weight similar to 3a have been observed in the
electrospray ionization mass spectrometry (ESI-MS) after
removal of solvent. Moreover, unidentified products were
observed in the ESI-MS when 7 was used in the complexa-
tion reaction. Direct oxidation of 3a with m-CPBA in
CH2Cl2 turned the solution from violet to brown instanta-
neously. However, after removal of solvent, only a purple
solid with molecular mass as 3a was observed. Hence, titra-
tion of 3a with m-CPBA monitored by UV Vis spectros-
copy in CH2Cl2 at 25 C was then performed. As shown
in Fig. 2 the absorption maxima at 526, 329, 321 nm were
gradually decreased and the shoulder at 337 nm was
increased when portions of m-CPBA solution was added
(see Section 4). Isosbestic points were observed at 354
and 327 nm. This phenomenon indicates that a single
Scheme 1. Proposed mechanism for the Ru(pybox)(pydic) catalyzed epoxidation of olefins.
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product was formed preferentially [27]. The ratio of 3a to
m-CPBA determined by the titration was approximately
1:1 in three different concentrations of 3a.
The ESI-MS of the 3a:m-CPBA 1:1 solution showed
only the molecular ion peak similar to 3a. No epoxide
was observed even in the presence of a 10-fold excess of sty-
rene. Reacting an excess of m-CPBA with 3a in CH2Cl2 or
CH3CN gave only a weak molecular ion peak of
[(3a + O + H)+] and high intensity of [(3a)+] in the ESI-
MS. Noteworthy, the molecular ion peak of [(3a + 2O)+]
has never been observed. In addition, there was no obser-
vable change in the UV Vis spectrum when benzoic acid
was added to the solution of 3a. Hence, the UV Vis
absorption spectrum shift is not due to the formation of
intermediate A nor protonation. Instead, we propose that
3a is easily oxidized by m-CPBA to intermediate D. This
is in agreement with the previous observation that 3 can
be oxidized to a paramagnetic Ru(III) state in solution
[28]. However, we could not exclude that intermediate A
is generated in low concentration or it decomposed back
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to 3a or intermediate D. In fact ruthenium (IV) oxo por-
phyrin has been reported to undergo disproportionation
to give a ruthenium (II) porphyrin and a ruthenium (VI)
dioxo porphyrin complex [29].
Thus, we computed the possible key intermediates aim-
ing to have further insight about the decomposition path-
ways of the oxidized complex 3 (Scheme 4 and Table 1).
All calculations were carried out by using the GAUSSIAN 03
program [30]. Structures were optimized at the B3LYP
[31] density functional level of theory with the LANL2DZ
basis set [32], and the nature of the optimized structures
on the potential energy surface (PES) was characterized
by the calculated number of imaginary frequency (NImag)
at the same level of theory (B3LYP/LANL2DZ), i.e.; mini-
mum structures without (NImag 0) [33]. The correspond-
ing frequency calculations provide also the thermal
corrections to Gibbs free energies at 298 K. The energies
for discussion and interpretation are the Gibbs free energies
(DG DH  TDS). At B3LYP/LANL2DZ, the parent
complex 3 has C2 symmetry, and the mono- and di-oxidized
species 3(O) and 3(O)2 are C1 and C2 symmetrical, respec-
tively. All three structures are energy minimums on the PES.
From the Gibbs free energy, both the bimolecular
decomposition of mono-oxo complex 3(O) to 3 and O2
and self decomposition of di-oxo ruthenium complex
3(O)2 to 3 and O2 are highly thermodynamically favourable
(about 30 kcal mol 1). Disproportionation of 3(O) to 3
and 3(O)2 is also not likely (+3.4 kcal mol
1). The calcula-
tions suggest that the ruthenium oxo-transfer species is not
3(O)2 due to insufficient stability, though the rate of this
decomposition is not so clear. Moreover, since the decom-
position of 3(O) is bimolecular, when the concentration of
3(O) is low (as in the catalytic reaction conditions: H2O2
is dosed to the catalytic reaction slowly in 12 h and pre-cat-
alyst is only in catalytic amount), the olefin acts as a good
trap and epoxide forms. The bimolecular decomposition
of two 3(O) to molecular oxygen also explain the observa-
tion in the ESI-MS [very low intensity of 3(O)] and the
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Table 1
B3LYP/LANL2DZ total electronic energies (Etot, au) and total Gibbs free
energies (Gtot, au, at 298 K) and number of imaginary frequencies
(NImag)
Etot Gtot NImag
3/C2 1460.51505 1460.23975 0
3(O)/C1 1535.65806 1535.38146 0
3(O)2/C2 1610.79774 1610.51774 0
2½3ðOÞ ! 2½3 þO2 DG ¼ 30:0 kcal mol1 ð1Þ
½3ðOÞ ! 2½3 þO2 DG ¼ 33:6 kcal mol1 ð2Þ
2½3ðOÞ ! ½3 þ ½3ðOÞ2 DG ¼ þ3:4 kcal mol1 ð3Þ
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Fig. 2. UV Vis titration of 3a with m CPBA.
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negative results in the attempts of isolating 3(O) since con-
centrating of the solution of 3(O) favours the bimolecular
decomposition of 3(O) to 3 and O2 (infra supra).
In order to have a better understanding of the reactivity
and transfer of chirality, we used the fragment-based
approach to address the essential part of the catalysts.
These C2 symmetric catalysts contain two meridional
ligands. Each of them contains four pyridine nitrogen
and two carboxylate oxygen atoms. We decided to synthe-
size and test new catalysts with similar coordinating groups
according to their possibility of modification, the availabil-
ity of starting materials, and the ease of synthesis. Hence,
different 2,2 0-bipyridines functionalized in the 6-position
were synthesized (Scheme 5). 2,2 0-Bipyridine N-oxide was
treated with TMSCN and benzoyl chloride at 0 C to room
temperature for 18 h to yield 2,2 0-bipyridine-6-carbonitrile
in 90% [34]. Hydrolysis of 2,2 0-bipyridine-6-carbonitrile
with HCl gave 2,2 0-bipyridine-6-carboxylic acid in good
yield (77%) [35].
Direct cyclization of unsymmetrical 6-[(4S)-4-phenyl-
4,5-dihydro-oxazol-2-yl]-[2,2 0]bipyridinyl (10) with (S)-2-
amino-2-phenylethanol and 2,2 0-bipyridine-6-carbonitrile
in refluxing anhydrous chlorobenzene using anhydrous
ZnCl2 as the catalyst showed inferior result and gave
only a trace of the desired product. To our delight, 10
was obtained in good yield when methyl 2,2 0-bipyri-
dine-6-carboxyimidate was refluxed with (S)-2-amino-2-
phenylethanol in CH2Cl2 for 48 h. Chiral non-racemic
2,2 0-bipyridine (11a) was reported to induce good enanti-
oselectivity in epoxidation of styrene with PhI(OAc)2,
though with low reactivity [36]. Therefore, we were inter-
ested to test this type of ligands in our reaction condi-
tions [20d]. Hence, 11a and 11b were synthesized by
Kro¨hnke condensation [37]. Subsequently, 11c and 11d
were obtained in good yields using the Suzuki Miyaura
cross coupling reaction [37b]. Other commercially avail-
able ligands and co-ligands used in this study are also
shown in Scheme 5.
N+
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N
N
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Scheme 5. Synthesis of ligands and commercially available ligands in this study. Reagents and conditions: (a) TMSCN, PhCOCl, CH2Cl2, 0 C to r.t.,
18 h, 90%; (b) 37% HCl, reflux, 2 h, 77%; (c) Na, anhy. MeOH, Ar, r.t., 4 days, 99%; (d) (S) 2 amino 2 phenylethanol, anhy. CH2Cl2, Ar, reflux, 48 h,
92%; (e) (1R) ( ) myrtenal, NH4OAc, formamide, 75 C, 6 h, 53%; (f) (1R) ( ) myrtenal, NH4OAc, HOAc, reflux, 6 h, 42%; (g) 0.2 mol% Pd(PPh3)4,
RB(OH)2, toluene/H2O, K2CO3, 120 C, 13 h, 11c: 99%, 11d: 84%.
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Next, six different ruthenium complexes have been syn-
thesized in moderate to good yields by heating [Ru(p-cym-
ene)Cl2]2 with the corresponding ligand in MeOH at 65 C
under Ar in the presence of NaOH (1 equiv. per carboxylic
acid) for 1 h (see Section 4) (Scheme 6).All pre-catalysts were
well characterized and subjected to two prototypical epoxi-
dation reactions. The results are summarized in Scheme 7
and Table 2. In case of complexes with 2,2 0-bipyridines
+ 30% H2O2
O
*CatalystR R
tert-AmOH, r.t.
12 h addition H2O2
*
R = H, Ph
Scheme 7. Ruthenium catalyzed epoxidation of styrene and trans stilbene.
Table 2
Ruthenium catalyzed epoxidation of styrene and trans stilbene with H2O2
a
Entry Catalyst
Ph
O
*
Ph
O
* Ph
*
Yield (%) Ee (%) Yield (%) Ee (%)
1 0.5 mol% 3a 71 96
2 0.5 mol% 12b 0 0
3 0.5 mol% 13 9 26
4 5 mol% 14c 70 +31d 100 67e
5 5 mol% 15 68 1 >99 0
6 5 mol% 16 18 n.d.f 14 n.d.
7 2.5 mol% [Ru(p cymene)Cl2]2, 5 mol% 11a, 5 mol% H2pydic, 12 mol% Et3N 67 +4 84 0
8 2.5 mol% [Ru(p cymene)Cl2]2, 5 mol% 11b, 5 mol% H2pydic, 12 mol% Et3N 40 2 28 0
9 2.5 mol% [Ru(p cymene)Cl2]2, 5 mol% 11c, 5 mol% H2pydic, 12 mol% Et3N 29 4 19 3
10 2.5 mol% [Ru(p cymene)Cl2]2, 5 mol% 11d, 5 mol% H2pydic, 12 mol% Et3N 77 0 69 0
a Ref. [20e].
b See Section 4.
c Ref. [22b].
d ‘‘+’’ sign means (R) (+) styrene oxide is the major enantiomer.
e ‘‘ ’’ sign means (S,S) ( ) trans stilbene oxide is the major enantiomer.
f Not determined.
[Ru(p-cymene)Cl2]2
MeOH, 65 ˚C, Ar, 1 h
L1 L2
NaOH
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Scheme 6. Synthesis of ruthenium catalysts: aRef. [20e]; bRef. [22a].
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11a d and 2,6-pyridinedicarboxylic acid we used an in situ
catalyst generation protocol [20a], due to the easy hydrolysis
of the resulting complexes [36].
All catalytic experiments were run with 30% aqueous
H2O2 at room temperature. Complex 3 has been shown
to be a general and efficient catalyst because of its robust-
ness [20e]. Surprisingly complexes 12 and 13, which contain
the same aromatic terpyridine unit as 3, showed a drastic
decrease of activity. Simply changing 2,6-pyridinedicarb-
oxylate (pydic) to 2-pyridinecarboxylate, the resulting
ruthenium complex 12 showed no reactivity at all. Even
13 containing four pyridine nitrogen and two carboxylate
groups similar to 3 gave only poor yield for the epoxides
[38]. Clearly, the chelating sub-unit ‘‘O N O’’ of pydic,
which stabilizes the Ru(III) oxidation state by donating
electron density to the metal center, plays a dominating
role on the catalytic reactivity.
The importance of this ‘‘O N O’’ sub-unit is also
reflected by the reduction and oxidation potentials of dif-
ferent ruthenium complexes (Table 3). It is with good
agreement that the higher the oxidation potential of
Ru2+/Ru3+, the lower the reactivity in the epoxidation
reaction. On the other hand, the higher the E1/2 (reduction
potential) the higher the stability of the ligands towards
reduction. Hence, 3 showed the highest reduction potential
on terpyridine. Moreover, no reduction potential of pydic
was observed [39]. As both terpyridine and ‘‘pydic’’ are
more stable, the whole catalytic system becomes more
robust.
Attempts to isolate catalysis intermediates from epoxida-
tion reactions in the presence of Ru(S,S-Ph2-pybox)(pydic)
(14) resulted in the isolation of suspected Ru(S,S-Ph2-
pybox)(pydic)(O) complexes in low yield (<10%). The 1H
NMR spectrum of the isolated product showed diamag-
netic behaviour and was not explainable. A careful analysis
of the ultra high resolution mass spectrum showed
three major peaks at m/z 636.05765 (C30H22N4O6Ru
+),
650.03980 (C30H20N4O7Ru
+), and 652.05383 (C30H22N4-
O7Ru
+). We believe that 14 is oxidized to a Ru(III) species
together with two Ru complexes with one oxygen atom
more, in which one of them has an aromatized oxazoline
ring. Catalytic tests with the chiral catalyst 15 demon-
strated that even one aromatized oxazoline ring on the cat-
alyst may lead to a total loss of enantioselectivity. In
agreement with this observation, the suspected Ru(S,S-
Ph2-pybox)(pydic)(O) mixture gave a significantly lower
enantioselectivity compared with the original catalyst 14.
The testing of in situ generated catalysts with chiral bipyri-
dines 11a d resulted in 29 77% of trans-stilbene oxide,
however none of the catalysts gave any reasonable ee (0
4%) (Scheme 8).
Finally, we were interested in improving our general
epoxidation protocol. In our original procedure, 30% aque-
ous H2O2 was delivered to the olefin in tert-amyl alcohol in
the presence of 0.5 mol% of 3 for 12 h by a syringe pump to
prevent unproductive decomposition of H2O2.
For a laboratory procedure, it is advantageous to apply
a solid oxidizing agent which can be dosed to the reaction
mixture without any additional equipment. In case of a
lower solubility of the solid oxidant in tert-amyl alcohol,
unwanted decomposition of H2O2 to O2 should be mini-
mized. Hence, we tested common solid oxidants for the
epoxidation of trans-stilbene (Table 4). To our delight, urea
hydrogen peroxide complex deserves our hypothesis and
gave an excellent yield of epoxide (>99%) in our model
reaction in only 1 h. Next, we tested this simplified protocol
and the results are shown in Table 5. UPH oxidized aro-
matic olefins in the presence of 0.5 mol% 3 with moderate
to very good selectivity. Compared to the original proce-Table 3
Redox potentials of various ruthenium terpyridine and pydic complexes
Complex E1/2 (oxidation) [V] E1/2 (reduction) [V] Ref.
1 2
Ru(tpy)2+ +1.31a 1.24 1.49 [38]
[Ru(tpy)(pic)][PF6] +0.88
b 1.39 2.12 [39]
Ru(tpy)(bpyCO2) +0.90 1.36 1.63 [38]
Ru(tpy)(pydic) (3) +0.60 1.53 not observed [39]
Ru(bpyCO2)2 (13) +0.52 1.49 1.79 [38]
KRu(pydic)2 +0.21
c n.d. n.d. [40]
n.d., Not determined.
a Reduction potential vs. SCE.
b Initial reported reduction potentials were referenced to Fc/Fc+ which
is taken as +0.48 V here.
c Determined by potentiometric titration at pH 7.
+ Oxidant
O
Ru(tpy)(pydic) 3
tert-AmOH, r.t.
Scheme 8. Screening of various solid oxidant for epoxidation of trans stilbene.
Table 4
Screening of various solid oxidant for epoxidation of trans stilbene
Entry Oxidant Time
(h)
Conv. (%) Yield (%) Selec. (%)a
1 30% H2O2 12 100 96 96
2 UHPb 1 100 >99 >99
3 Na2CO3 Æ 1.5H2O2 16 0 0 0
4 Oxonec 16 9 4 44
5 Ca(OCl)2 16 14 0 0
a Selectivity towards epoxide.
b Urea hydrogen peroxide complex.
c 2KHSO4 Æ KHSO4 Æ K2SO4.
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dure the reaction time is shortened. Mono-, 1,1-di, trans-
and cis-1,2-di-, tri- and even tetra-substituted olefins all
have good to excellent selectivity towards the correspond-
ing epoxides. Functional groups like alcohol and halogens
are tolerant in the reaction system. Clearly, slow dosage of
the oxidant is no longer needed for this method.
3. Conclusion
In summary, mechanistic studies of ruthenium-cata-
lyzed epoxidations of olefins were performed experimen-
tally and theoretically with high level density functional
theory calculations. Mono-N-oxide A3 and active oxo-
transfer catalyst A1 are possible intermediates in the reac-
tion pathway. A fragment-based catalyst design showed
that the 2,6-pyridinedicarboxylic acid ligand is essential
for the reactivity. Moreover, a C2 symmetric chiral ligand
provides the necessary chiral induction. Hence, catalyst 15
gave no ee for the epoxidation of trans-stilbene and sty-
rene. This suggests that a partial ligand oxidation of the
catalyst is possibly one of the non-productive asymmetric
epoxidation pathways. Moreover, a general simplified and
more active ruthenium-catalyzed epoxidation procedure
of olefins utilizing urea hydrogen peroxide complex has
been developed. Further development towards asymmetric
epoxidation reactions are under investigation in our
laboratory.
4. Experimental
4.1. General
Unless specified, all chemicals are commercially avail-
able and used as received. Ru(tpy)(pydic) (3) [19],
Ru(tBu3-tpy)(pydic) (3a) [20e], bpyCO2H (9) [32], 2,2
0-
bipyridines (11a d) [37], Ru(bpyCO2)2 (13) [38], and
Ru(S,S-Ph2-pybox)(pydic) (14) [19], are synthesized
according to the literature procedures. Qualitative analysis
of reaction products was done on a gas chromatograph HP
5890 with mass selective detector HP 5989A (Hewlett-
Packard) and a capillary column of type HP 5 was used
for separation. For quantitative analysis of reaction mix-
ture, the measurement was performed on a HP 6890 gas
chromatograph (Hewlett-Packard) with flame ionization
detector. The separation is obtained on a capillary column
of type HP 5 (5% phenylmethylsiloxane, length 30 m, inner
diameter 250 lm, film thickness 0.25) with argon as flowing
gas. Enantiomeric excess of epoxides were determined with
HP 1090 liquid chromatography (Hewlett-Packard)
equipped with a DAD detector. UV Vis spectroscopic
measurements were performed with a Shimadzu UV-1601
spectrophotometer. Nuclear magnetic resonance spectra
were recorded on Bruker ARX300 or ARX400 spectrome-
ters. All NMR spectra were taken in pure deuteriated sol-
vents, such as CDCl3, CD2Cl2, etc. Chemical shifts (d) are
given in ppm and refer to residual solvent as internal stan-
dard. Signal multiplicity and coupling constants (J in Hz)
are shown in the parentheses. For multiplicity the follow-
ing abbreviations are used: s, singlet; d, duplet; dd, duplet
of duplet; t, triplet and m, multiplet.
Table 5
Scope and limitations of Ru(tpy)(pydic) 3 catalyzed epoxidation of olefin
with UHP
Entry Olefin Time
(h)
Conv.
(%)
Yield
(%)a
Selec.
(%)b
1 Ph 3 41 39 95
2
H3C
3 81 74 91
3
F
3 49 39 80
4
Cl
3 40 28 71
5 Ph 3 100 >99 >99
6
MeO
3 100 95 95
7 Ph OPh 3 100 92
c 92
8 Ph OH 3 100 63 63
9 Ph
 
3 65 59 91
10
Ph  
3 67 51 76
11 Ph 3 100 83 83
12
Ph
3 99 95 96
13 Ph 3 99 92 93
14
Ph
Ph 3 100 96d 96
15
Ph
3 53 48 91
a GC yields.
b Chemoselectivity towards epoxide.
c Isolated yield.
d NMR yield.
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4.2. Ligand synthesis
4.2.1. Synthesis of 4,4 0,400-tri-tert-butyl-2,2 0:6 0,200-terpyridine
1-N-oxide (6)
To the solution of 4,4 0,400-tri-tert-butyl-2,2 0:6 0,200-terpyri-
dine (5a) (300 mg, 0.75 mmol) in CH2Cl2 (7.5 ml), m-CPBA
(77%, 167 mg, 0.75 mmol) in CH2Cl2 (7.5 ml) was added
dropwise. The reaction mixture was stirred at r.t. for
15 h. It was then diluted with CH2Cl2 (10 ml) and washed
with NaHCO3 (10 ml · 3). The organic layer was dried
over MgSO4, filtered and evaporated under reduced pres-
sure. The crude product was chromatographed on silica
gel (70 230 mesh) using ethyl acetate:Et3N:MeOH
100:1:0 to 100:1:1 as the gradient eluent. An off-white solid
was obtained after removal of solvent (165 mg, 53%). 6:
Rf 0.60 (ethyl acetate:Et3N:MeOH 100:1:10);
1H NMR
(400.1 MHz, CDCl3): d 1.37 (s, 9H), 1.38 (s, 9H), 1.42
(s, 9H), 7.25 (dd, J 6.9, 3.0 Hz, 1H), 7.35 (dd, J 5.4,
2.0 Hz, 1H), 8.23 (d, J 6.9 Hz, 1H), 8.47 (d, J 3.0 Hz,
1H), 8.53 (d, J 2.0 Hz, 1H), 8.57 (d, J 1.7 Hz, 1H),
8.62 (d, J 5.4 Hz, 1H), 9.17 (d, J 1.7 Hz, 1H); 13C
NMR (100.6 MHz, CDCl3): d 30.46, 30.67, 34.65,
35.08, 35.44, 116.29, 118.51, 118.95, 121.89, 122.37,
123.12, 124.86, 140.06, 146.35, 148.18, 148.93, 150.12,
154.52, 155.50, 161.82; IR (KBr) 1588, 1546, 1480, 1377,
1261, 1192, 1067, 895, 831; 728, 609; EI-MS m/z 417
(M+); FAB-MS m/z 418 (M + H+); HRMS Calc. for
C27H36ON3: 418.28583. Found: 418.28564.
4.2.2. Synthesis of 4,4 0,400-tri-tert-butyl-2,2 0:6 0,200-terpyridine
1,100-di-N-oxide (7)
To the solution of 4,4 0,400-tri-tert-butyl-2,2 0:6 0,200-terpyri-
dine (5a) (100 mg, 0.25 mmol) in CH2Cl2 (2.5 ml), m-CPBA
(77%, 210 mg, 0.94 mmol) in CH2Cl2 (2.5 ml) was added in
one portion. The reaction mixture was stirred at r.t. for
15 h. It was then diluted with CH2Cl2 (15 ml) and washed
with NaHCO3 (10 ml · 3). The organic layer was dried over
MgSO4, filtered and evaporated under reduced pressure.
The crude product was chromatographed on silica gel
(70 230 mesh) using ethyl acetate:Et3N:MeOH 100:1:0 to
100:1:3 as the gradient eluent. A white solid was obtained
after removal of solvent (88 mg, 81%). 7: Rf 0.23 (ethyl
acetate:Et3N:MeOH 100:1:10);
1H NMR (400.1 MHz,
CDCl3): d 1.34 (s, 18H), 1.39 (s, 9H), 7.29 (dd, J 6.9,
3.0 Hz, 2H), 8.18 (d, J 3.0 Hz, 2H), 8.29 (d, J 6.9 Hz,
2H), 8.96 (s, 2H); 13C NMR (100.6 MHz, CDCl3):
d 30.44, 30.56, 34.76, 35.38, 122.62, 123.71, 125.02,
139.94, 146.48, 149.23, 151.57, 160.87; IR (KBr) 1590,
1547, 1476, 1383, 1255, 1193, 887, 827; 709, 617, 604; EI-
MS m/z 433 (M+); FAB-MS m/z 434 (M + H+); HRMS
Calc. for C27H35O2N3: 433.27292. Found: 433.27271.
4.2.3. Synthesis of 6-[(4S)-4-phenyl-4,5-dihydro-oxazol-2-
yl]-[2,2 0]bipyridinyl (10)
4.2.3.1. Synthesis of 2,2 0-bipyridine-6-carbonitrile. 2,2 0-
Bipyridine N-oxide (300 mg, 1.74 mmol) was dissolved in
anhydrous CH2Cl2 (5 ml) under Ar. It was then cooled to
0 C and TMSCN (1.0 ml, 8.71 mmol) was added. Benzoyl
chloride (404 ll, 3.48 mmol) was added dropwise. The reac-
tion mixture was stirred overnight. Then 10% Na2CO3
(10 ml) was added and the mixture was separated and the
aqueous layer was extracted with CH2Cl2 (5 ml · 3). The
combined organic layer was dried over MgSO4, filtered
and evaporated under reduced pressure. The crude product
was chromatographed on silica gel (70 230 mesh) using
CH2Cl2 to CH2Cl2:ethyl acetate (10:1) as the gradient
eluent. An off-white solid was obtained after removal of
solvent (285 mg, 90%). 2,2 0-bipyridine-6-carbonitrile:
Rf 0.68 (CH2Cl2:ethyl acetate 6:1);
1H NMR
(400.1 MHz, CDCl3): d 7.37 (ddd, J 7.5, 4.8, 1.2 Hz,
1H), 7.68 (dd, J 7.6, 0.9 Hz, 1H), 7.85 (unresolved ddd,
1H), 7.93 (unresolved dd, 1H), 8.45 (d, J 7.9 Hz, 1H),
8.66 8.68 (m, 2H); 13C NMR (100.6 MHz, CDCl3):
d 117.33, 121.65, 124.27, 124.80, 128.17, 133.18, 137.41,
137.92, 149.09, 153.82, 157.44;MS (EI, 70 eV)m/z 181 (M+).
4.2.3.2. Synthesis of methyl 2,2 0-bipyridine-6-carboxyimi-
date. 2,2 0-Bipyridine-6-carbonitrile (1.0 g, 5.5 mmol) was
dissolved in anhydrous MeOH with gentle heating under
Ar. After it was cooled to r.t., Na (13 mg, 0.58 mmol) was
added. The reaction mixture was stirred for four days at
r.t. HOAc (33 ll, 0.58 mmol) was then added. The solvent
was removed under reduced pressure to give an off-white
solid (1.17 g, 99%). Methyl 2,2 0-bipyridine-6-carboxyimi-
date: m.p. 69.4 69.7 C; 1H NMR (300.1 MHz, d7-DMF):
d 3.99 (s, 3H), 7.52 (ddd, J 7.5, 4.8, 1.3 Hz, 1H), 7.91
(dd, J 7.6, 1.0 Hz, 1H), 8.02 (ddd, J 7.7, 7.7, 1.9 Hz,
1H), 8.13 8.19 (unresolved dd, 1H), 8.59 (dd, J 7.9,
1.1 Hz, 1H), 8.67 8.70 (unresolved ddd 1H), 8.74 (ddd,
J 4.8, 1.8, 0.9 Hz, 1H); 13C NMR (75.5 MHz, d7-DMF):
d 53.94, 121.62, 121.67, 123.06, 124.31, 125.29, 138.03,
139.74, 147.37, 150.10, 155.51, 156.24, 166.61; MS (EI,
70eV) m/z 213 (M+); IR (KBr, cm 1): 3290, 3050, 3002,
2951, 1976, 1654, 1185, 1099, 784, 748, 709; HRMS Calc.
for C19H15N3O m/z: 213.0897. Found: 213.08844.
4.2.3.3. Synthesis of 6-[(4S)-4-phenyl-4,5-dihydro-oxazol-
2-yl]-[2,2 0]bipyridinyl (10). Methyl 2,2 0-bipyridine-6-
carboxyimidate (400 mg, 1.88 mmol) and (S)-2-amino-2-
phenylethanol (257 mg, 1.88 mmol) were dissolved in
anhydrous CH2Cl2 (8 ml) under Ar in a pressure tube.
The mixture was then heated at 60 C for three days. After
removal of solvent, the crude product was chromato-
graphed on silica gel (70 230 mesh) using CH2Cl2:Et3N:-
MeOH 100:1:0 to 100:1:2 as the gradient eluent. A pale
yellow solid was obtained after removal of solvent
(519 mg, 92%). Analytically pure product was obtained
by slow evaporation of the etherate solution of 10 to yield
an off-white product (310 mg, 55%). 10: Rf 0.22 (CH2Cl2:
Et3N: MeOH 100:1:5); m.p. 108.0 111.8 C; 1H NMR
(300.1 MHz, CDCl3): d 4.37 4.42 (unresolved dd, 1H),
4.91 (dd, J 10.2, 8.6 Hz, 1H), 5.46 (dd, J 10.2,
8.5 Hz, 1H), 7.25 7.37 (m, 6H), 7.79 (ddd, J 7.8, 7.8,
1.8 Hz, 1H), 7.88 7.93 (unresolved dd, 1H), 8.17 (dd,
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J 7.7, 1.1 Hz, 1H), 8.52 (ddd, J 7.9, 2.5, 1.1 Hz, 2H),
8.66 (ddd, J 4.8, 1.8, 0.9 Hz, 1H); 13C NMR (75.5 MHz,
CDCl3): d 70.31, 75.36, 121.64, 123.11, 124.04, 124.31,
126.81, 127.71, 128.76, 136.97, 137.55, 141.84, 146.13,
149.09, 155.30, 156.22, 164.04; MS (EI, 70 eV) m/z 301
(M+); [a]D 115.1 (c 0.50, CHCl3); IR (KBr, cm 1):
3069, 3032, 2972, 2897, 1643, 1263, 1114, 787, 749, 700.
Elementary analysis Calc. for C19H15N3O: C, 75.73; H,
5.02; N, 13.94. Found: C, 75.69; H, 4.62; N, 14.03%.
4.3. Synthesis of ruthenium complexes
4.3.1. Synthesis of chloro-ruthenium (2,2 0:6 0,200-terpyridine)
(pyridine-2-carboxylate) complex (12)
[Ru(p-cymene)Cl2]2 (131 mg, 0.21 mmol) and 2,2
0:6 0,200-
terpyridine (100 mg, 0.43 mmol) were dissolved in MeOH
(7 ml) at r.t. under Ar to form a deep violet solution. Sodium
2-pyridinecarboxylate (62 mg, 0.43 mmol) was dissolved in
H2O (3 ml) and MeOH (4 ml) was added. This solution
was purged with Ar for 15 min and then added dropwise
to the reaction mixture via a cannular. The whole reaction
mixture was heated at 70 C for 1 h. It turned to deep purple
in15 min at 70 C.After the reactionmixturewas cooled to
r.t., CH2Cl2 (25 ml) and H2O (25 ml) were added. The
organic layer was separated and the aqueous layer was
extracted with CH2Cl2 (5 ml · 3). The combined organic
layer was dried over MgSO4, filtered and evaporated under
reduced pressure. It was then chromatographed on silica
gel (70 230 mesh) using CH2Cl2:MeOH 100:1 to 100:5 as
the gradient eluent. After removal of solvent, a purple solid
was obtained (140 mg, 66%). The product can be further
purified by recrystallization in CH2Cl2/hexane to give a deep
purple solid. The product was not soluble enough to give sat-
isfactory 1H and 13C spectra. 12:Rf 0.15 (CH2Cl2/MeOH
100:5); UV Vis (CH2Cl2, kmax/nm, log e) 326 (4.40), 402
(3.94), 551 (3.82). HRMS Calc. for (C21H15ClN4O2
96Ru)
m/z: 485.99611. Found: 485.99540. Elementary analysis
Calc. C21H15ClN4O2Ru
CH2Cl2 (%) C, 45.81; H, 2.97; N,
9.71. Found: C, 45.87; H, 3.21; N, 10.17.
4.3.2. Synthesis of ruthenium bis-(2,2 0-bipyridine-6-
carboxylate) complex (13) [38]
[Ru(p-cymene)Cl2]2 (46 mg, 0.075 mmol) and 2,2
0-bipyri-
dine-6-carboxylic acid (60 mg, 0.30 mmol) were dissolved in
anhydrous MeOH (10 ml) under Ar at r.t. and Et3N (42 ll,
0.30 mmol) was then added. The reaction mixture was
heated at 65 C for 13 h and turned from pale orange to
deep orange in color. After the reaction mixture was cooled
to r.t., a purple solid precipitated with a clear orange solu-
tion. The purple solid was filtered, washed with MeOH and
dried under high vacuum (63 mg, 84%). 13: Rf 0.57
(CH2Cl2/MeOH 10:1);
1H NMR (300 MHz, d6-DMSO,
ppm) d 7.10 (d, J 5.1 Hz, 1H), 7.19 7.21 (m, 1H), 7.77
7.82 (m, 1H), 8.10 8.14 (m, 2H), 8.69 (d, J 7.2 Hz, 1H),
8.91 8.97 (m, 1H); UV Vis (EtOH:MeOH 4:1, kmax/
nm, log e) 298 (4.69), 369 (3.89), 511 (4.11). HRMS Calc.
for (C22H14N4O4
96Ru) m/z: 499.00868. Found: 499.008554.
4.3.3. Synthesis of ruthenium {6-[(4S)-4-phenyl-4,5-
dihydro-oxazol-2-yl]-[2,2 0]bipyridinyl}
(2,6-pyridinedicarboxylate) complex (15)
[Ru(p-cymene)Cl2]2 (102 mg, 0.17 mmol) and 10
(100 mg, 0.33 mmol) were dissolved in MeOH (2 ml) at
r.t. under Ar to form a deep violet solution. Disodium
2,6-pyridinedicarboxylate (70 mg, 0.33 mmol) was dis-
solved in H2O (1 ml) and MeOH (1 ml) was then added.
This solution was purged with Ar for 15 min and then
added dropwise to the reaction mixture via a cannular.
The whole reaction mixture was heated at 65 C for 1 h.
It turned to deep red in 5 min at 65 C. After the reaction
mixture was cooled to r.t., CH2Cl2 (50 ml) and H2O (25 ml)
were added. The organic layer was separated and the aque-
ous layer was extracted with CH2Cl2 (5 ml · 3). The com-
bined organic layer was dried over MgSO4, filtered and
evaporated under reduced pressure. It was then chromato-
graphed on silica gel (70 230 mesh) using CH2Cl2:MeOH
100:3 to 100:7 as the gradient eluent. After removal of sol-
vent, a purple solid was obtained (111 mg, 59%). The prod-
uct can be further purified by recrystallization in CH2Cl2/
hexane to give a deep purple solid. Rf 0.09 (CH2Cl2/
MeOH 100:5); 1H NMR (300 MHz, CDCl3, ppm) d 4.63
(dd, J 10.6, 8.9 Hz, 1H), 4.81 4.88 (unresolved dd, 1H),
5.17 5.23 (unresolved dd, 1H), 6.78 (d, J 7.2 Hz, 2H),
7.07 7.22 (m, 4H), 7.35 (d, J 5.3 Hz, 1H), 7.55 7.68
(m, 3H), 7.81 (t, J 7.7 Hz, 1H), 8.04 (d, J 7.7 Hz,
1H), 8.09 8.22 (m, 3H); 13C NMR (75.5 MHz, CDCl3,
ppm) d 67.91, 78.18, 121.12, 121.90, 123.76, 126.10,
126.71, 126.90, 127.25, 127.98, 128.59, 129.18, 134.01,
134.81, 136.42, 146.70, 149.40, 150.23, 151.09, 158.32,
167.67, 171.40, 171.92; UV Vis (CH2Cl2,kmax/nm, log e)
399 (3.94), 514 (4.10). HRMS Calc. for (C26H18N4-
O5
102Ru + H+) m/z: 569.03989. Found: 569.03990. Ele-
mentary analysis Calc. C26H18N4O5Ru Æ H2O: C, 53.33;
H, 3.44; N, 9.57. Found: C, 52.89; H, 3.00; N, 9.35%.
4.3.4. Synthesis of chloro-ruthenium {bis[(4S)-4-phenyl-4,5-
dihydro-oxazol-2-yl]-pyridine}(2,6-pyridinedicarboxylate)
complex (16)
[Ru(p-cymene)Cl2]2 (83 mg, 0.14 mmol) and bis[(4S)-4-
phenyl-4,5-dihydro-oxazol-2-yl]-pyridine (100 mg, 0.27
mmol) were dissolved in MeOH (2 ml) at r.t. under Ar to
form a deep red solution. Disodium 2,6-pyridinedicarboxy-
late (70 mg, 0.33 mmol) was dissolved in H2O (1 ml) and
MeOH (1 ml) was then added. This solution was purged
with Ar for 15 min and then added dropwise to the reac-
tion mixture via a cannular. The whole reaction mixture
was heated at 65 C for 1 h. It turned first to orange then
brownish orange in color at 65 C. After the reaction mix-
ture was cooled to r.t., CH2Cl2 (20 ml) and H2O (20 ml)
were added. The organic layer was separated and the
aqueous layer was extracted with CH2Cl2 (5 ml · 3). The
combined organic layer was dried over MgSO4, filtered
and evaporated under reduced pressure. It was then chro-
matographed on silica gel (70 230 mesh) using
CH2Cl2:MeOH 100:1 to 100:5 as the gradient eluent. After
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removal of solvent, a purple solid was obtained (131 mg,
77%). The product can be further purified by recrystalliza-
tion in CH2Cl2/hexane. Rf 0.20 (CH2Cl2/MeOH 100:5);
1H NMR (300 MHz, CDCl3, ppm) d 4.49 4.69 (m, 3H),
4.93 5.00 (unresolved dd, 1H), 5.09 5.26 (m, 2H), 6.75
(d, J 7.0 Hz, 2H), 6.89 7.16 (m, 9H), 7.38 7.39 (m,
2H), 7.58 (t, J 7.8 Hz, 1H), 7.75 7.80 (m, 2H), 8.96 (d,
J 5.3 Hz, 1H); 13C NMR (75.5 MHz, CDCl3, ppm) d
68.35, 68.69, 78.22, 78.43, 123.23, 123.25, 124.99, 125.21,
127.01, 127.32, 127.99, 128.13, 128.32, 128.68, 134.24,
136.27, 136.80, 150.12, 150.16, 150.52, 150.80, 167.21,
167.64, 172.48; MS (EI 70 eV) m/z 627 (M+). UV Vis
(CH2Cl2, kmax/nm, log e) 378 (3.45), 506 (4.11). Elementary
analysis Calc. C29H23ClN4O4Ru
H2O: C, 53.91; H, 3.90; N,
8.67. Found: C, 54.24; H, 4.21; N, 8.52%.
4.4. UV Vis spectroscopic titration
Ru(tBu3-tpy)(pydic) 3a (2.70 mg, 4.04 · 10 3 mmol) was
dissolved in CH2Cl2 (100.00 ml) in a volumetric flask. m-
CPBA was purified according to literature before use
[41]. m-CPBA (10.51 mg, 6.09 · 10 3 mmol) was dissolved
in CH2Cl2 (10.00 ml) in a volumetric flask. A solution of
3a (3.00 ml) was transferred to a Teflon stoppered 1.0 cm
quartz cell. Then the initial UV Vis spectrum was
recorded. Next m-CPBA solution (2.0 ll) was added to
the solution of 3a and the reaction was monitored by
UV Vis spectroscopy. When there was no further change
indicated by the absorption spectrum, further portions of
m-CPBA solution (2.0 ll each) were given. The ratio
between 3a and m-CPBA was determined at different wave
lengths (at least 5) other than the isosbestic points.
4.5. Catalytic reactions
All olefins and epoxides are known compounds. The
conversions and yields were determined by comparing the
authentic samples with an internal standard on GC-FID.
The identities of the products were further confirmed by
GC MS.
4.5.1. Screening of different oxidants
4.5.1.1. General procedure for non-asymmetric epoxidation
with hydrogen peroxide. In a 25 ml Schlenk tube, the cat-
alyst (0.0025 mmol) and trans-stilbene (90.1 mg,
0.50 mmol) were stirred with gentle heating in tert-amyl
alcohol (9 ml) until all trans-stilbene was dissolved. After
the reaction mixture was cooled to r.t., dodecane (GC inter-
nal standard, 100 ll) was added. To this reaction mixture, a
solution of 30% hydrogen peroxide (170 ll, 1.5 mmol) in
tert-amyl alcohol (830 ll) was added over a period of 12 h
by a syringe pump. After the addition, aliquots were taken
from the reaction mixture and subjected to GC analysis for
determination of yield and conversion data.
4.5.1.2. General procedure for asymmetric epoxidation with
hydrogen peroxide. In a 25 ml Schlenk tube, the catalyst
(0.025 mmol) and trans-stilbene (90.1 mg, 0.50 mmol) were
stirred with gentle heating in tert-amyl alcohol (9 ml) until
all trans-stilbene was dissolved. After the reaction mixture
was cooled to r.t., dodecane (GC internal standard, 100 ll)
was added. To this reaction mixture, a solution of 30%
hydrogen peroxide (170 ll, 1.5 mmol) in tert-amyl alcohol
(830 ll) was added over a period of 12 h by a syringe pump.
After the addition, aliquots were taken from the reaction
mixture and subjected to GC analysis for determination
of yield and conversion data. The reaction mixture was
then quenched with Na2SO3solution (10 ml) and
extracted with dichloromethane (10 ml · 2) and washed
with water (20 ml). The combined organic layer was dried
over MgSO4 and evaporated to give the crude epoxide. It
was then dissolved in n-hexane for HPLC measurement.
4.5.1.3. General procedure for in situ generation of catalyst
in asymmetric epoxidation with hydrogen peroxide. In a
25 ml Schlenk tube, [Ru(p-cymene)Cl2]2 (7.7 mg,
0.013 mmol) and the chiral ligand (0.025 mmol) were dis-
solved in tert-amyl alcohol (2 ml) under Ar. To this solution,
H2pydic (4.2 mg, 0.025 mmol) and Et3N (8.4 ll,
0.060 mmol) in tert-amyl alcohol (2 ml) were added drop-
wise via a cannular. The reaction mixture was heated at
65 C for 1 h. trans-Stilbene (90.1 mg, 0.50 mmol) and
tert-amyl alcohol (5 ml) were added and the whole reaction
mixture was heated until all trans-stilbene was dissolved.
After the reaction mixture was cooled to r.t., dodecane
(GC internal standard, 100 ll) was added. To this mixture,
a solution of 30% hydrogen peroxide (170 ll, 1.5 mmol) in
tert-amyl alcohol (830 ll) was added over a period of 12 h
by a syringe pump. After the addition, aliquots were taken
from the reaction mixture and subjected to GC analysis
for determination of yield and conversion data. The reaction
mixture was then quenched with Na2SO3 solution (10 ml),
extracted with dichloromethane (10 ml · 2) and washed
with water (20 ml). The combined organic layer was dried
over MgSO4 and evaporated to give the crude epoxide. It
was then dissolved in n-hexane for HPLC measurement.
4.5.1.4. General procedure for screening of solid
oxidants. In a 25 ml Schlenk tube, Ru(tpy)(pydic) (3)
(0.0025 mmol) and trans-stilbene (90.1 mg, 0.50 mmol) were
stirred with gentle heating in tert-amyl alcohol (10 ml) until
all trans-stilbene was dissolved. After the reaction mixture
was cooled to r.t., dodecane (GC internal standard, 100 ll)
was added. To this reaction mixture, the solid oxidant
(1.5 mmol) was added. After the addition, aliquots were
taken from the reaction mixture and subjected to GC analy-
sis for determination of yield and conversion data.
4.5.1.5. General procedure for epoxidation with urea hydro-
gen peroxide complex for solid olefins. In a 25 ml Schlenk
tube, Ru(tpy)(pydic) 3 (0.0025 mmol) and olefin
(0.50 mmol) were stirred with gentle heating in tert-amyl
alcohol (10 ml) until it was dissolved. After the reaction
mixture was cooled to r.t., dodecane (GC internal stan-
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dard, 100 ll) was added. Urea hydrogen peroxide complex
(47 mg, 0.50 mmol) was added in three portions at 0, 1, and
2 h as a total of (141 mg, 1.5 mmol). The reaction mixture
was stirred at r.t. for an additional hour. Aliquots were
taken from the reaction mixture and subjected to GC anal-
ysis for determination of yield and conversion data.
4.5.1.6. General procedure for epoxidation with urea hydro-
gen peroxide complex for liquid olefins. In a 25 ml Schlenk
tube, Ru(tpy)(pydic) (3) (0.0025 mmol) was stirred with
gentle heating in tert-amyl alcohol (10 ml). After the reac-
tion mixture was cooled to r.t., olefin (0.50 mmol) and
dodecane (GC internal standard, 100 ll) were added. Urea
hydrogen peroxide complex (47 mg, 0.50 mmol) was added
in three portions at 0, 1 and 2 h as a total of (141 mg,
1.5 mmol). The reaction mixture was stirred at r.t. for an
additional hour. Aliquots were taken from the reaction
mixture and subjected to GC analysis for determination
of yield and conversion data.
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A new, environmentally benign and practical epoxidation
method was developed using inexpensive and efficient Fe
catalysts. FeCl3?6H2O in combination with commercially
available pyridine-2,6-dicarboxylic acid and amines showed
excellent reactivity and selectivity towards aromatic olefins and
moderate reactivity towards 1,3-cyclooctadiene utilizing H2O2
as the terminal oxidant.
Nature utilizes iron proteins such as hemoglobin, myoglobin, and
cytochrome oxygenases for vital biochemical processes such as
transport of oxygen and electron transfer reactions in plants,
animals and microorganisms.1 3 Understanding such mechanisms
may lead to new insights in biocatalysis and drug design as well as
the development of new industrial catalysts.
Following nature’s path, numerous reports on biomimetic
oxidation of olefins using metalloporphyrins are known at present;
a major problem curtailing these catalysts for use in industry is
their difficult multi step synthesis.4 Among the various oxidation
methods, epoxidation of olefins continues to be an important field
of research in industry and academia due to the formation of two
C O bonds in one reaction and the facile opening of the epoxide
ring to useful synthons.5
With respect to the oxidants6 commonly used, molecular
oxygen7 and H2O2
8 are the reagents of choice. The latter is more
convenient to use and produces only water as the by product.
Thus, a combination of H2O2 with a catalytic amount of cheap
and relatively non toxic metals such asMn or Fe would be an ideal
system for large scale production in industry. However, the use of
H2O2 in combination with simple non heme manganese
9 or iron10
is limited, since H2O2 is well known to decompose vigorously in
the presence of these metals.11 Consequently, iron catalyzed
epoxidation using non heme complexes and H2O2 are scant in
the literature.12 For example, the Jacobsen’s Fe mep catalyst13 is
known to epoxidize aliphatic olefins in the presence of acetic
acid.14 However, to the best of our knowledge there is no Fe
catalyst known which allows for a general epoxidation under
neutral conditions.12c
In this context, we were interested in exploring the possibility of
Fe catalyzed epoxidation using H2O2, since iron and H2O2 are
cheap, environmentally benign and reactive. As a starting point of
our work on Fe catalysts, we tried to extrapolate our previously
developed Ru reaction protocols15 18 with Fe. Not surprisingly,
initial attempts with pre made Fe complexes resulted in low yield
and selectivity. Therefore in situ generated iron complexes, which
are more easily tuned, were used for the epoxidation of trans
stilbene at room temperature.19
A screening of different iron sources of Fe2+ and Fe3+ in the
presence of acid or base revealed that complete conversion was
observed only in the case of FeCl3?6H2O. Hence, our further
investigations focused on this iron source. While studying various
nitrogen ligands, it was observed that simply pyridine 2,6
dicarboxylic acid (H2pydic) is sufficient to form an active Fe
epoxidation catalyst! Advantageously, the in situ formation of the
active complex with H2pydic and Fe occurs at rt. The combination
of FeCl3?6H2O, H2pydic, and an organic base, such as
benzylamine, 4 methylimidazole and pyrrolidine, leads to an active
and highly selective epoxidation catalyst (see ESI{).
Unlike the corresponding Ru complexes, the use of disodium
pyridine 2,6 dicarboxylate or using H2pydic with 10 mol% of
inorganic base was not effective in the case of Fe. To our delight,
the addition of organic bases, such as benzylamine, 4 methylimi
dazole and pyrrolidine, gave full conversion and almost quanti
tative yield and selectivity. It is envisaged that one of the roles of
the base is to deprotonate the pyridine 2,6 dicarboxylic acid;
however reports on the influence of base on the stability of the
catalyst and selectivity of the oxidation are known.20 When the
NH group of imidazole was substituted with an alkyl group,
the reactivity remained. However, the reactivity dropped signifi
cantly when 2 methylimidazole was used (12% conv., 11% yield).
In comparison with the reactivity of pyridine (56% conv., 50%
yield) and pyrrolidine (100% conv., 97% yield), this effect must be
attributed to coordination effects to some extent. This is not the
case with 4 methylimidazole, which led to full conversion with
excellent yield (97%) of trans stilbene oxide. In order to explain the
observed ligand effects, gelicification and redissolution of the
ligand or catalyst should be considered, too. Such effects were
reported during the deprotonation of the pyridine 2,6 dicarboxylic
acid in aqueous alkaline solution due to pH dependent electrostatic
interactions and hydrogen bonding between the polar species and
water.21 We have not noticed any such process in our reactions,
obviously due to the less polar nature of tert amyl alcohol
compared to water. Importantly, the formation of trans stilbene
oxide was not observed when pyrrolidine, pyridine 2,6 dicar
boxylic acid or the iron source was not used in the reaction. It is
remarkable that the epoxidation reaction is quite fast and an
optimum yield can be achieved by addition of the oxidant (H2O2)
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over a period of one hour using a syringe pump. Even an addition
of hydrogen peroxide within 5 minutes showed no decrease in
reactivity and selectivity for trans stilbene.
Next, different substrates were tested in these optimized reaction
conditions (Table 1). Styrene, generally known as a difficult
substrate for epoxidation, afforded excellent yield and selectivity of
styrene oxide (Table 1, entries 3 4). The reaction also performed
well for ortho and electron donating/withdrawing substituted
styrenes (Table 1, entries 5 8). Cinnamyl acetate, cinnamyl
chloride, and cis as well as trans b methyl styrene gave good to
excellent yields (Table 1, entries 9 13). In the case of a methyl
styrene, in addition to the epoxide, a small amount of
2 phenylpropanal was also formed, presumably by the iron
promoted rearrangement of the epoxide via a stable benzyl
carbocation.
To further extend the scope of the reaction 1,3 cyclooctadiene
was tested. Here, the corresponding mono epoxide is obtained in
65% yield with 84% selectivity (Table 1, entry 14). To understand
the mechanism of the reaction in more detail, trans stilbene was
subjected to epoxidation using the new protocol in the presence of
a radical scavenger (2,6 di tert butyl 4 methoxyphenol), which
afforded the epoxide in very low yield (,10%) suggesting a
selective radical pathway occurring as the major process in this
reaction. Although to date we have no direct structural evidence of
the active catalyst species, and discussions on the nature of the
intermediate are so far speculative,22 non heme dioxygenases, such
as TauD,23 TfdA24 and NDO,25 which contain carboxylate and
histidine on their coordination sphere, may give us some insights.26
In conclusion, we have developed a new biomimetic, convenient
and fast epoxidation protocol using a cheap and environmentally
friendly iron source in combination with H2O2. The system
showed excellent reactivity and selectivity towards terminal and
1,2 disubstituted aromatic olefins, and moderate reactivity towards
1,3 dienes. Unlike previous procedures, our protocol is much
simpler and demands no pre made catalyst, acetic acid or freezing
reaction temperature. Gratifyingly, all the reagents used in our
Table 1 Scope and limitations of the reaction
Entry Substrate Conv. (%)a,b Yield (%)b Selectivity (%)c
1 100 97 97
2 98d 96d 98d
3 94 93 99
4 88d 69d 78d
5 100 97 97
6 88d 87d 99d
7 100 77 77
8 100d 79d 79d
9 71 69 97
10 77 63 82
11 100 95 95
12 75 56e 75
13 93 64 69
14 77 65 84
a Reaction conditions: in a 25 mL Schlenk tube, FeCl3?6H2O (0.025 mmol), H2pydic (0.025 mmol), tert amyl alcohol (9 mL), pyrrolidine
(0.05 mmol), olefin (0.5 mmol) and dodecane (GC internal standard, 100 mL) were added in sequence at rt in air. To this mixture, a solution of
30% H2O2 (114 mL, 1.0 mmol) in tert amyl alcohol (886 mL) was added over a period of 1 h (or 5 min) at rt by a syringe pump.
b Conversion
and yield were determined by GC analysis. c Selectivity refers to the ratio of yield to conversion as percentage. d The oxidant was added over a
period of 5 min. e 19% trans b methylstyrene oxide was observed.
290 | Chem. Commun., 2007, 289 291 This journal is  The Royal Society of Chemistry 2007
system are simple and commercially available and the reaction can
be performed at rt. To the best of our knowledge, the system
described here is the simplest and most practical iron catalyzed
epoxidation procedure available for olefins today. Efforts are
underway in our group aimed at realizing the asymmetric version
of this reaction.
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Introduction
Many essential biological processes, such as the transport
and storage of oxygen, oxidation, and electron transfer reac
tions, depend on iron containing enzymes.[1,2] New insight in
the fields of biocatalysis, drug design, and even development
of industrial processes is expected to arise from a more de
tailed understanding of the mechanism of these processes
and the development of novel iron catalysts. To date, numer
ous reports have dealt with biomimetic oxidation reactions
involving metalloporphyrins, but the complex multistep syn
thesis of these catalysts obstructs further applications.[3]
Therefore, the search for easily available and more effective
ligands is a major goal in current research with respect to Fe
catalysts.[4]
Among the different feedstocks, olefins are one of the
most important starting materials for organic synthesis.
Their oxidation leads to various value added products such
as epoxides, alcohols, diols, aldehydes, ketones, and carbox
ylic acids, which are important building blocks for the pro
duction of bulk and fine chemicals as well as for the synthe
sis of pharmaceuticals.[5] The formation of two C O bonds
from olefins in one reaction and subsequent facile ring
opening make epoxides particularly crucial as key inter
mediates.[6] For these reasons, we are interested in develop
ing novel epoxidation catalysts.[7] From ecological and eco
nomic points of view, molecular oxygen[8] and hydrogen per
oxide are the oxidants of choice. In general, hydrogen per
oxide is easier to handle. Furthermore, it is cheap and pro
duces only water as by product.[9] The combination of
hydrogen peroxide with catalytic amounts of a cheap and
less toxic metal such as Mn or Fe would lead to an ideal
system for environmentally benign oxidations. Unfortunate
ly, the use of H2O2 in combination with simple non heme
manganese[10] or iron[11] is limited as H2O2 is well known to
decompose vigorously in the presence of these metals.[12]
Hence, only a handful of examples of non heme iron cata
lyzed epoxidations with H2O2 are known.
[13] Of note are the
Jacobsen Fe catalyst[14] derived from N,N’ dimethyl N,N’
bis(2 pyridylmethyl)ethane 1,2 diamine (the so called mep
ligand) and the Stack catalyst[15] derived from phenanthro
line. However, both catalysts are only active in the presence
of large amounts of acetic acid. In case of the Stack catalyst,
H2O2 is used to generate peracetic acid, which then acts as
the “real” oxidant. Thus, acid labile epoxides cannot be pre
pared by this route. To the best of our knowledge, there is
no Fe catalyst known that allows for the epoxidation of ali
phatic and aromatic olefins under neutral conditions with
H2O2 as the terminal oxidant.
Keywords: alkenes · epoxidation ·
homogeneous catalysis · hydrogen
peroxide · iron
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of aliphatic olefins.
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In earlier investigations, we showed the utility of Ru com
plexes derived from N,N,N tridentate ligands such as pyri
dinebisoxazolines (pyboxes),[16] pyridinebisoxazines (pyboxa
zines),[17] terpyridines,[18] and pyridinebisimidazolines
(pybims),[19] together with the coligand pyridine 2,6 dicar
boxylic acid (H2pydic), in the epoxidation of various ole
fins.[20] To develop an improved, environmentally benign,
and more economical procedure, we were interested in re
placing the central metal Ru in these complexes by Fe. In
an initial communication, we reported the influence of dif
ferent bases on the reactivity and selectivity of Fe epoxida
tion catalysts.[21] Herein, we report the successive develop
ment of novel iron catalysts and their behavior in the epoxi
dation of olefins with hydrogen peroxide.
Results and Discussion
Our general catalyst modification strategy started with the
simple idea of replacing Ru with Fe, followed by variation
of bi and tridentate nitrogen ligands (Figure 1). Various
iron(II) complexes were initially synthesized and tested in
the epoxidation of trans stilbene with 3 equivalents of hy
drogen peroxide at room temperature. Similar reaction con
ditions were chosen as in our previously developed rutheni
um catalyzed epoxidation reactions.[17] Tridentate nitrogen
ligand derivatives of pybox, pybim, and terpyridine were ex
amined (Figure 2). Selected results from this study are
shown in Table 1. Notably, all the iron complexes tested ex
hibited some activity towards the formation of trans stilbene
oxide. Typically, with pybox and terpyridine ligands, trans
stilbene oxide was obtained in 15 30% yield and with 67
69% selectivity.
The high activity of the chiral terpyridine Fe complex
(96% conversion) is also remarkable, although the chemose
lectivity was low. In the presence of the pybim ligand, only
poor conversion was observed. Although the yields were not
satisfactory, the results are promising as significant conver
sion and selectivity were achieved. For a more efficient and
convenient testing of various catalytic systems with versatile
ligands, we decided to apply Fe complexes prepared in situ.
We assumed that FeII was oxidized during the reaction with
hydrogen peroxide and decided to use FeIII sources instead.
From our previous studies of the Ru catalyzed epoxidation,
H2pydic is known to enhance the stability and reactivity of
the catalyst.[22] Thus, commercially available H2pydic and
2,6 bis[(S) 4 phenyl 4,5 dihydrooxazol 2 yl]pyridine (Ph2
pybox) together with FeCl3·6H2O were tested in the model
reaction (Table 2).
Notably, the combination of these easily available compo
nents is sufficient to form an active and selective Fe epoxi
dation catalyst. To our surprise, the metal to ligand ratio has
a significant influence on the reactivity and selectivity. The
best result was obtained with an FeCl3·6H2O/Ph2 pybox
ratio of 1:1; 100% conversion and 82% yield of stilbene
oxide were observed (Table 2, entry 3). With these results in
hand, we investigated the influence of different iron sources
(Table 3). Importantly, only the hydrate of iron trichloride
gave complete conversion and high yield of the correspond
ing epoxide. Apparently, the presence of chloride ions is
Figure 1. Catalyst modification strategy.
Figure 2. Different ligands for the epoxidation of olefins.
Table 1. Epoxidation of trans stilbene with different iron complexes.
Entry Iron cat. Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
ee
[%][d]
1 FeCl2+1 22 15 67 0
2 FeCl2+2 7 4 62 n.d.
[f]
3 FeCl2+3 30 20 69 n.d.
[f]
4 FeCl2+4 96 30 31
[e] 0
[a] Reaction conditions: Iron complex (0.025 mmol), tert amyl alcohol
(9 mL), trans stilbene (0.5 mmol), and dodecane (GC internal standard;
100 mL) were added in sequence to a 25 mL Schlenk tube at room tem
perature in air. A solution of hydrogen peroxide (30%, 170 mL,
1.5 mmol) in tert amyl alcohol (830 mL) was added to this mixture over a
period of 12 h at room temperature by a syringe pump. [b] Conversion
and yield were determined by GC analysis. [c] Ratio of yield to conver
sion as a percentage. [d] Determined by HPLC analysis. [e] Side prod
ucts: diol, benzil, benzoin. [f] Not determined.
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necessary for the reaction (Table 3, entries 5 8). The differ
ence in the results with anhydrous iron trichloride (Table 3,
entry 3) can be explained by the lower solubility of the
latter, which inhibits complex formation. Interestingly,
during the formation of the active iron complex in situ, a
red precipitate was observed in the reaction mixture
(Table 3, entry 1). This precipitate was then filtered off, and
both the filtrate and precipitate were tested in the epoxida
tion of trans stilbene. Unexpectedly, they gave similar results
(precipitate: 70% conversion and 37% yield; filtrate: 71%
conversion and 36% yield). Mass spectrometric investiga
tions (ESI MS) of both fractions showed unambiguously
that decomposition of the pybox ligand into H2pydic and
phenyl glycinol occurred during the formation of the active
catalyst in situ (Figure 3). The ESI MS spectrum of the pre
cipitate showed various peaks that were assigned to differ
ent decomposition fragments of the ligand, whereas those in
the ESI MS spectrum of the solution were assigned to the
amino alcohol.
Owing to the similar catalytic activity of filtrate and pre
cipitate, it is likely that the active catalyst contains frag
ments of the completely decomposed ligand as well as Fe.
To confirm this assumption, we performed the epoxidation
of trans stilbene with 5 mol% FeCl3·6H2O and possible de
composition fragments of the ligand (Table 4). The applica
tion of H2pydic and phenyl glycinol, which could be formed
by acidic hydrolysis of the pybox ligand (Figure 2), gave sim
ilar results to the case of pybox as the only ligand (Table 4,
Table 2. Epoxidation of trans stilbene with H2pydic, Ph2 pybox, and
FeCl3·6H2O.
Entry Mole ratio Conv. Yield Selectivity
FeCl3·6H2O Ph2 pybox H2pydic [%]
[a,b] [%][b] [%][c]
1 1 1 1 55 48 87
2 1 13 7 52
3 1 1 100 82 82
4 1 2 70 55 78
5 1 1 69 53 77
6 1 2 32 18 55
7 1 2 1 63 52 83
8 2 1 85 61 72
[a] Reaction conditions: Iron trichloride hexahydrate (0.025 mmol), Ph2
pybox (0.025 mmol), and H2pydic (0.025 mmol) were dissolved in tert amyl
alcohol (4 mL) in a 25 mL Schlenk tube and heated for 1 h at 65 8C. After
wards, trans stilbene (0.5 mmol), tert amyl alcohol (5 mL), and dodecane
(GC internal standard; 100 mL) were added in sequence at room tempera
ture in air. A solution of hydrogen peroxide (30%, 170 mL, 1.5 mmol) in
tert amyl alcohol (830 mL) was added to this mixture over a period of 12 h
at room temperature by a syringe pump. [b] Conversion and yield were de
termined by GC analysis. [c] Ratio of yield to conversion as a percentage.
Table 3. Epoxidation of trans stilbene in the presence of different iron
sources.
Entry Iron source Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
1 FeCl3·6H2O 100 82 82
2 FeCl2·4H2O 33 22 66
3 FeCl3 (anhydrous) 21 13 62
4 FeCl2 (anhydrous) 36 15 42
5 Fe(acac)3 11 5 44
6 Fe(NO3)3·9H2O 7 0 0
7 Fe(ClO4)3·xH2O 1 0 0
8 Fe(BF4)2·6H2O 0 0 0
[a] Reaction conditions: The iron source (0.025 mmol) and Ph2 pybox
(0.025 mmol) were dissolved in tert amyl alcohol (4 mL) in a 25 mL
Schlenk tube and heated for 1 h at 65 8C. Afterwards, trans stilbene
(0.5 mmol), tert amyl alcohol (5 mL), and dodecane (GC internal stan
dard; 100 mL) were added in sequence at room temperature in air. A so
lution of hydrogen peroxide (30%, 170 mL, 1.5 mmol) in tert amyl alcohol
(830 mL) was added to this mixture over a period of 12 h at room temper
ature by a syringe pump. [b] Conversion and yield were determined by
GC analysis. [c] Ratio of yield to conversion as a percentage.
Figure 3. Decomposition of the ligand.
Table 4. Epoxidation of trans stilbene with different ligands.
Entry Ligand Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
1 69 53 77
2 9 6 69
3 100 84 84
4 73 44 61
[a] Reaction conditions: Iron trichloride hexahydrate (0.025 mmol) and the
ligands (0.025 mmol) were dissolved in tert amyl alcohol (4 mL) in a 25 mL
Schlenk tube and heated for 1 h at 65 8C. Afterwards, trans stilbene
(0.5 mmol), tert amyl alcohol (5 mL), and dodecane (GC internal standard;
100 mL) were added in sequence at room temperature in air. A solution of
hydrogen peroxide (30%, 170 mL, 1.5 mmol) in tert amyl alcohol (830 mL)
was added to this mixture over a period of 12 h at room temperature by a sy
ringe pump. [b] Conversion and yield were determined by GC analysis.
[c] Ratio of yield to conversion as a percentage.
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entry 3; see also Table 2, entry 3). This result confirms our
hypothesis of ligand degradation. Notably, the catalyst
system without any phenyl glycinol showed lower reactivi
ty.[23] The application of the sodium salt of H2pydic led to
73% conversion and 44% yield (Table 4, entry 4). This can
be attributed either to the low solubility of Na2pydic in tert
amyl alcohol or the possibility that the amino alcohol acts as
a coligand in the active catalyst system.[24] Control experi
ments of the epoxidation of trans stilbene showed that iron
is essential in the reaction.[21] Unfortunately, none of our re
actions showed significant enantioselectivity, so we concen
trated on nonchiral reagents in subsequent reactions.
Next, we studied the effect of the amine in detail
(Table 5). Hence, 12 different nitrogen ligands were tested
in the model reaction. Most importantly, the combination of
FeCl3·6H2O, H2pydic, and organic bases such as benzyl
amine, 4 methylimidazole, and pyrrolidine led to active and
highly selective epoxidation catalysts (Table 5, entries 5, 7,
and 12). The NH group is beneficial to the reactivity. This is
shown clearly from the activities of substituted imidazoles
and pyridine (Table 5, entries 6 11). The reactivity dropped
significantly when 2 methylimidazole was used (Table 5,
entry 9). In comparison with the reactivity of pyridine, 4
methylimidazole, and pyrrolidine (Table 5, entries 7, 9, and
12), this effect must, to some extent, be attributed to coordi
nation effects.
By changing the amount of hydrogen peroxide, we found
that no more than 2 equivalents are necessary to achieve
high conversion and yield (>90%). Advantageously, the
time for H2O2 addition could be decreased from 12 to 1 h.
In fact, the model reaction is so fast that full conversion was
obtained after 5 min. However, for better comparison, we
continued to add the oxidant over 1 h.
For a better understanding of the catalytic system and fur
ther improvement of the selectivity, we varied systematically
the pyridine 2,6 dicarboxylic acid component. Hence, vari
ous ligands with a similar structure to H2pydic were investi
gated (Table 6). The pyridine nitrogen atom and the carbox
ylic acid in the 2 position are clearly needed for high reac
tivity (Table 6, entries 1, 2, and 7). By omitting or changing
these functional groups, the reactivity decreased significantly
except in the case of 2,6 pyridinedimethanol (Table 6,
entry 4). This can be attributed to the oxidation of this
ligand during the reaction, which generated the H2pydic
ligand in situ. Also, scrambling of a second carboxylic acid
group (Table 6, entry 3), introduction of phenoxy groups
(Table 6, entries 5 and 8), or addition of an amide group
(Table 6, entry 6) resulted in decreased conversion.
To understand of the active catalyst further, UV/Vis spec
troscopic investigations with FeCl3·6H2O, H2pydic, and pyr
rolidine were performed (Figures 4 and 5). Owing to the
strong absorbance of tert amyl alcohol (TAA), the measure
ments were analyzed at above 225 nm.[25] In the absence of
Fe, the curve of pyrrolidine and H2pydic showed only a
small difference to the calculated curve of the individual
components (Figures 4 and 5, curve b). This indicates that
no strong interaction between the ligands is present in solu
tion. In contrast, the UV/Vis spectra of pyrrolidine or
H2pydic in the presence of FeCl3·6H2O showed a significant
difference to the calculated curves (Figures 4 and 5, curves c
and d). This clearly suggests that the metal interacts with
the corresponding ligands and supports the assumption that
pyrrolidine acts also as a ligand in the system. Consequently,
there is also a difference between the measured and calcu
lated curves for the whole catalyst system (Figure 6, curves d
and e). The calculated addition curve, which includes indi
vidual interactions, shows that there has to be an additional
interaction when the two ligands are present at the same
time (Figure 7, curves c and d).[26] For comparison, UV/Vis
measurements with an inactive catalytic system were per
formed. Hence, 2,6 pyridine dicarboxamide (PDCA) instead
of H2pydic was chosen as the ligand, and it showed no sig
nificant reactivity in the catalytic test reaction (Table 6,
entry 6).
Table 5. Epoxidation of trans stilbene with different bases.
Entry Base Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
1 KOH 33[d] 30 91
2 DMAP 19[d] 16 84
3 DABCO 40 33 82
4 Et3N 86 74 86
5 100 97 97
6 91 90 99
7 100[e] 97 97
8 78[e] 72 92
9 12[e] 11 92
10 95[e] 85 89
11 56 50 89
12 100 97 97
13 61 59 97
[a] Reaction conditions: FeCl3·6H2O (0.025 mmol), H2pydic
(0.025 mmol), tert amyl alcohol (9 mL), base (0.05 mmol), trans stilbene
(0.5 mmol), and dodecane (GC internal standard; 100 mL) were added in
sequence to a 25 mL Schlenk tube at room temperature in air. A solution
of hydrogen peroxide (30%, 170 mL, 1.5 mmol) in tert amyl alcohol
(830 mL) was added to this mixture over a period of 1 h at room tempera
ture by a syringe pump. [b] Conversion and yield were determined by
GC analysis. [c] Ratio of yield to conversion as a percentage. [d] H2O2
addition over a period of 12 h. [e] Addition of 2 equivalents of H2O2.
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Table 6. Epoxidation of trans stilbene with different H2pydic like
structures.
Entry Ligand Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
1 96 84 87
2 52 43 83
3 9 4 38
4 77 69 90
5 20 18 86
6 1 0 0
7 70 65 93
8 3 0 0
9 8 5 63
10 3 2 65
11 7 2 26
12 6 4 67
13 5 2 43
14 13 4 29
15 14 9 65
16 37[d] 37 100
17 33[e] 24 74
[a] Reaction conditions: FeCl3·6H2O (0.025 mmol), ligand (0.025 mmol),
tert amyl alcohol (9 mL), pyrrolidine (0.05 mmol), trans stilbene
(0.5 mmol), and dodecane (GC internal standard; 100 mL) were added in
sequence to a 25 mL Schlenk tube at room temperature in air. A solution
of hydrogen peroxide (30%, 114 mL, 1.0 mmol) in tert amyl alcohol
(886 mL) was added to this mixture over a period of 1 h at room tempera
ture by a syringe pump. [b] Conversion and yield were determined by
GC analysis. [c] Ratio of yield to conversion as a percentage. [d] Addi
tion of 1 equivalent of pyrrolidine. [e] Addition of 2 equivalents of pyrro
lidine.
Figure 4. UV/Vis spectra of FeCl3·6H2O and pyrrolidine in tert amyl alco
hol. a) 0.25 mm FeCl3·6H2O; b) 0.6 mm pyrrolidine; c) 0.25 mm
FeCl3·6H2O+0.6 mm pyrrolidine; d) curves (a+b TAA).
Figure 5. UV/Vis spectra of FeCl3·6H2O and H2pydic in tert amyl alcohol.
a) 0.25 mm FeCl3·6H2O; b) 0.25 mm H2pydic; c) 0.25 mm FeCl3·6H2O+
0.25 mm H2pydic; d) curves (a+b TAA).
Figure 6. UV/Vis spectra of FeCl3·6H2O, pyrrolidine, and H2pydic, part 1.
a) 0.25 mm FeCl3·6H2O; b) 0.25 mm H2pydic; c) 0.6 mm pyrrolidine;
d) 0.25 mm FeCl3·6H2O+0.25 mm H2pydic+0.6 mm pyrrolidine; e) curves
(a+b+c 2TAA).
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As expected, no additional change in the UV/Vis spec
trum by adding PDCA to a solution of FeCl3·6H2O and pyr
rolidine in tert amyl alcohol could be observed (Figure 8,
curves c and d). Apparently, there is no interaction between
the metal and ligands that causes a change in the UV/Vis
spectrum. UV/Vis spectra of the catalyst together with
trans stilbene and hydrogen peroxide did not give interpret
able results due to the strong absorbance of trans stilbene.
The change in the curves was so imprecise that conclusive
results cannot be deduced. From the accumulated results, it
is clear that the complexity of this Fe catalytic system pres
ents a challenge for catalytic and mechanistic chemists and
will require further scrutiny.
Next, we tested different aromatic and aliphatic olefins in
the presence of FeCl3·6H2O, pyrrolidine, and H2pydic
(Tables 7 10). Styrene, which is generally known as a diffi
cult substrate for epoxidation, afforded excellent yield and
selectivity of styrene oxide (Table 7, entry 1). The reaction
also performed well for o and p substituted styrenes as well
as those with electron donating and withdrawing substitu
ents (Table 7, entries 2 7). Substitution at the a or b trans
positions led to good results (Table 8, entries 1 and 2),
whereas b cis substitution gave only poor to moderate re
sults (Table 8, entries 6 and 7). Presumably, b cis substitu
tion inhibits the coordination of these substrates to the cata
lyst because of steric hindrance. With p methoxy substituted
trans stilbene and 2 vinylnaphthalene, moderate yields were
obtained (Table 8, entries 9 and 10). Notably, functionalized
olefins such as cinnamyl acetate, cinnamyl alcohol, and even
cinnamyl chloride gave good to excellent yields of the corre
sponding epoxides (Table 9, entries 1 3). However, ethers of
cinnamyl alcohol led to moderate or poor yields (Table 9,
entries 4 6). Aliphatic olefins and 1,3 cyclooctadiene also
gave moderate to good yields (Table 10, entries 1 3).
Figure 7. UV/Vis spectra of FeCl3·6H2O, pyrrolidine, and H2pydic, part 2.
a) 0.25 mm FeCl3·6H2O+0.6 mm pyrrolidine; b) 0.25 mm FeCl3·6H2O+
0.25 mm H2pydic; c) 0.25 mm FeCl3·6H2O+0.25 mm H2pydic+0.6 mm pyr
rolidine; d) curves (a+b FeCl3·6H2O (curve a, Figure 6)).
Figure 8. UV/Vis spectra of FeCl3·6H2O, pyrrolidine, and PDCA.
a) 0.25 mm FeCl3·6H2O+0.6 mm pyrrolidine; b) 0.25 mm PDCA;
c) 0.25 mm FeCl3·6H2O+0.25 mm PDCA+0.6 mm pyrrolidine; d) curves
(a+b TAA).
Table 7. Scope and limitations of the Fe catalyzed epoxidation: styrenes.
Entry Olefin Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
1 94 93 99
2 100 97 97
3 100 75 75
4 57 52 91
5 100 70 70
6 95 77 81
7 73 43 59
[a] Reaction conditions: FeCl3·6H2O (0.025 mmol), H2pydic
(0.025 mmol), tert amyl alcohol (9 mL), pyrrolidine (0.05 mmol), olefin
(0.5 mmol), and dodecane (GC internal standard; 100 mL) were added in
sequence to a 25 mL Schlenk tube at room temperature in air. A solution
of H2O2 (30%, 114 mL, 1.0 mmol) in tert amyl alcohol (886 mL) was
added to this mixture over a period of 1 h at room temperature by a sy
ringe pump. [b] Conversion and yield were determined by GC analysis.
[c] Ratio of yield to conversion as a percentage.
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Conclusions
We have developed a convenient epoxidation protocol by
using economical and environmentally friendly iron catalysts
in combination with H2O2. 2,6 Pyridine dicarboxylic acid
and pyrrolidine turned out to be the most effective ligands
in this system. The system showed excellent reactivity and
selectivity towards terminal and 1,2 disubstituted aromatic
olefins, and moderate reactivity towards 1,3 dienes and ali
phatic olefins. All the reagents used in our system are com
mercially available, and the reaction can be performed at
room temperature in air under very mild conditions. To the
best of our knowledge, the system described herein is the
simplest and most practical iron catalyzed epoxidation pro
cedure available for olefins today. Effort is underway in our
group to realize the asymmetric version of this reaction.
Table 8. Scope and limitations of the Fe catalyzed epoxidation: aromatic
olefins.
Entry Olefin Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
1 93 64 69
2 100 95 95
3 44 16 36
4 25 11 44
5 40 21 53
6 22 8 36
7 75 56 75
8 91 38 42
9 100 40 40
10 78 40 51
11 85 21 25
12 94 26 28
[a] Reaction conditions: FeCl3·6H2O (0.025 mmol), H2pydic
(0.025 mmol), tert amyl alcohol (9 mL), pyrrolidine (0.05 mmol), olefin
(0.5 mmol), and dodecane (GC internal standard; 100 mL) were added in
sequence to a 25 mL Schlenk tube at room temperature in air. A solution
of H2O2 (30%, 114 mL, 1.0 mmol) in tert amyl alcohol (886 mL) was
added to this mixture over a period of 1 h at room temperature by a sy
ringe pump. [b] Conversion and yield were determined by GC analysis.
[c] Ratio of yield to conversion as a percentage.
Table 9. Scope and limitations of the Fe catalyzed epoxidation: cinnamyl
alcohol derivatives.
Entry Olefin Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
1 71 69 97
2 100 74 74
3 90 61 68
4 100 18 18
5 90 33 37
6 100 15 15
[a] Reaction conditions: FeCl3·6H2O (0.025 mmol), H2pydic
(0.025 mmol), tert amyl alcohol (9 mL), pyrrolidine (0.05 mmol), olefin
(0.5 mmol), and dodecane (GC internal standard; 100 mL) were added in
sequence to a 25 mL Schlenk tube at room temperature in air. A solution
of H2O2 (30%, 114 mL, 1.0 mmol) in tert amyl alcohol (886 mL) was
added to this mixture over a period of 1 h at room temperature by a sy
ringe pump. [b] Conversion and yield were determined by GC analysis.
[c] Ratio of yield to conversion as a percentage. TBS= tert butyldimethyl
silyl.
Table 10. Scope and limitations of the Fe catalyzed epoxidation: aliphat
ic olefins.
Entry Olefin Conv.
[%][a,b]
Yield
[%][b]
Selectivity
[%][c]
1 63 32 51
2 48 36 75
3 77 65 84
[a] Reaction conditions: FeCl3·6H2O (0.025 mmol), H2pydic
(0.025 mmol), tert amyl alcohol (9 mL), pyrrolidine (0.05 mmol), olefin
(0.5 mmol), and dodecane (GC internal standard; 100 mL) were added in
sequence to a 25 mL Schlenk tube at room temperature in air. A solution
of H2O2 (30%, 114 mL, 1.0 mmol) in tert amyl alcohol (886 mL) was
added to this mixture over a period of 1 h at room temperature by a sy
ringe pump. [b] Conversion and yield were determined by GC analysis.
[c] Ratio of yield to conversion as a percentage.
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Experimental Section
General
All reagents were used as purchased from commercial suppliers without
further purification. Solvents were dried and purified by conventional
methods prior to use. Mass spectra were recorded with an AMD 402/3
mass spectrometer. GC analysis was performed with a Hewlett Packard
HP 6890 model spectrometer. Elemental analysis was performed on a
CHNS 932 analyzer from Leco Company. To determine the amount of
metal, a Type A Analyst 300 atom absorbance spectrometer from
Perkin Elmer was used.
Syntheses
All manipulations of air and moisture sensitive compounds were per
formed by using standard Schlenk or cannula techniques under an argon
atmosphere. THF and diethyl ether were heated at reflux and distilled
from sodium/benzophenone under argon atmosphere. Complexes were
prepared by the reaction of dry FeCl2 with the corresponding ligand in
THF. The solution was stirred for several hours and filtered to separate
the product from the unreacted metal chloride. The volume of the filtrate
was decreased and diethyl ether was added. The resulting solid was dried
under vacuum.
2,6 Bis(4 phenyl 4,5 dihydrooxazol 2 yl)pyridineiron(II) chloride: Prepa
ration proceeded as described above. 2,6 Bis(4 phenyl 4,5 dihydrooxazol
2 yl)pyridine (0.295 g, 0.8 mmol) and FeCl2 (0.1 g, 0.79 mmol) reacted to
give a magenta solid in 80% yield. MS (EI, 70 eV): m/z (%)=495 (<1)
[M]+ , 459 (<1) [M Cl], 369 (70.64) [L], 337 (12.87), 265 (16.84), 219
(41.92), 192 (29.84), 131 (28.82), 118 (47.44), 104 (100), 89 (67.54); MS
(FAB, pos., NBA): m/z (%)=794 [FeL2] (30.6), 460 [M Cl] (51), 424
[M Cl2] (29.75).
5,4’,5’’ Tri tert butyl 2,2’;6’,2’’ terpyridineiron(II) chloride: Preparation
proceeded as described above. 5,4’,5’’ Tri tert butyl 2,2’;6’,2’’ terpyridine
(0.321 g, 0.8 mmol) and FeCl2 (0.1 g, 0.79 mmol) reacted to give a black
solid in 85% yield. MS (ESI+ ): m/z (%)=893.47283 (4.38) [FeL2Cl],
492.18770 (3.28) [M Cl], 429.25030 (100), 143.09015 (12.66).
2,6 Bis (4,5 diphenyl 4,5 dihydro 1H imidazol 2 yl)pyridineiron(II) chlo
ride: Preparation proceeded as described above. 2,6 Bis (4,5 diphenyl
4,5 dihydro 1H imidazol 2 yl)pyridine (0,353 g, 0.68 mmol) and FeCl2
(0,085 g, 0.67 mmol) reacted to give a blue solid in 98% yield. MS
(ESI+ , CapExit 240 eV): m/z (%)=1092.40498 (100) [FeL2], 604.14556
(20), 576.17158 (8) [FeL], 520.25121 (46) [L].
Terpyridinemyrtanaliron(II) chloride: Preparation proceeded as de
scribed above. Terpyridinemyrtanal (0.18 g, 0.43 mmol) and FeCl2
(0.053 g, 0.042 mmol) reacted to give a dark brown solid in 80% yield.
MS (ESI+ , CapExit 240 eV): m/z (%)=547.12926 (32.76) [M]+ ,
512.16012 (100) [M Cl], 391.14395 (26.15), 376.12027 (25.76), 363.11249
(18.07).
Epoxidation of trans Stilbene with Iron(II) Complexes
The iron complex (0.025 mmol), tert amyl alcohol (9 mL), trans stilbene
(0.5 mmol), and dodecane (GC internal standard; 100 mL) were added in
sequence to a 25 mL Schlenk tube at room temperature in air. A solution
of hydrogen peroxide (30%, 170 mL, 1.5 mmol) in tert amyl alcohol
(830 mL) was added to this mixture over a period of 12 h at room temper
ature by a syringe pump.
Epoxidation of Olefins In Situ
The iron source (0.025 mmol) and ligands (each 0.025 mmol) were dis
solved in tert amyl alcohol (4 mL) in a 25 mL Schlenk tube and heated
for 1 h at 65 8C. Afterwards, the olefin (0.5 mmol) in tert amyl alcohol
(5 mL) and dodecane (GC internal standard; 100 mL) were added in se
quence at room temperature in air (in experiments without 1 h of heating
at 65 8C, the iron source, ligands, olefin, and dodecane were dissolved at
once in 9 mL tert amyl alcohol). A solution of hydrogen peroxide (30%,
170 mL, 1.5 mmol or 116 mL, 1.0 mmol) in tert amyl alcohol (830 or
884 mL) was added to this mixture over a period of 12 or 1 h at room
temperature by a syringe pump.
UV/Vis Spectroscopic Measurements
UV/Vis spectra were recorded on a Cary 1 E UV/Vis spectrophotometer
(Varian) in double beam mode with zero/baseline (empty cuvette) cor
rection (40 nmmin 1, 0.2 nm data interval, 2 nm spectral bandwidth).
Measurements were performed in a UV quartz cuvette (Hellma GmbH,
QS 110, path length 10 mm) at room temperature and after the measur
ing solutions were filtered, if necessary. To obtain lower absorbance, solu
tions of tenfold dilution (relative to reaction solutions) were used.
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A convenient and practical method for the iron-catalyzed
epoxidation of aromatic and aliphatic olefins is described.
The iron catalyst system is generated in situ from iron trichlo-
ride hexahydrate, pyridine-2,6-dicarboxylic acid (H2pydic),
and benzylamines. By variation of the benzylamine ligand, a
Introduction
The epoxidation of olefins is an important synthetic
method in organic chemistry as well as for the chemical
industry. With respect to generality, it still remains challeng-
ing to discover catalytic epoxidations that allow efficient
and selective reactions for both aromatic and aliphatic ole-
fins.[1,2] In general, state-of-the-art epoxidations should run
under environmentally benign reaction conditions with in-
expensive catalysts by using sustainable terminal oxidants
and simple operation protocols.[3] Traditionally, stoichio-
metric oxidants such as organic peracids have been applied
in epoxidation reactions.[4] More recently, hydrogen perox-
ide has become one of the terminal oxidants of choice, be-
cause it produces only water as a byproduct and is advan-
tageous regarding costs, safety, and storage.[5] With regard
to catalysts, the use of Fe- or Mn-based complexes is at-
tractive due to their price and low toxicity.[6,7] On the basis
of ruthenium-catalyzed epoxidation of olefins with hydro-
gen peroxide,[8] we found that FeCl3·6H2O in combination
with pyridine-2,6-dicarboxylic acid and pyrrolidine shows
high reactivity and selectivity towards the epoxidation of
mono- and disubstituted aromatic olefins.[9] Unfortunately,
aliphatic olefins and highly substituted aromatic olefins
were less reactive and selective under the conditions of our
previous system. Hence, we are interested in improved Fe-
catalyzed epoxidations, which can be applied to all classes
of olefins.
Herein, we report the development of a general method
for the epoxidation of a broad scope of olefins with hydro-
gen peroxide.
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variety of aliphatic and aromatic olefins were oxidized in
high yield (up to 96%) and good-to-excellent selectivity in
the presence of hydrogen peroxide as the terminal oxidant.
(© Wiley-VCH Verlag GmbH & Co. KGaA, 69451 Weinheim,
Germany, 2008)
Results and Discussion
The key to the success of the Fe-catalyzed epoxidation is
the use of pyridine-2,6-dicarboxylic acid (H2pydic) as li-
gand. By studying the effect of the organic coligand on the
epoxidation of cyclooctene as a model substrate, we ob-
served a strong influence on the reactivity.
In Table 1 a small selection of the tested amines is shown.
To our delight, the yield of cyclooctene oxide is improved
from 4% (without ligand) up to 89% in the presence of
N-(diphenylmethyl)methylamine (Table 1, entries 1 and 7).
Notably, also our standard base pyrrolidine gave a signifi-
cantly lower yield (16%) and selectivity with respect to
epoxidation (Table 1, entry 2). Interestingly, in comparison
to previous investigations the epoxidation of trans-stilbene
with these amines did not display apparent differences in
reactivity.[10] This can be attributed to the high reactivity of
trans-stilbene. Hence, differences in the amine coligands did
not show a significant influence on the reactivity. De novo
analysis of the structural motif indicates that benzylamine is
the important element in order to achieve high conversion.
Strong coordinative 2-picolylamine gave inferior results
as compared to benzylamine (Table 1, entries 5 and
8).[6a,6b,6d,6e] Slow dosing of hydrogen peroxide to the sys-
tem increased the yield but is not the crucial factor. In fact,
the addition of hydrogen peroxide can be performed within
seconds, and cyclooctene oxide is obtained in 75% yield at
88% conversion. Further investigations on the concentra-
tion of the ligands showed 10 to 15 mol-% of the amine to
be optimum. For better comparison and general applica-
bility, the H2O2 addition time (1 h) and the amine concen-
tration (12 mol-%) were maintained for all experiments. Re-
placement of H2pydic with picolinic acid or quinaldic acid
or the use of other iron sources resulted in a total loss of
reactivity. Apparently, the H2pydic component is essential
in this system.[11]
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Table 1. Effect of the amine coligand on the epoxidation of cyclooc-
tene.[a]
[a] Reaction conditions: In a test tube, FeCl3·6H2O (0.025 mmol),
H2pydic (0.025 mmol), tert-amyl alcohol (9 mL), amine
(0.060 mmol), cyclooctene (0.50 mmol), and dodecane (GC in-
ternal standard, 100 μL) were added in sequence at r.t. in air. To
this mixture was added a solution of 30% hydrogen peroxide
(114 μL, 1.0 mmol) in tert-amyl alcohol (886 μL) over a period of
1 h at r.t. by syringe pump. [b] Conversion and yield were deter-
mined by GC analysis. [c] Selectivity refers to the chemoselectivity
of epoxide from olefin. [d] Addition of hydrogen peroxide within
some seconds.
As shown in Table 1, it appears that benzylamine is a
preferred structural element for the epoxidation of cyclooc-
tene (Table 1, entries 5 to 7). For this reason we tested a
selection of various commercially available benzylamines
for the epoxidation of different classes of aromatic and ali-
phatic olefins (Scheme 1). Table 2 shows the epoxidation re-
sults for different substituted aromatic olefins. By applying
the novel protocol, we could maintain the high reactivity
and selectivity toward trans-stilbene and styrene as com-
pared to our previous pyrrolidine system (Table 2, entries 1
and 3). Even though active catalysts for aliphatic olefins
often lead to subsequent over oxidation reactions of the
much-more reactive aromatic olefins, the benzylamine/
H2pydic/FeCl3 system gives a general activity and good
selectivity with respect to epoxidation in both of these
classes of olefins.
Epoxidation of cis-stilbene proceeded in 24% yield in
comparison to 8% yield with the pyrrolidine-based sys-
tem.[10] In addition, we could also increase the yields for
trisubstituted aromatic olefins such as trans-β-methylstil-
bene (Table 2, entry 5; from 21 to 68% yield, respectively)
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Scheme 1. Epoxidation of olefins with benzylamine derivatives 1.
Table 2. Epoxidation of aromatic olefins with benzylamine deriva-
tive 1.[a]
[a] Reaction conditions: In a test tube, FeCl3·6H2O (0.025 mmol),
H2pydic (0.025 mmol), tert-amyl alcohol (9 mL), amine
(0.060 mmol), olefin (0.50 mmol), and dodecane (GC internal stan-
dard, 100 μL) were added in sequence at r.t. in air. To this mixture
was added a solution of 30% hydrogen peroxide (114 μL,
1.0 mmol) in tert-amyl alcohol (886 μL) over a period of 1 h at r.t.
by syringe pump. [b] Conversion and yield were determined by GC
analysis. [c] Selectivity refers to the chemoselectivity of epoxide
from olefin.
and 2-methyl-1-phenyl-1-propene (Table 2, entry 4; from 16
to 37% yield, respectively) in comparison to our previous
system. However, the tetrasubstituted olefin 2-methyl-3-
phenyl-2-butene gave no corresponding epoxide (Table 2,
entry 6).
Aliphatic olefins work particularly well with the new cat-
alyst system (Table 3). Internal olefins like trans-2-octene
(Table 3, entry 1) and trans-5-decene (Table 3, entry 2) were
oxidized in high yield and selectivity. Trisubstituted 2-
methyl-2-heptene (Table 3, entry 3) and cyclic olefins
(Table 3, entries 4 and 5) gave the corresponding epoxides
in good yield. Terminal olefins are intrinsically poorly reac-
tive substrates and catalytic methods for their epoxidation
are limited.[6,7,12] Our system afforded 32% yield of 1-oc-
tene oxide, whereas 2-methyl-2-heptene was oxidized in
58% yield (Table 3, entries 6 and 7). Moreover, the iron cat-
Iron-Catalyzed Epoxidation of Aromatic and Aliphatic Olefins
alyst system showed good chemoselectivity towards olefins
in the presence of hydroxy and carboxyl groups (Table 3,
entries 8 and 9).
Table 3. Fe-catalyzed epoxidation of aliphatic olefins with benzyl-
amine derivative 1.[a]
[a] Reaction conditions: In a tube, FeCl3·6H2O (0.025 mmol),
H2pydic (0.025 mmol), tert-amyl alcohol (9 mL), amine
(0.060 mmol), olefin (0.50 mmol), and dodecane (GC internal stan-
dard, 100 μL) were added in sequence at r.t. in air. To this mixture
was added a solution of 30% hydrogen peroxide (114 μL,
1.0 mmol) in tert-amyl alcohol (886 μL) over a period of 1 h at r.t.
by syringe pump. [b] Conversion and yield were determined by GC
analysis. [c] Selectivity refers to the chemoselectivity of epoxide
from olefin.
Acetic acid is a well-known additive for the epoxidation
of olefins with hydrogen peroxide by in situ formation of
peracetic acid.[13] In contrast, addition of certain amounts
of acetic acid to our catalyst system inhibited the conver-
sion of 1-octene. Furthermore, to exclude the possibility of
in situ formation of the alkyl hydroperoxide from tert-amyl
alcohol, we used tert-BuOOH (70% aqueous) as an oxidant
instead of hydrogen peroxide. Again no reactivity was ob-
served for the epoxidation of cyclooctene. This indicates
that tert-amyl hydroperoxide is not likely to be involved in
the reaction and hydrogen peroxide is the only terminal oxi-
dant in our system.
Conclusions
In conclusion, we developed an improved iron-catalyzed
epoxidation, which can be performed under mild conditions
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with hydrogen peroxide as the terminal oxidant. The simple
and practical catalyst system consists of iron trichloride
hexahydrate, pyridine-2,6-dicarboxylic acid, and a benzyla-
mine derivative. It was demonstrated that benzylamine is a
preferred structural element for the coligand in this general
epoxidation of aromatic and aliphatic olefins. The system
showed good-to-excellent reactivity to mono-, di-, and tri-
substituted aromatic olefins, as well as to internal di- and
trisubstituted and functionalized aliphatic olefins. Note-
worthy is that inactive aliphatic olefins can be oxidized in
up to 96% yield. Currently, further efforts are underway
to improve the protocol for tetrasubstituted aromatic and
monosubstituted terminal aliphatic olefins and to investi-
gate the mechanistic aspects of this reaction.
Experimental Section
General Remarks: All reagents were used as purchased from com-
mercial suppliers (Aldrich, Fluka, Merck, etc.) without further pu-
rification. 2-Methyl-3-phenyl-but-2-ene (Table 2, entry 6) was syn-
thesized according to literature procedures.[14] “30%” aqueous
H2O2 from Merck was used as received. The peroxide content var-
ied from 30% to 40% as determined by titration. GC analyses were
performed with a Hewlett Packard HP 6890 model spectrometer.
GC calibrations for alkenes and epoxides were carried out with
authentic samples and dodecane as an internal standard.
General Procedure for the Epoxidation of Olefins: In a test tube,
FeCl3·6H2O (0.025 mmol), H2pydic (0.025 mmol), tert-amyl
alcohol (9 mL), amine (0.060 mmol), olefin (0.50 mmol) and do-
decane (GC internal standard, 100 μL) were added in sequence at
r.t. in air. To this mixture was added a solution of 30% hydrogen
peroxide (aqueous, 114 μL, 1.0 mmol) in tert-amyl alcohol (886 μL)
over a period of 1 h at room temperature by syringe pump. Conver-
sion and yield were determined by GC analysis without further
manipulations.
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Abstract A new selective and easily manageable epoxidation method is presented using an inexpensive and efficient FeCl3Æ6H2O
and imidazole derivatives as catalysts. Aqueous hydrogen peroxide as an environmentally benign oxidant is utilized. This novel
Fe/imidazole system gives moderate to excellent yields toward aromatic mono , di , and tri substituted olefins.
 2007 Elsevier Ltd. All rights reserved.
Epoxides play an important role in industry as inter-
mediates for the production of fine chemicals as well
as pharmaceuticals. With respect to environmental and
economical considerations, the applied oxidant deter-
mines to a significant extent the value of the system.1
Thus, the combination of hydrogen peroxide with a
non-toxic and inexpensive metal source constitutes an
ideal system for epoxidation reactions, especially in li-
quid phase processes in industry.2,3 Among the various
metals iron is the most abundant metal in nature and
is indispensable in nearly all organisms.4 Many biologi-
cal systems such as hemoglobin, myoglobin, cytochrome
oxygenases, and non-heme oxygenases are iron contain-
ing enzymes or co-enzymes.5,6
Due to its low cost and biological relevance there is an
increasing interest to use iron complexes as catalysts
for a wide range of reactions.7 In this respect, recently
we developed iron catalysts for C C-coupling reac-
tions,8 transfer hydrogenations9 as well as epoxida-
tions.10,11 Based on the latter work, we report here a
novel biomimetic FeCl3/imidazole-system for epoxida-
tions of olefins using aqueous hydrogen peroxide as
the oxidant.12
Imidazole derivates play a fundamental role as ligands
or base in enzymes.13 For instance, the imidazole part
of histidine often acts as a ligand in metalloenzymes,
for example, hemoglobin.14 With regard to epoxidations
it is noteworthy that 1-sulfonylated imidazoles and
hydrogen peroxide are known as powerful oxidant in
stoichiometric amount for the reactions.15 Besides, imi-
dazoles and pyrazoles are widely employed as additives
in epoxidation systems, such as iron16 and manganese17
porphyrins, manganese salen complexes,18 methyltri-
oxorhenium,19 and manganese schiff bases.20
Recently, we demonstrated that a combination of FeCl3Æ
6H2O, pyridine-2,6-dicarboxylic acid (H2pydic) and an
organic base like pyrrolidine catalyzes the epoxidation
of trans-stilbene with 30% H2O2 to trans-stilbene oxide
in high yield within 1 h.11 Key to the success of this reac-
tion is the use of pyridine-2,6-dicarboxylic acid as
ligand. By studying the effect of the organic base in more
detail, we found that a combination of FeCl3Æ6H2O with
simple imidazole without any pyridine-2,6-dicarboxylic
acid gave also trans-stilbene oxide in 38% yield with
90% selectivity (Table 1, entry 1).21 Further investiga-
tions showed that the activity and selectivity of the cat-
alytic system can be improved by varying the imidazole
ligands (Table 1).
The influence of the substitution pattern of the imidazo-
le ligands reveals some interesting aspects. Substitution
0040 4039/$ see front matter  2007 Elsevier Ltd. All rights reserved.
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at the 2-position of the imidazole gave inferior results
(Table 1, entries 1, 2, 6, and 8). Furthermore, N-substi-
tution of the 5-bromoimidazole led to a higher yield and
conversion (Table 1, entries 4 and 7). In addition, 5-
halo-N-methylimidazoles enhanced the yield signifi-
cantly. In fact 5-chloro-1-methylimidazole (Table 1,
entry 3) gave the best result (80% yield; 97% selectivity).
It is noteworthy that 5-chloro-1-methylimidazole (5-Cl-
1-MeIm) is a near-optimal imidazole activity enhancing
additive with balanced steric and electronic factors in an
iron porphyrin system.16
Next, we tried to find out more about the mechanism
of this novel epoxidation catalyst. One of the possibili-
ties for the effectiveness of these imidazole ligands might
be the participation of a carbene type ligand in the
reaction system due to their outstanding r-donor
strength.22
However, replacement of the imidazole derivative with
1,3-dimesityl-2,3-dihydro-1H-imidazol-2-ide gave no
conversion at all. Besides, in the presence of the radical
trap TEMPO (2,2,6,6-tetramethyl-piperidine-1-oxyl;
1.5 equiv), the reaction showed insignificant conversion
and yield. This suggests the participation of a radical
in the catalytic cycle in this epoxidation system. Control
experiments indicated that all the components are essen-
tial for the activity and selectivity. Indeed, in the pres-
ence of 10 mol % of 5-Cl-1-MeIm without FeCl3Æ6H2O
no product formation is observed. On the other hand
5 mol % of FeCl3Æ6H2O without 5-Cl-1-MeIm gave only
5% yield. These results exclude the possibility of
organocatalysis.
Further optimization showed that a higher yield (84%
yield and 99% selectivity) can be reached when 3 equiv
of 30% hydrogen peroxide is used.23 The yield was main-
tained with a slight drop of selectivity when 4 equiv of
hydrogen peroxide was added. Applying a higher
amount of the ligand 5-Cl-1-MeIm gave slightly better
results. Hence, with 15 mol % of 5-Cl-1-MeIm and
5 mol % FeCl3Æ6H2O, the product yield reached 86%
with 97% selectivity. No further significant improvement
is observed with higher ligand loading.
Next, various olefins were applied to the reaction under
the optimized reaction conditions (3 equiv H2O2,
5 mol % FeCl3Æ6H2O, and 15 mol % 5-Cl-1-MeIm)
(Table 2).
In the presence of Fe/imidazole catalyst mono-, di-, and
tri-substituted olefins can be epoxidized in moderate to
excellent yield with high selectivity (Table 2). Compared
with our previously reported first generation iron cata-
lyst, this reaction system improved both the yield
and selectivity especially for trisubstituted olefins.11
For example, epoxidation of (cyclohexylidenemethyl)-
benzene gave 25% yield with 64% selectivity in the
new protocol (Table 2, entry 3) while the old system
gave only 11% yield with 39% selectivity. Furthermore,
all halogen-substituted styrenes gave improved selectiv-
ity compared to the first generation catalysts (up to
91%).
In conclusion, we have developed a novel, biomimetic
and easily manageable epoxidation reaction. For the
first time it is possible to perform epoxidations with
hydrogen peroxide in the presence of simple Fe/imid-
azole catalysts. Compared to our previous catalyst
system the newly developed iron catalyst does not need
any pyridine-2,6-dicarboxylic acid and gave improved
yield and selectivity for more difficult tri-substituted
olefins and styrenes.24 Efforts to examine the reaction
mechanism and to realize an asymmetric version of this
reaction are going on in our group.
Table 1. Reactivity of different imidazole derivatives
O
5 mol % FeCl3 6H2O,
 10 mol % imidazole derivative
2 equiv. H2O2,  
r.t., 1 h addition
tert-amyl alcohol,
Entry Imidazole
derivative
Conv.a,b
(%)
Yieldb
(%)
Selectivityc
(%)
1
N
H
N
43 38 90
2 N
N
Bn
47 39 83
3
N
N
Cl
83 80 97
4
N
N
Br
69 69 100
5 N
N
Bu
40 39 99
6
N
H
N
5 4 90
7
N
H
N
Br
39 36 93
8 N
N
Bn
5 5 87
a Reaction conditions: in a 25 mL Schlenk tube, FeCl3Æ6H2O
(0.025 mmol), imidazole derivative (0.05 mmol), tert amyl alcohol
(9 mL), trans stilbene (0.5 mmol) and dodecane (GC internal stan
dard, 100 lL) were added in sequence at rt in air. To this mixture, a
solution of 30% H2O2 (115 lL, 1.0 mmol) in tert amyl alcohol
(885 lL) was added over a period of 1 h at rt by a syringe pump.
b Conversion and yield were determined by GC analysis.
c Selectivity refers to the ratio of yield to conversion in percentage.
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Ar1
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R3
R2 Ar1
R3
R2
O
Entry Substrates Conv.a,b (%) Yieldb (%) Selectivityc (%)
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4 34 24d 71
5 52 36 68
6 74 70 95
7
Cl
90 79 88
8
Br
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9
F
73 62 86
10
Cl
74 67 91
11
Cl
55 46 84
a Reaction conditions: in a 25 mL Schlenk tube, FeCl3Æ6H2O (0.025 mmol), 5 chloro 1 methylimidazole (0.075 mmol), tert amyl alcohol (9 mL),
trans stilbene (0.5 mmol) and dodecane (GC internal standard, 100 lL) were added in sequence at rt in air. To this mixture, a solution of 30% H2O2
(170 lL, 1.5 mmol) in tert amyl alcohol (830 lL) was added over a period of 1 h at rt by a syringe pump.
b Conversion and yield were determined by GC analysis.
c Selectivity refers to the ratio of yield to conversion in percentage.
d Additionally 3% trans stilbene oxid and trans stilbene were observed.
K. Schro¨der et al. / Tetrahedron Letters 48 (2007) 6339 6342 6341
Mr. I. Zenz, Dr. Feng Shi and Dr. B. Spilker (LIKAT)
are acknowledged for their valuable support in the
laboratory.
References and notes
1. For a list of common oxidants, their active oxygen
contents and waste products, see: Ba¨ckvall, J. E. Modern
Oxidation Methods; Wiley VCH: Weinheim, 2004; p 22.
2. Lane, B. S.; Burgess, K. Chem. Rev. 2003, 103, 2457
2473.
3. For recent examples of transition metal catalyzed epoxida
tions using hydrogen peroxide see: (a) Colladon, M.;
Scarso, A.; Sgarbossa, P.; Michelin, R. A.; Strukul, G. J.
Am. Chem. Soc. 2006, 128, 14006 14007; (b) Sawada, Y.;
Matsumoto, Z.; Kondo, S.; Watanabe, H.; Ozawa, T.;
Suzuki, K.; Saito, B.; Katsuki, T. Angew Chem., Int. Ed.
2006, 45, 3478 3480; (c)Matsumoto,K.; Sawada, Y.; Saito,
B.; Sakai, K.; Katsuki, T. Angew. Chem., Int. Ed. 2005, 44,
4935 4939; (d) Mahammed, A.; Gross, Z. J. Am. Chem.
Soc. 2005, 127, 2883 2887; (e) Ku¨hn, F. E.; Scherbaum, A.;
Herrmann, W. A. J. Organomet. Chem. 2004, 689, 4149
4164; (f) Kamata, K.; Yamaguchi, K.; Hikichi, S.; Mizuno,
N. Adv. Synth. Catal. 2003, 345, 1193 1196; (g) Adam, W.;
Alsters, P. L.; Neumann, R.; Saha Mo¨ller, C. R.; Sloboda
Rozner, D.; Zhang, R. J. Org. Chem. 2003, 68, 1721 1728;
(h) Lane, B. S.; Vogt, M.; DeRose, V. J.; Burgess, K. J. Am.
Chem. Soc. 2002, 124, 11946 11954.
4. Lippard, S. J.; Berg, J. M. Principles of Bioinorganic
Chemistry; University Science Books: Mill Valley, CA,
1994.
5. Metalloporphyrins in Catalytic Oxidations; Sheldon, R. A.,
Ed.; Marcel Dekker Ltd: New York, 1994.
6. (a) Bioinorganic Chemistry: Transition Metals in Biology
and their Coordination Chemistry; Trautheim, A. X., Ed.;
Wiley VCH: Weinheim, 1997; (b) Ponka, P.; Schulman, H.
M.; Woodworth, R. C. Iron Transport and Storage; CRC
Press. Inc: Boca Raton, Florida, 1990.
7. Bolm, C.; Legros, J.; Le Paih, J.; Zani, L. Chem. Rev.
2004, 104, 6217 6254.
8. (a) Kischel, J.; Michalik, D.; Zapf, A.; Beller, M. Chem.
Asian J. 2007, 6, 865 870; (b) Kischel, J.; Mertins, K.;
Michalik, D.; Zapf, A.; Beller, M. Adv. Synth. Catal. 2007,
349, 871 875; (c) Kischel, J.; Jovel, I.; Mertins, K.; Zapf,
A.; Beller, M. Org. Lett. 2006, 8, 19 22; (d) Jovel, I.;
Mertins, K.; Kischel, J.; Zapf, A.; Beller, M. Angew.
Chem., Int. Ed. 2005, 44, 3913 3916.
9. Enthaler, S.; Erre, G.; Tse, M. K.; Junge, K.; Beller, M.
Tetrahedron Lett. 2006, 47, 8095 8099.
10. For our recent work on catalytic epoxidations see: (a)
Tse, M. K.; Bhor, S.; Klawonn, M.; Anilkumar, G.; Jiao,
H.; Do¨bler, C.; Spannenberg, A.; Ma¨gerlein, W.; Hugl, H.;
Beller, M. Chem. Eur. J. 2006, 12, 1855 1874; (b) Tse, M.
K.; Bhor, S.; Klawonn, M.; Anilkumar, G.; Jiao, H.;
Spannenberg, A.; Do¨bler, C.; Ma¨gerlein, W.; Hugl, H.;
Beller, M. Chem. Eur. J. 2006, 12, 1875 1888; (c) Tse, M.
K.; Klawonn, M.; Bhor, S.; Do¨bler, C.; Anilkumar, G.;
Hugl, H.; Ma¨gerlein, W.; Beller, M. Org. Lett. 2005, 7,
987 990; (d) Tse, M. K.; Do¨bler, C.; Bhor, S.; Klawonn,
M.;Ma¨gerlein, W.; Hugl, H.; Beller, M.Angew. Chem., Int.
Ed. 2004, 43, 5255 5260; (e) Bhor, S.; Anilkumar, G.; Tse,
M. K.; Klawonn, M.; Do¨bler, C.; Bitterlich, B.; Grote
vendt, A.; Beller, M. Org. Lett. 2005, 7, 3393 3396; (f)
Anilkumar, G.; Bhor, S.; Tse, M. K.; Klawonn, M.;
Bitterlich, B.; Beller, M. Tetrahedron: Asymmetry 2005, 16,
3536.
11. (a) Bitterlich, B.; Anilkumar, G.; Gelalcha, F. G.; Spilker,
B.; Grotevendt, A.; Jackstell, R.; Tse, M. K.; Beller, M.
Chem. Asian J. 2007, 2, 521 529; (b) Anilkumar, G.;
Bitterlich, B.; Gelalcha, F. G.; Tse, M. K.; Beller, M.
Chem. Commun. 2007, 289 291.
12. For other non heme Fe catalysts for epoxidation see: (a)
Taktak, S.; Ye, W. h.; Herrera, A. M.; Rybak Akimova,
E. V. Inorg. Chem. 2007, 46, 2929 2942; (b) Suh, Y.; Seo,
M. S.; Kim, K. M.; Kim, Y. S.; Jang, H. G.; Tosha, T.;
Kitagawa, T.; Kim, J.; Nam, W. J. Inorg. Biochem. 2006,
100, 627 633; (c) Dubois, G.; Murphy, A.; Stack, T. D. P.
Org. Lett. 2003, 5, 2469 2472; (d) Chen, K.; Costas, M.;
Kim, J.; Tipton, A. K.; Que, L., Jr. J. Am. Chem. Soc.
2002, 124, 3026 3035; (e) Bassan, A.; Blomberg, M. R. A.;
Siegbahn, P. E. M.; Que, L., Jr. J. Am. Chem. Soc. 2002,
124, 11056 11063; (f) White, M. C.; Doyle, A. G.;
Jacobsen, E. N. J. Am. Chem. Soc. 2001, 123, 7194
7195; (g) Francis, M. B.; Jacobsen, E. N. Angew. Chem.,
Int. Ed. 1999, 38, 937 941; (h) Nam, W.; Kim, H. J.; Kim,
S. H.; Ho, R. Y. N.; Valentine, J. S. Inorg. Chem. 1996, 35,
1045 1049; (i) Nam, W.; Ho, R.; Valentine, J. S. J. Am.
Chem. Soc. 1991, 113, 7052 7054; (j) Sugimoto, H.;
Sawyer, D. T. J. Org. Chem. 1985, 50, 1784 1786; (k)
Yamamoto, T.; Kimura, M. J. Chem. Soc., Chem.
Commun. 1977, 948 949.
13. Costas, M.; Mehn, M. P.; Jensen, M. P.; Que, L. Chem.
Rev. 2004, 104, 939 986.
14. For special examples: Yu, Y.; Liang, Y. H.; Brostromer,
E.; Quan, J. M.; Panjikar, S.; Dong, Y. H.; Su, X. D. J.
Bio. Chem. 2006, 281, 36929 36936.
15. (a) Kluge, R.; Hocke, H.; Schulz, M. Tetrahedron:
Asymmetry 1997, 8, 2513 2516; (b) Kluge, R.; Schulz,
M.; Liebsch, S. Tetrahedron 1996, 52, 2957 2976.
16. Nam, W.; Lee, H. J.; Oh, S. Y.; Kim, C.; Jang, H. G. J.
Inorg. Biochem. 2000, 80, 219.
17. (a) Battioni, P.; Renaud, J. P.; Bartoli, J. F.; Reina
Artiles, M.; Fort, M.; Mansuy, D. J. Am. Chem. Soc.
1988, 110, 8462 8470; (b) Renaud, J. P.; Battioni, P.;
Bartoli, J. F.; Mansay, D. J. Chem. Soc., Chem. Commun.
1985, 888 889.
18. Pietika¨inen, P. Tetrahedron Lett. 1994, 35, 941 944.
19. (a) Adolfsson, H.; Converso, A.; Sharpless, K. B. Tetra
hedron Lett. 1999, 40, 3991 3994; (b) Hermann, W. A.;
Kratzer, R. M.; Ding, H.; Thiel, W. R.; Glas, H. J.
Organomet. Chem. 1998, 555, 293 295.
20. (a) Kureshy et al. Tetrahedron: Asymmetry 2001, 12, 433
437; (b) Krishnan, R.; Vancheesan, S. J. Mol. Catal. 1999,
142, 377 382.
21. A few defined complexes of iron and simple imidazole
derivatives are known in coordination chemistry. See: (a)
Cotton, S. A.; Franckevicius, V.; Fawcett, F. Polyhedron
2002, 21, 2055 2061; (b) Cotton, S. A.; Pisani, P. V. H.;
Stubbs, R. Inorg. Nucl. Chem. Lett. 1976, 12, 695; (c) Seel,
F.; Wende, P.; Marcolin, H. E.; Trautwein, A. T.; Maeda,
Y. Z. Anorg. Allg. Chem. 1976, 426, 198 204.
22. Hermann, W. A. Angew. Chem., Int. Ed. 2002, 41, 1290
1309.
23. Aqueous H2O2 (30%) from Merck was used as received.
The peroxide content varied from 33% to 40% as deter
mined by titration.
24. Side products are rearrangement products of the corre
sponding epoxide.
25. Most of the substrates and epoxides for GC FID
calibration are commercially available. The others were
synthesized according to literature methods and deter
mined by NMR and GC MS. In addition, authentic
samples of the commercial products were analyzed by
GC MS and GC FID.
6342 K. Schro¨der et al. / Tetrahedron Letters 48 (2007) 6339 6342
118
Publication 3.9.
Iron Catalyzed Asymmetric Epoxidation of Aromatic Alkenes
Using Hydrogen Peroxide
Feyissa Gadissa Gelalcha, Bianca Bitterlich, Gopinathan Anilkumar, Man Kin Tse,
Matthias Beller
Angew. Chem. 2007, 119, 7431-7435; Angew. Chem. Int. Ed. 2007, 46, 7293-
7296
Contributions:
In this paper, I contributed to a significant amount of the argumentation and the
synthetic work. I was involved in the development of the catalyst system, the
synthesis of ligands, the interpretation of the results and the study design. I
developed the in situ iron catalyst system and synthesized a library of
approximately 20 ligands containing chiral prolinol and diphenylethylene diamine
as key structures. My contribution as co-author of this paper is
approximately 45 %.
Epoxidation
DOI: 10.1002/anie.200701235
Iron-Catalyzed Asymmetric Epoxidation of Aromatic Alkenes Using
Hydrogen Peroxide
Feyissa Gadissa Gelalcha, Bianca Bitterlich, Gopinathan Anilkumar, Man Kin Tse, and
Matthias Beller*
Dedicated to Sd Chemie on the occasion of its 150th anniversary
Optically active oxiranes are key building blocks for the
synthesis of fine chemicals and pharmaceuticals.[1] They are
available from resolution processes[2] and more interestingly
from catalytic asymmetric epoxidations. State of the art pro
tocols are the Sharpless epoxidation of allylic alcohols,[3] the
Katsuki Jacobsen epoxidation of unfunctionalized alkenes
using chiral Mn(salen) catalysts (salen=N,N’ bis(salicylide
ne)ethylenediamine),[4] and organocatalytic methods using
chiral ketones and oxone (2KHSO5·KHSO4·K2SO4).
[5]
Despite the usefulness of the known procedures, the develop
ment of less expensive and environmentally more benign
catalysts and oxidant systems is a major goal for organic
synthesis.
Among the various oxidants, hydrogen peroxide is one of
the most practical reagents (second only to air) in terms of
cost and atom efficiency. In recent years hydrogen peroxide
has become increasingly important not only for bulk epox
idations but also for asymmetric catalyis.[6] In this respect the
work of Katsuki and co workers, who developed convenient
Ti catalysts for asymmetric alkene epoxidation with hydrogen
peroxide, is most notable.[7] In addition, also Pt[8] and Ru
catalysts[9] have been reported for asymmetric epoxidations of
olefins. While these systems give high enantioselectivity, the
catalysts involved are relatively expensive.
Nature relies on various iron containing enzymes for the
oxidative degradation of a number of xenobiotics often with
exceptional selectivities. Iron is not only ubiquitous but also
one of the most versatile transition metals.[10] Hence, it is
surprising that research on epoxidations using iron based
catalysts has largely been neglected. Only recently, a success
ful biomimetic approach was reported with iron porphyrin
complexes for the epoxidation of styrene derivatives applying
iodosobenzene as oxidant.[11] Unfortunately, the synthesis of
the required chiral porphyrin ligands is notoriously diffi
cult,[12] and the oxidant is not environmentally friendly.
Moreover, Cheng et al. reported recently the aerobic epox
idation of styrene derivatives catalyzed by tris(d,d dicampho
lylmethanato) iron(III) complex, [Fe(dcm)3].
[13] Although
encouraging results were achieved, a drawback of this
method is the need to employ an excess of aldehyde as
sacrificial reductant and dichloroethane as the solvent.
To the best of our knowledge there is no Fe based
asymmetric epoxidation catalyst known that gives more than
20% enantiomeric excess when hydrogen peroxide is used as
the oxidant. This currently highest ee value was reported by
Francis and Jacobsen, who used an elaborate combinatorial
screening of 5760 metal ligand combinations to identify three
Fe complexes with peptide like ligands suitable for asym
metric epoxidation of trans b methylstyrene.[14] Using bio
mimetic non porphyrin Fe catalysts, Costas et al. reported the
[Fe(bpmcn)(CF3SO3)2] catalyzed dihydroxylation of of trans
2 heptene with hydrogen peroxide which gave the epoxide as
a by product with 12% ee (bpmcn=N,N’ bis(2 pyridyl
methyl) N,N’ dimethyl 1,2 cyclohexanediamine).[15] Clearly,
it has not yet been possible to replace the established
epoxidation catalysts with iron complexes.
For some time we have been interested in Ru catalyzed
epoxidations with hydrogen peroxide in the presence of
nitrogen ligands such as 2,6 di(4,5 dihydro 1,3 oxazol 2
yl)pyridine (pybox),[16a] 2,2’ (pyridine 2,6 diyl)bis(5,6 dihy
dro 4H 1,3 oxazine) (pyboxazine),[16b] terpyridines,[16c] and
pyridinebisimidazolines (pybims)[16d] together with the col
igand pyridine 2,6 dicarboxylic acid (H2pydic). Our initial
approach to extend these Ru systems to Fe failed in terms of
the stereoselectivity of the epoxidation. Nevertheless, a
general racemic epoxidation of aromatic alkenes with hydro
gen peroxide is possible with a convenient in situ catalyst
consisting of ferric chloride hexahydrate (FeCl3·6H2O),
H2pydic, and organic bases such as pyrrolidine.
[17] Herein,
we report the first genuinely promising iron catalyzed asym
metric epoxidation of aromatic alkenes without porphyrin
ligands and using hydrogen peroxide. This method not only
gives good to excellent yields of isolated epoxides but also ee
values up to 97%.
For our investigations we chose trans stilbene (1a) as the
model substrate because of its nonvolatility and the stability
of the product epoxide for reliable determination of con
version, yield, and selectivity by gas chromatography. In
testing a large number of commercially available optically
pure amines we often obtained high conversions and excellent
chemoselectivities. However, we could not obtain the corre
sponding epoxide 2a with enantioselectivities anywhere close
to 10% ee. Among the ligands that gave small but reprodu
cible enantioselectivities, we identified 2,2 diphenylprolinol
(3d). A closer look at the effect of different chiral pyrrolidine
derivatives 3 revealed a relationship between the type and
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size of substituents adjacent to the chiral center and the ee
values (Table 1). While prolinol (3a) gave the racemic
product (Table 1, entry 1), the diphenyl substituted 3d led
to 10% ee (Table 1, entry 4). Interestingly, maintaining the
phenyl substituents and replacing the hydroxy group by
fluoride led to a much more active catalyst (complete
substrate conversion in less than 1 h at room temperature)
and increased the ee value to 17% (Table 1, entries 5 and 6).
This suggested the importance of H bonding in addition to
steric factors in the enantioselectivity determining step.
Although, H bonding has also been implicated in asymmetric
oxidations catalyzed by 3e using oxone,[18] under our reaction
conditions no epoxide is formed when the ligand is used
without Fe.
Next, we extended our search to chiral amine ligands with
a neighboring group capable of intramolecular H bonding
such as carbonyl and sulfonyl groups. The required ligands are
easily accessible by monoamidation or sulfonylation of
optically pure C2 symmetrical 1,2 diamines such as ( )
(S,S) 1,2 diphenylethylenediamine and N alkylation of the
resulting products where necessary. In Table 2 the influence of
ligands 4a,b and 5a,b on the enantioselectivity of the model
reaction is summarized.
To our delight, application of this basic concept led to the
identification of the commercially available ligand 4b, which
gave trans stilbene oxide ( ) (2S,3S) 2a in 28% ee under the
standard reaction conditions (Table 2, entry 2). Interestingly
this starkly contrasts with the nearly racemic product
obtained when the unsubstituted ( ) (S,S) 1,2 diphenylethyl
enediamine is used as the ligand. Among the modified ligands
5 the N benzyl substituted derivative (S,S) 5b led to the most
significant increase in ee values, giving (+) (2R,3R) 2a in
42% ee (Table 2, entry 5) at room temperature which
improved to 47% ee when the temperature was lowered to
8 8C (Table 2, entry 6). It is also striking that in the oxidation
of trans stilbene, use of the mono(arenesulfonyl) protected
ligands 4a,b and the N benzylated ligands 5a,b resulted in
selectivity for enantiomers of 2a with opposite absolute
configurations (Table 2, entries 1 and 3). In general, manip
ulations of the N benzyl substituent led to decreased reac
tivity in the epoxidation reaction and did not improve results.
To explore the scope of the reaction, we epoxidized
different aromatic olefins in the presence of 5b, which was the
best ligand in the model reaction in terms of costs, selectivity,
and product yields (Table 3). The reaction performed well for
b methylstyrene (1b), a cinnamyl alcohol derivative (1c), and
various trans stilbenes (1d h). While 1b furnished (+)
(2R,3R) 2b with 28% ee, substrate 1c was oxidized to (+)
(2R,3R) 2c with 35% ee (Table 3, entries 1 and 2).
In reactions of trans stilbenes 1d h, the substrates with
substituents in the para position were more reactive than the
analogous ortho ormeta substituted compounds, presumably
on steric grounds (Table 3, entries 3 7). Best enantioselectiv
ities were obtained with sterically demanding 4,4’ dialkyl
substituted stilbenes. Here, the enantioselectivity increases
with steric bulk of the substituents, H<Me< tBu, and
reaches a maximum value for 1e, which gave the correspond
ing oxirane 2e in 82% yield and 81% ee at room temperature
within one hour (Table 3, entry 4). On the other hand, for 3,3’
Table 1: Iron catalyzed asymmetric epoxidation of trans stilbene (1a)
using ligands 3.
Entry Ligand, abs.
config.
R R’ t [h] Conv.[a]
[%]
Yield[a]
[%]
ee(2a) [%],[b]
abs. config.[c]
1 3a, (S) H OH 1 95 73 0
2 3b, (S) H NH2 36 60 58 1, ( ) (2S,3S)
3 3c, (S) Ph H 60 61 45 0
4 3d, (S) Ph OH 36 78 53 10, (+) (2R,3R)
5 3e, (R) Ph F 1 100 90 16, ( ) (2S,3S)
6[d] 3e, (R) Ph F 14 100 98 17, ( ) (2S,3S)
7 3 f, (S) F F 1 100 93 2, (+) (2R,3R)
[a] Determined by gas chromatography using dodecane as the internal
standard. [b] Determined by HPLC on a chiral column. [c] Determined by
comparing the sign of the optical rotation of the major enantiomer on a
chiral detector coupled to a chiral HPLC, with known data.[19] [d] Reaction
at 0 8C.
Table 2: Iron catalyzed asymmetric epoxidation of trans stilbene (1a)
using ligands 4 and 5.[a]
Entry Ligand Conv.[b] [%] Yield[b] [%] ee(2a) [%][c] ,
abs. conf.[d]
1 100 88 26, ( ) (2S,3S)
2 100 86 28, ( ) (2S,3S)
3 100 98 36, (+) (2R,3R)
4 100 92 41, ( ) (2S,3S)
5 100 87 42, (+) (2R,3R)
6[e] (S,S) 5b 100 97 47, (+) (2R,3R)
[a] Conditions: 0.5 mmol 1a, 1 mmol H2O2, 5 mol%, FeCl3·6H2O,
5 mol% H2pydic, 12 mol% 4a,b/5a,b, 2 methylbutane 2 ol, RT, 1 h.
[b] Determined by gas chromatography using dodecane as the internal
standard. [c] Determined by HPLC on a chiral column. [d] Determined by
comparing the sign of the optical rotation of the major enantiomer on a
chiral detector coupled with a chiral HPLC, with known data.[19]
[e] Reaction at 8 to 10 8C, 24 h.
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dialkyl substituted stilbenes the ee values decrease with
increasing size of the substituent. The highest ee value was
achieved with 1 i as the substrate in the presence of 10 mol%
of the iron catalyst (Table 3, entry 8). In this case oxirane 2 i
was obtained with 91% ee and 46% yield. When the the
reaction temperature was lowered slightly to 10 8C, the ee
value increased to 97% with complete substrate conversion
within one hour (Table 3, entry 9).
In summary, we have demon
strated for the first time that high
enantioselectivity can be achieved
in Fe catalyzed epoxidations with
hydrogen peroxide. This long
standing goal in oxidation catalysis
was realized by combining FeCl3
with appropriately chosen chiral
diamine ligands and pyridine 2,6
dicarboxylic acid. Clearly the cata
lyst system has to be improved with
respect to generality. Further work
to extend the substrate scope and
towards a mechanistic understand
ing of this new catalyst are under
way.
Experimental Section
General: Alkenes 1a,b,d, ligands 3, 4b,
(S,S) ( ) 1,2 diphenylethylenediamine,
H2pydic, FeCl3·6H2O, and 2 methylbu
tan 2 ol are commercially available.
Monosufonylated ligand 4a was pre
pared by analogy with known proto
cols.[21] Alkenes 1e h were synthesized
by McMurry[22] coupling of the corre
sponding alkyl substituted benzalde
hydes in high yields and purities. Ana
lytical data are in accord with literature
values. Alkene 1 i was synthesized by the
Heck reaction of 4 tert butylbromoben
zene with 2 vinylnaphthalene by modi
fication of themethod of Chandrasekhar
et al.[23] Alkene 1c was synthesized by
silylation of trans cinamyl alcohol with
triphenylsilylchloride in the presence of
pyridine in 87% yield. All racemic
epoxides 2 required as references for
chiral HPLC data were synthesized by
epoxidation withmeta chloroperbenzoic
acid (mCPBA): Typically 1 2 equiva
lents of a solution of mCPBA were
added dropwise to an ice cooled solu
tion of the alkene in CH2Cl2. After
stirring overnight at room temperature
the solvent was removed and the residue
purified by flash chromatography to
furnish high yields (80 92%) of the
corresponding epoxides.
Synthesis of (S,S) 5b : Amine 4b
(2 g, 5.45 mmol) and freshly distilled
benzaldehyde (582 mL, 5.81 mmol)
were refluxed in 20 mL anhydrous eth
anol for 2 h under Ar. The initially
formed precipitate went into solution at 80 8C bath temperature.
The progress of the reaction was monitored by TLC. After complete
consumption of 4b the reaction vessel was cooled to room temper
ature. An equal volume of ethanol was added and NaBH4 (186.40 mg,
8.72 mmol) was introduced portionwise. The mixture was stirred at
room temperature overnight. After the imine had been consumed
completely (TLC), water was added dropwise until no more gas
evolved. The gelatinous granules were filtered off and washed with
ethanol. The filtrate was dried over MgSO4 and filtered. The solvent
Table 3: Fe catalyzed asymmetric epoxidation of different aromatic alkenes.
Entry Alkene Conv.[a] [%] Yield[b] [%] ee(2) [%],[c] abs. config.
1 100[d] 94[d] 28, (+) (2R,3R)[e]
2 100 67 35, (+) (2R,3R)[f ]
3 100 92 64, (+) (2R,3R)[g]
4 100 82 81, (+) (2R,3R)[g]
5 >95 88 27, (+) (2R,3R)[h]
6 >95 66 10, ( ) (2S,3S)[h]
7 60[i] 57[i] 55, ( ) (2S,3S)[h]
8[j] 100 46 91, (+) (2R,3R)[h]
9[j,k] 1 i 100 40 97, (+) (2R,3R)[h]
[a] Estimated by GC MS and/or TLC which indicated absence of substrate. [b] Yield of isolated pure
product. [c] Determined by HPLC on chiral columns. [d] Determined by GC. [e] Assigned by comparing
the retention times of the two enantiomers on a chiral HPLC with that of an authentic sample of the S,S
enantiomer; [f ] Assigned by desilylation to the corresponding epoxy alcohol by analogy with literature
protocol[20] and comparing the sign of optical rotation of the resulting product with that of an authentic
sample. [g] Determined by comparing the sign of the optical rotation of the major enantiomer on a chiral
detector coupled with a chiral HPLC, with known data; the CD spectra of these products are positive,
opposite to those reported for the S,S enantiomers.[19a] [h] Tentatively assigned by comparing the CD
spectrum with those of 2a,d,e. [i] Determined after 24 h by 1H NMR spectrum of crude product using an
internal standard. [j] 4 equiv H2O2, 10 mol% H2pydic, 10 mol% FeCl3·6H2O, 24 mol% (S,S) 5b.
[k] Reaction at 10 8C.
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was removed by rotary evaporator and the residue purified by flash
chromatography (silicagel 60, n hexane: ethyl acetate 3:1 (v/v), Rf
0.43) to give 5b (2.33 g, 93%). M.p. 139.9 8C; [a]25D
+ 58.0 degcm3g 1dm 1 (c 0.72 gcm 3, CH2Cl2); IR (KBr): n˜
3338, 3305, 3086, 3064, 3028, 2788, 2713, 1599, 1494, 1453, 1348,
1324, 1152; 1H NMR (400.13 MHz, CD2Cl2): d 1.6 (br s, 1H, NH),
2.34 (s, 3H, CH3), 3.42 (d, J 13.16 Hz, 1H, CH2), 3.60 (d, J
13.16 Hz, 1H, CH2). 3.74 (d, 7.80 Hz, 1H, CHPh), 4.27 (dd, J
7.84 Hz, 1H, CHPh), 6.21 (br s, 1H, NH), 6.95 7.00 (m, 4H, Ar),
7.05 7.13 (m, 5H, Ar), 7.15 7.19 (m, 5H, Ar), 7.22 7.32 (m, 3H, Ar),
7.37 7.39 ppm (m, 2H, Ar); 13C NMR (75.47 MHz, CD2Cl2): d
21.56 (CH3), 51.16 (CH2), 63.45 (CHPh), 67.22 (CHPh), 127.36,
127.48, 127.69, 127.92, 127.94, 128.04, 128.34, 128.40, 128.76, 128.77,
129.66, 137.21, 139.16, 139.33, 139.90, 143.49 ppm; elemental analysis
calcd (%) for C28H28N2O2S: C 73.65, H 6.18, N 6.14, S 7. 02; found: C
73.60, H 6.44, N 6.01, S 7.24. MS (CI, positive mode, isobutane) m/z :
457.3 [M+H]+(100), 349(15), 196 (40); HRMS (CI, negative mode,
isobutane) m/z : calcd for C28H27N2O2S: 455.1788 [M H]
+;
found:455.1784.
General protocol for Fe catalyzed asymmetric epoxidation of
alkenes: Pyridine 2,6 dicarboxylic acid (4.24 mg, 0.025 mmol), ferric
chloride hexahydrate (6.76 mg, 0.025 mmol), ligand 3, 4, or 5
(0.06 mmol), and the corresponding alkene 1 (0.5 mmol) were
mixed in 9 mL 2 methylbutane 2 ol and stirred at room temperature
for ca. 30 min.[24] The resulting mixture usually assumes pale yellow
color. When the yields and conversions were determined by GC,
100 mL dodecane was added as the internal standard. After samples
were removed for GC analysis, 1 mmol of aqueous “30%” hydrogen
peroxide[25] dissolved in 1 mL 2 methylbutane 2 ol was added to the
reaction mixture over one hour using a syringe pump. In most cases
complete conversion was achieved after this time (GC or TLC
monitoring). For preparative purposes excess peroxide was destroyed
by adding 1 mL of a saturated aqueous solution of sodium sulfite and
shaking well. After addition of diethyl ether (10 mL) the organic
phase was separated. The aqueous phase was extracted with diethyl
ether (3  10 mL). The combined organic phases were dried over
anhydrous MgSO4. After filtration and solvent removal by rotary
evaporator, the crude product was either directly analyzed by chiral
HPLC or purified by silica gel chromatography on a short column
(hexane/ethylacetate 20:1, 1% Et3N) for full characterization.
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a b s t r a c t
The hydroxylation of b ketoesters was studied using simple iron catalysts and 30 wt % hydrogen peroxide
as the terminal oxidant. The highest activity and yield were achieved in the presence of iron(III) chloride.
Cyclic b ketoesters could be smoothly hydroxylated in 75 90% yield. For linear b ketoester and b keto
amide, the chloro substituted products were obtained.
 2008 Elsevier Ltd. All rights reserved.
a Hydroxy b ketoester is an important scaffold found in a lot of
bioactive molecules.1 The hydroxylation of 1,3 dicarbonyl com
pounds is a straight forward important technique in organic syn
thesis to access these compounds. A variety of reagents including
hydrogen peroxide, m CPBA, molecular oxygen, and (camphor
ylsulfonyl) oxaziridines were applied in the selective oxidation of
b keto carbonyl compounds.1d,2 Recently, it was reported that
CoCl2, CeCl3, and Mn(OAc)2 could be effective catalyst for this
transformation using molecular oxygen as oxidant.3 Noteworthy,
the asymmetric hydroxylation of b ketoesters was also success
fully demonstrated using a titanium TADOL based catalyst and
up to 94% ee was achieved.4 Hydrogen peroxide is known to be
an environmentally benign oxidant with the ease of laboratory
handling. The development of general, simple and efficient catalyst
system using H2O2 is still a challenging goal for the hydroxylation
of b keto carbonyl compounds.
Great progress has been advanced in iron catalysis in the last
decade. Various reactions such as olefin hydroxylation,5 sulfide
oxidation,6 cross coupling reactions,7 heterolytic RO OH bond
cleavage,8 hydroamination,9 allylic alkylation or amination,10 and
alcohol oxidation11 were investigated. Based on our recent experi
ence in iron catalyzed selective oxidation of olefin to epoxide and
alcohol to aldehyde,12 here we report our new findings about iron
catalyzed selective hydroxylation of b ketoesters to the corres
ponding a hydroxy b ketoesters. The selective hydroxylation of
2 ethoxycarbonyl 1 oxo cyclohexane (1) was used as the model
reaction (Scheme 1).
Initial screening of the reaction conditions, that is, different iron
salts, organic solvents, and the amount of catalyst loading revealed
that 1 mol % of iron(III) chloride hexahydrate, 2 equiv of hydrogen
Table 1
Catalyst screening using 1 as model substratea
Entry Iron salts Con.b (%) Yieldc (%) Sel.d (%)
1 FeCl3 79 79 99
2 FeCl36H2O 82 82 99
3 FeCl2 80 80 99
4 FeBr3 13 13 99
5 Fe(OAc)2 7 7 99
6 Fe(NO3)39H2O 7 7 99
7 Fe2(SO4)35H2O 13 13 99
8 FePO44H2O 14 14 99
a 1 mmol (170 mg) 1, 1 mol % iron salt, 2 equiv (0.20 mL) 30 wt % H2O2, and
25 mL tert-amyl alcohol were added into a 50 mL reaction tube, respectively. After
being shaken, the reaction vessel was allowed to react at rt for 1 h without stirring.
1 mmol (170 mg) dodecane was added as an internal standard for quantitative
analysis.14
b Conversion of 1.
c Calibrated GC yield.
d Chemoselectivity toward the desired product with respect to consumed starting
material.
0040-4039/$ - see front matter  2008 Elsevier Ltd. All rights reserved.
doi:10.1016/j.tetlet.2008.07.157
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Scheme 1. Selective hydroxylation of 2-ethoxycarbonyl-1-oxo-cyclohexane.
Tetrahedron Letters 49 (2008) 5976–5979
Contents lists available at ScienceDirect
Tetrahedron Letters
journal homepage: www.elsevier .com/ locate / tet let
peroxide, and 25 mL of tert amyl alcohol were suitable for the
hydroxylation of 1a;13 86% conversion with 70% yield could be
obtained with magnetic stirring in 1 h. The usage of other solvents,
such as THF, dioxane, ethanol, acetonitrile, and N methyl 2 pyrro
lidinone, caused lower selectivity. However, the yield of the reac
tion varied significantly in some cases. With careful investigation
of the possible factors, it was surprisingly found that the selectivity
of the reaction significantly increased from 81% to >99% with sim
ilar conversion without stirring. The addition of more iron chloride
or hydrogen peroxide and with longer reaction time gave no
improvement of the reaction but instead more byproducts. The re
sults under the reaction conditions without stirring are highly
reproducible, but the effect of stirring in this reaction is still not
clear at this moment. Hence, all the following reactions were
carried out without any stirring except specifically mentioned.
The catalytic activity of different iron salts was investigated in
the presence of 1 mol % catalyst and 2 equiv, 30 wt % hydrogen per
oxide (Table 1). The counter anions of iron salts highly affect the
catalytic activity (Table 1, entries 1 8). The corresponding hydr
oxylation product was obtained in high yield when using iron
chlorides as the catalysts, no matter anhydrous or hydrated, Fe(II)
Table 2
Selective oxidation of diketone compounds catalyzed by iron(III) chloridea
Entry Substrate Product t (h) Conv.b (%) Yieldc (%) Sel.d (%)
1
O O
OEt
1a
O O
OEt
OH
1b
1 82 82 99
2
OMe
OO
2a
OMe
OO
OH
2b
0.75 75 75 99
3 OEt
O O
3a
OEt
O O
OH
3b
8 98 90 92
4 OMe
O O
4a
OMe
O O
OH
4b
6 98 84 86
5
O O
OEt
Me
5a
O O
OEt
Me
OH
5b
0.75 89 85e 96
6f
O
OMe
O
6a
O
OMe
O
HO
6b
24 90 81 90
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Figure 1. Yield of 1b against time.
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or Fe(III) (Table 1, entries 1 3). This small difference in all iron
chloride catalysts indicates the reaction may be catalyzed by sim
ilar intermediates as oxidation of iron(II) chloride to iron(III) chlo
ride by hydrogen peroxide readily takes place. Noteworthy, this
reaction is also easy to be scaled up in laboratory scale. 80% yield
and 99% selectivity maintained when 13 mmol (2.21 g) 1a was
employed.15
An interesting phenomenon was also observed during the reac
tion when using iron(III) chloride as catalyst. At the early stage of
reaction, the color of the reaction mixture was yellow due to the
color of FeCl3 6H2O. It turned brown immediately after the addi
tion of b ketoester. This color stays during the reaction even after
H2O2 has been added. When the conversion was above 80%, the
reaction mixture changed back to yellow in color. This color change
was not observed in the reactions with low conversion. Hence, the
formation of a new iron complex from iron chloride and b ketoes
ter is suspected. This phenomenon provides an opportunity to de
velop high throughput screening methods with direct visual aids.
Close monitoring of the reaction showed that the reaction fin
ished fast and smoothly in 1 h (Fig. 1). Although our reaction con
ditions constitute typical Fenton reagent recipe,16 the product is
stable in our reaction system after its formation within 10 h.
The selective oxidation of other b ketocarbonyl compounds was
further studied (Table 2). In most of the cases, the reaction can be
finished overnight. However, shorter reaction time is also feasible.
The time necessary to achieve high conversion is substrate depen
dent, as also demonstrated in other reports.3a,4 While 1a and 2a,
gave higher than 75% conversion in less than 1 h, more than 6 h
should be used in order to get high conversion and yield using
3a and 4a as starting materials (Table 2, entries 1 4). The reactivity
of the preformed intermediate from iron chloride and b ketoesters
(1a or 2a) governs the productivity. More iron chloride (10 mol %)
and longer reaction time (24 h) can be used to produce 6b from
unreactive 6a in good yield (81%) (Table 2, entry 6). With higher
catalyst loading (10 mol %), 7a can be hydroxylated in 80% yield
with 91% conversion (Table 2, entry 7).
It is interesting to note that chlorination occurred when the cat
alyst loading increased. In the presence of 5 mol % iron chloride,
the conversion of 8a was 20% with 50% selectivity to the
a hydroxylated 8b. When the amount of iron chloride increased
to 20 mol %, the conversion could reach to 57%. However, the major
product under such conditions was a chloro b ketoester 8c in 38%
yield (Table 2, entry 8). For the non cyclic b ketoester 9a, a chloro
b ketoester 9c was the main product even with only 10 mol % of
FeCl3 6H2O. Up to 60% of 9c could be obtained when 35 mol % of
catalyst was used (Table 2, entry 9). Therefore, this system has
potential to develop a new oxidative chlorination protocol for the
synthesis of a chloro b ketocarbonyl compounds.
In summary, a simple and highly effective iron catalyst system
was developed for the a oxidation of b ketoesters. 75 90% yield of
the hydroxylation products could be obtained using cyclic b keto
esters as starting material.
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Table 2 (continued)
Entry Substrate Product t (h) Conv.b (%) Yieldc (%) Sel.d (%)
7g
O
O
Me
O
7a
O
O
Me
O
OH
7b
0.2 91 80 88
8h
N
H
OEt
O
O
8a
N
H
OEt
O
O
Cl
8c
4 57 38 67
9i
Me OEt
Ph
O O
9a
Me OEt
Ph
O OCl
9c
15 82 60 73
a The same reaction conditions as given in Table 1.
b Conversion of starting material.
c Calibrated GC yield.
d Chemoselectivity toward the desired product with respect to consumed starting material.
e A mixture of diastereomers in 1:1 (GC–MS) was obtained.
f The substrates and 2 equiv 30 wt % H2O2 were dissolved in 5 mL tert-amyl alcohol, and 10 mol % FeCl36H2O (27 mg/20 mL tert-amyl alcohol) was added in 24 h.
g 10 mol % FeCl36H2O.
h 1 mol % FeCl36H2O, 2 equiv 30 wt % H2O2, and 15 mL tert-amyl alcohol were added initially. 19 mol % FeCl36H2O (51 mg/10 mL tert-amyl alcohol) and 6 equiv 30 wt %
H2O2 were added in 4 h.
i 35 mol % FeCl36H2O/20 mL tert-amyl alcohol and 6 equiv H2O2 were added in 15 h.
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